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Responsive Lanthanide Complexes for Metal Ions Sensing 
Aileen Congreve 
The speciation and distribution of zinc (II) within cells is not well established and 
the range of zinc (II) probes available are of limited use. 
The quest was to develop responsive lanthanide complexes to bind selectively and 
respond (by change in hydration state) to biologically relevant concentrations of 
zinc at physiological pH for possible application in MRI and luminescence. 
A pyridyl sulfonamide ligand with an a-CH2NHS02CF3 substituent was found to 
have the desired properties for strong zinc (II) coordination. The presence of a 
methyl group at 6', inhibited the formation of related square planar copper (II) 
complexes. 
Pyridyl amide appended europium and gadolinium (Ill) complexes, based on 
cyclen were developed with C2 and C3 spacers separating the macrocyclic ring and 
the amide. The mono-aqua C2 complex exhibited fast water exchange, due to the 
steric hindrance of the seven-membered chelate between the amide carbonyl and 
the lanthanide centre. The increase in steric hindrance caused by the eight-ring 
chelate in the c3 analogue rendered it q = 0. 
A trifluoromethanesulfonamide moiety at the 6' position of the pyridine group 
resulted in a mono-aqua complex for the C2 and C3 appended systems. This system 
showed no change in hydration state on addition of Zn2+. The addition of a-N-
carboxyalkyl groups to give a GdaD03A system resulted in the formation of q = 2 
complexes which showed no zinc (II) responsive properties. However, the C2-
linked species exhibited a high binding affinity to HSA which resulted in a 
dramatic increase in the relaxivity. 
Eu and Gd complexes of an octadentate N50 3 pyridyl sulfonamide containing 
ligand were developed as pH and pZn responsive probes. The pyridyl nitrogen 
bound irreversibly to the lanthanide centre, resisting protonation even in the 
presence of zinc and copper ions, for which the pyridyl sulfonamide group has an 
establiblished high affinity. 
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Chapter 1 
Introduction 
1 
1 Introduction 
Metal ions play essential roles, both structural and catalytic, in the regulation of 
many cellular functions, including metabolism, signal transduction, gene 
expression and proliferation.1 Small, selective and sensitive sensor molecules that 
can penetrate through cell membranes without harming the cell are necessary tools 
that can allow the role of metal ions in such mechanisms to be evaluated.2 
1. 1 Biological Importance of Zinc 
Zinc is the second most abundant transition metal within the human body: an 
average 70 kg person contains approximately 2.3 g of zinc. 3 For more than a 
century, zinc has been known to be an essential trace element in eukaryotes4 and in 
19345 zinc was shown to be essential for the normal growth of mammals. However, 
due to the spectroscopically silent nature of zinc (11), it is difficult to monitor. 
Consequently, details of the chemical speciation and compartmentalisation of zinc 
(11) within cells are not currently well established.6 
The total zinc (11) ion concentration in serum is of the order of 10 to 20 micromolar 
and this rises towards the millimolar levels in mammalian cells.3 There are thought 
to be two pools of intracellular zinc. The first contains zinc that is tightly 
complexed to proteins and thus is invisible to cytological stains. The second pool, 
which can be visualised histochemically, contains approximately 10% of the total 
cellular zinc (11)? This zinc is free and ionised and found in vesicles, that are rich in 
glutamate and aspartate? 
A study by Outten and O'Halloran8 has revealed that although the concentration of 
zinc (11) within the cell is in the millimolar range, the availability of free zinc (11) 
within the cytoplasm is very stringently controlled. Their study showed that only a 
femtomolar concentration of zinc (11) may be required for the triggering of zinc-
responsive transcription factors. This hypothesis is inconsistent with the possibility 
of a cytosolic pool of free zinc (11) ions, suggesting that any zinc within cells must 
be very tightly bound, either in vesicles or to proteins. Cells must have a very tight 
control over cytosolic metal ion concentrations. 
2 
Zinc (II) has numerous cellular functions and is important in the various processes 
. d "th 11 . . d th7 910 th . 1 d . associate wi ce activation an grow ' ' : ese me u e gene expression, 
apoptosis, neurotransmission, signal transduction, enzyme regulation and catalysis. 
In gene expression/'3'11 zinc (II) is involved in the transcription and replication of 
genetic material. Zinc fingers are special zinc containing proteins, which recognise 
DNA base sequences and serve in the selective activation and regulatory control of 
genetic transcription. Zinc (II) is also present in transcription factors and core 
proteins of DNA. 
Zinc forms an essential part of more than 300 enzymes?'12 Each of the six classes of 
enzyme13 are known to employ zinc in either a catalytic or structural role. At the 
active site of many hydrolytic enzymes, zinc lowers the pK3 of coordinated oxygen 
ligands: the potential for undesired electron transfer is avoided as zinc (11), being 
d10, has no readily accessible redox state. 
Elevated levels of zinc (11) are localised in areas of the brain, especially the 
hippocampus.11 Here, there is a requirement for high activity of many peptide 
triggers and hormones such that their release and removal must be rapid. It is thus 
concluded that a huge range of hormones have a connection with zinc biological 
action. 
High levels of free ionic zinc are exhibited throughout the mammalian central 
nervous system (CNS).14 Hippocampal synaptic nerve vesicles typically contain a 
200- 300 ]lM concentration of zinc (11).10'15 Stimulated release of this metal ion from 
zincergic neurons in the hippocampus is thought to be important in 
neurotransmission.13 
Zinc deficiency3'16 in humans may cause a variety of symptoms such as loss of 
appetite, reduced sense of taste and an enhanced disposition for inflammations and 
an impairment of the immune system. However, free zinc (11) at physiologically 
reasonable concentrations can cause the precipitation of human A~ amyloid 
protein, the major constituent of plaques in Alzheimer's disease and thus may play 
3 
a role in its pathophysiology.15 Zinc has also been implicated in stroke and in 
aetiology of excitotoxic cell death in seizures, a condition in which vesicular zinc is 
vigorously released.17 
Total intracellular zinc (11) content can be readily measured by standard analytical 
techniques, but the detection and measurement of available zinc (11) within cells is 
more challenging.7 The role of intravesicular zinc remains enigmatic15 and the 
importance of zinc-specific probes is particularly apparent in understanding zinc 
chemistry in the brain.13 As more roles for non-enzymatic zinc become apparent, so 
has the need for cell permeant chemical probes of zinc biology. 
1.2 Zinc Solution Chemistry 
Under physiological conditions zinc occurs in its dicationic state.3 It is diamagnetic 
and colourless due to its closed d shell (d10) configuration.4,18 
This d10 electron configuration has four biologically important consequences:4 
• Zn2+ has no ligand field stabilisation energy (LFSE) when coordinated by 
ligands in any geometry. For ligands with partially filled d shells, this 
electronic energy term can favour certain arrangements of ligands over 
others. 
• In hard-soft acid-base theory, zinc is regarded as a borderline acid, so zinc 
can interact with a variety of ligand types including sulfur, nitrogen, oxygen 
and water. 
• Divalent zinc is not redox active; neither the potential oxidised form Zn3+, 
nor the potential reduced form is accessible under physiological conditions. 
• Zn2+ is relatively labile in kinetic terms. It undergoes ligand exchange 
reactions relatively rapidly. 
Zinc (11) has a highly concentrated charge as it has a small ionic radius; 0.65A in a 
, d' 1l d 0 60 Ao , f d' 19 SIX-coor mate geometry an . m a our-coor mate geometry. A 
combination of this highly localised charge and high electron affinity make zinc a 
4 
very effective attacking group. This is used in enzymes in the activation of small 
molecules, which cannot be handled by organic groups in a multipoint attachment. 
Zinc (11) is a good electron acceptor or Lewis acid. It polarises groups to which it 
binds and either increases the attacking power of a bound base or increases the 
probability of attack on the bound group by acting as an acid.20 
1.3 Complexation Chemistry of Zinc (//) 
In order to design chemical probes for the detection of zinc (11), it is important to 
understand its chemical properties. The probe molecule must be able to selectively 
and reversibly coordinate the metal ion of interest. 
1.3.1 Donor Atoms 
When trying to complex a specific metal, the selection of the correct donor atom can 
lead to an increase in the complex stability. 
Metals can be sorted into two groups according to their preference for various 
ligands; this is the concept of Hard and Soft Acids and Bases.Z0 Metals are Lewis 
acids and ligands are Lewis bases. Hard metals are ones that retain their valence 
electrons very strongly: they are of a small size and high charge and are not readily 
polarised. Soft metals, conversely, are relatively large and easily polarisable. They 
do not retain their valence electrons firmly. Ligands containing highly 
electronegative donor atoms (0, N, F) that are hard to polarise are classified as hard 
bases. These include ammonia, amines, water, phosphate and sulfate. Soft bases 
are large and easily polarisable (e.g. r, CO, R3P). Stable complexes are formed as a 
result of interactions between hard acids and hard bases or soft acids and soft 
bases. Hard-soft interactions are weak. 
Zinc (11) is classified as a borderline acceptor and therefore should tolerate both 
hard and soft bases. 
5 
~ .3.2 CompieJt Stability 
The lrving-Williams series21 shows the binding preference for a given ligand across 
the divalent first row transition metal ions. There is an increase in stability across 
the series reaching a maximum at copper. 
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II) 
This order can be related to the decrease in ionic radii across the series leading to 
stronger metal to ligand bonds. 
1.3.3 Geometrica~ Preferences 
To change the order of ligand binding preference, the ligand must be able to bind 
the desired metal more strongly than its neighbours. Synthesising a ligand that 
only binds in the preferred geometry for the desired metal can lead to greater 
selectivity. The preferred binding geometries for divalent cobalt, nickel, copper 
and zinc are shown in Table 1.1. 
Table 1.1 Preferred binding geometry of some transition metals.22 
Metal Preferred Geometry 
Cobalt (11) Octahedral 
Nickel (11) Octahedral I Square Planar 
Copper (11) Jahn-Teller distorted I Square Planar 
Zinc (11) Tetrahedral 
The partially filled d orbitals of cobalt (11), copper (11) and nickel (11) favour these 
geometries because the LFSE is maximised. As zinc (11) is d10, LFSE does not affect 
the geometry of the complex formed. In the absence of any other preferred 
geometry, a tetrahedral arrangement of ligands is favoured as this minimises 
repulsion between donor groups.18 
1.3.4 Chelation Effects 
The coordination of two or more donor atoms from a single ligand to a central 
metal ion leads to an unusual increase in the stability. This is derived in part from 
the favourable en tropic factor accompanying the release of non-chelating ligands. 5 
6 
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1.3.5 Zinc Specificity. 
Koike and coworkers23 have shown that zinc (11) has a strong affinity for aromatic 
sulfonamides. Zinc (11) forms a strong bond to a deprotonated sulfonamide 
nitrogen at physiological pH. However, copper (11), which is also an essential 
element, typically binds more tightly to nitrogen containing ligands than Zn (11).21 
As copper (11) is a d 9 transition metal, it prefers to occupy a square planar or 
tetragonally distorted octahedral coordination geometry, whereas zinc prefers to 
have a tetrahedral environment. By making a ligand with sulfonamide nitrogen 
donors that have steric restrictions to prevent binding in an octahedral or square 
planar geometry, specificity for zinc may be obtained.24 
1.4 Zinc Sensors 
Chemosensors are typically molecules of abiotic origin that are able to bind 
selectively and reversibly to the molecule of interest.2'25 Chemosensors usually 
consist of three different components: a receptor which selectively binds; an active 
unit whose properties change upon complexation and a spacer that can change the 
geometry of a system and change the electronic interaction between the receptor 
and active unit, Figure 1.1. Chemosensors allow the analyte to be monitored in real 
time and real space. 
Analyte 
+ 
Spo.eer 
Aetive Unit l«ceptor Unit 
Figure 1.1 Schematic representation of a luminscent chemosensor.2 
Fluorescence based chemosensors are currently the most common and present 
many advantages as fluorescence measurements are low cost, easy to perform, 
versatile and very sensitive (single molecule detection is possible)? 
7 
The zinc sensors currently available can be divided into four main groups: fluoro-
phore appended cyclic amines, fluorophore appended acyclic amines, quinolines 
and proteins/ peptides. 
As the majority of zinc (11) sensors are currently fluorescent molecules, they will be 
discussed now with the limited number of lanthanide systems, both luminescent 
and MRI active, being addressed later. 
1.4.1 Fluorophore Appended Azamacrocycles. 
Macrocyclic polyamines with appended fluorophores have been synthesised by 
several groups as potential cellular zinc probes. This group of sensor molecules all 
work on the same principle. A fluorophore is directly linked to a macrocyclic 
polyamine, which strongly complexes with transition metal ions such as zinc (11). 
In the absence of zinc (11), fluorescence is quenched by a photoinduced electron 
transfer (PET). This is an intramolecular quenching mechanism caused by the lone 
pair of electrons of an amine nitrogen. 26'27 However, when zinc (11) is complexed by 
the nitrogen atoms of the macrocycle, the lone pair of electrons on nitrogen become 
coordinated to the metal. This prevents PET occurring, so fluorophore fluorescence 
is not quenched. As a result of this, an increase in the fluorescence emission is 
observed with increasing zinc (11) concentration (Figure 1.2). These probes have the 
disadvantage that the amine nitrogen can become protonated at low pH. This 
protonation can also cause inhibition of PET, resulting in an increase in 
fluorescence. 
hu 
PET quenching of 
fluorophore excited 
state 
NO ~ 
fluorescence ~ 
hu 
PET 
inhibited 
fluorescence~ 
Figure 1.2 Schematic representation of zinc (II) binding inhibiting fluorescence 
by inhibiting PET. 
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Aromatic sulfonamides have a high affinity for zinc (11). The strong bond that 
forms between zinc (II) and deprotonated sulfonamides at physiological pH28 has 
formed the basis of a series of ligands (1- 4) which has been sequentially 
developed by Kimura and eo-workers. 13'28' 29,3° 
1 
~e), 
yv 
y02 
~) 
CHN NJ 
HNuNH 
2 
~e), 
yv 
y02 
HN ~()) 
c~~ 
H 
3 
Tosylamidopropyl[12]aneN3 1 was initially shown to form a stable 1 : 1 tetrahedral 
complex with zinc (II) at physiological pH.28 [12]aneN4 (cyclen), which forms a 
much more stable complex with zinc (II), replaced the [12]aneN3 to bind the zinc 
(11) while a dansylamide with an ethyl link was adopted as a new fluorophore 2.13 
Chelation enhanced fluorescence (CHEF) resulted with the binding of zinc (II), with 
the fluorescence emission increasing linearly with zinc (II) concentration until a 1 : 1 
ligand: zinc (11) ratio was reached (Ka = 7 x 109 M-1, pH 7.0).13 In order to make the 
ligand responsive to zinc (II) at intracellular concentrations, the cyclen was replaced 
with [12]aneN3 3 in a homologous system?9 This resulted in a zinc (II) fluorophore 
that is responsive to zinc (11) in a micromolar concentration. It was also found that 
by functionalising cyclen with three carbamoylmethyl groups along with a 
dansylamide pendant arm 4,30 a system was obtained that bound zinc (11) but did 
not fluoresce in its presence. In this latter case the sulfonamide nitrogen is not 
coordinating. 
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Fluorescein-appended cyclic amines 5 and 6 that use cyclen to bind zinc (11) have 
been developed by Nagana et al. 31 A 1: 1 complex forms slowly(> 100 minutes) in 
the presence of zinc (11). This complexation hinders PET, resulting in a 14-fold 
fluorescence enhancement at micromolar zinc (11) concentrations at physiological 
pH (detection limit: 0.5 J.tM, pH 7.5). However, the slow complexation rate makes 
these ligands unsuitable for use in a biological system. 
Fluorescein is a good fluorophore for use in biological systems as it is excited using 
visible light. Short wavelength ultra violet light, which is often required by simpler 
fluorophores, is potentially damaging to cells. 
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Naphthyl dendrimers attached to a 1,4,8,11-tetraazacyclotetradecane (cyclam) core, 
7 and 8, have been shown by Sauden and co-workers32 to form luminescent 
complexes with zinc (11). In the absence of Zn (11), exciplexes form between the 
cyclam nitrogen and the naphthyl groups. Zinc(ll) complexation engages the 
nitrogen lone pairs, preventing exciplex formation and resulting in intense 
10 
naphthyl fluorescence. The fluorescence has been shown to increase linearly with 
zinc (11) concentration until a 1 Zn (11) : 7 or 1 Zn (II) : 2 8 complex, i.e. [Zn(8)zf+ has 
formed. The complexes that form are very stable (Ka > 107 M-1 for 7 and Ka > 
1013 M-2 for 8). These molecules would be of limited use as biological probes 
because they are not water soluble. 
1.4.2 Fluorophore Appended Acyclic Amines 
Fluorophore appended acyclic amines are being investigated by many groups for 
possible application as sensors for biological zinc (II). In general, these probes work 
on the same principle as the flurophore appended cyclic amines, whereby the 
complexation of free zinc (11) involves binding of the lone pair of electrons on the 
amine nitrogen, preventing PET. This results in an increase in fluorescence 
intensity. In the absence of metal ions (or protons), the fluorescence of the active 
unit is quenched by the occurrence of a PET process between the lone pair on the 
nitrogen and the appended chromophore.2 
Lippard and coworkers10'14' 33'34 have recently developed the Zinpyr family of high 
affinity, selective fluorescent sensors for zinc. (The name Zinpyr comes from both 
the utilisation of pyridine ligands and the ability to "peer" at zinc concentrations 
within the cell.) These probes all have sub-nM dissociation constants. They consist 
of a fluoroscein core, which can be excited at visible wavelengths, coupled to a zinc 
(II) chelator; DPA (bis(2-pyridylmethyl)amine) in the case of 9 (Zinpyr-1) and 10 
(Zinpyr-2) and BPAMP [2-{bis(2-pyridylmethyl)aminomethyl}-N-methylaniline) in 
11 (Zinpyr-4). 
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The chelation of zinc (11) prevents the PET from the benzylic amine lone pair from 
quenching the fluorescein emission in each of these Zinpyr probes. However, the 
fluorescence enhancement on zinc coordination of 9 and 10 is greater at higher pH, 
due to protonation of the tertiary amines at physiological pH (apparent pKa 8.3 (9), 
9.4 (10)). This problem was addressed with the modified zinc binding moiety of 11, 
which has a lower pKa and so is less sensitive to protonation under physiological 
conditions. Although 11 is more sensitive to zinc (11) than the previous zinpyr 
sensors, it has the disadvantage that, unlike the others, it is not membrane 
permeant.35 Zinpyr-1 has been applied to cells and was found to preferentially 
stain the Golgi apparatus and acidic cellular compartments.10 However, this 
staining may be due to the acidic conditions within these compartments 
protonating the benzylic amine, preventing PET, rather than elevated 
concentrations of zinc (II) in these areas. 
F 
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Fluoroscein appended acyclic amines have also been synthesised by Nagana et 
al. 36•37 and Gee and Kennedy.38 12 is tetra-anionic and therefore cell impermeant, 
although it has been used to show zinc (11) secretion from pancreatic cells.38 It is 
sensitive to zinc (II) at nanomolar concentrations (Kd 15 nm) and fluorescence 
emission is not affected by pH over the physiological range (pH 6- 9). 
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TI1e probes synthesised by Nangano and coworkers36'37 use N,N,N',N'-tetra(2-
picolyl)ethylenediamine (TPEN) to coordinate to zinc (II). The initial probes 13 and 
14, although showing an increase in fluorescence intensity in the presence of zinc 
(II), have the disadvantage of having a fluorescence intensity that is dependent on 
pH (pKa 6.2). This was rectified with the development of 15 and 16 wherein the 
electron-withdrawing fluorine substituents on the fluorescein reduced the phenolic 
pKa, resulting in a system with stable fluorescence under physiological conditions. 
This system has the added advantage of being able to distinguish between zinc (11) 
and cadmium (II). The increase in ionic radius of cadmium, compared with zinc, 
results in the cadmium ion being coordinated by the carboxylate rather than the 
benzylic nitrogen. PET can still occur so fluorescence is quenched when Cd (II) is 
bound. These probes are not cell permeant, but their diacetyl derivatives are more 
lipophilic and able to pass though cell membranes. Inside the cell they are cleaved 
by esterase enzymes and so are retained within the cell. 
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The water soluble naphthalimide derivative 17 is a zinc (II) chemosensor developed 
by Gunnlaugsson et al. 39 This molecule shows an increase in fluorescence intensity 
with increasing zinc (II) concentration at pH 7.4, due to the 1 : 1 binding of zinc (II) 
to the carboxylates of the iminodiacetate and the benzylic nitrogen. This results in a 
reduction of the ability of the nitrogen lone pair to quench the naphthalimide 
fluorescence via PET. 
A ratiometric probe was also developed by Nagano et al.,40 which employs an 
internal charge transfer (ICT) mechanism. A fluorophore containing an electron-
donating group (e.g. amino) conjugated to an electron-withdrawing group 
undergoes ICT from the donor to the acceptor upon excitation by light. If the 
electron rich terminal interacts with a cation, a partial positive charge is 
13 
photogenerated adjacent to the cation, and that affects the absorption or excitation 
spectral wavelength of the fluorophore with an ICT excited state. Therefore, a 
cation-induced blue-shift is expected in the absorption or excitation spectra. 
Fluorescence emission spectra are less affected due to cation ejection during the 
lifetime of the excited state. 
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The probes 18 and 19 were generated using benzofuran derivatives as the fluoro-
phore and TPEN derivatives as the chelators of zinc (11). Although the probe is not 
cell permeable, the ethyl ester derivative is. The study40 has shown that the ethyl 
ester passes into cells, where it is transformed into 19 by the action of esterases in 
the cytoplasm. These probes have been shown to selectively bind zinc (11) in a 
nanomolar range (Kct 0.79 mM 18, and Kct 2.8 nM 19). The nature of this probe 
makes it possible to detect zinc (11) ratiometrically, thereby eliminating most, if not 
all of the possible variability due to differences in instrument efficiency and content 
of effective dye. 
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Another system which employs an ICT mechanism resulting in a large red-shift in 
emission, was recently developed by Goodall and Williams.41 Terpyridine 20 is 
highly fluorescent and its emission is affected very distinctively and ratiometrically 
upon coordination to zinc (11) ions. The ligand binds zinc (11) in a 2L: lZn complex 
14 
(Kct 4.3 nM-2). Water insolubility does not allow the use of this system m 
physiological studies. 
1.4.3 Quinoline Based Zinc (11) Molecular Probes 
The most widely used fluorescent probes for biological zinc (11) used at the present 
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These 8-p-toluenesulfonamidoquinoline systems are cell permeable and have been 
utilised for the detection of zinc (11) in neurochemical and histochemical staining 
procedures. 12'15,42 They can detect zinc (11) at 100 pM to 10 nM concentrations. In all 
cell lines tested, these probes show zinc (11) pools localised in vesicle-like regions. 
The ester functionality was introduced to TSQ to form Zinquin in a desire to 
improve cellular retention.48 It was thought that cleavage of the ester by esterases 
in the cytoplasm to produce anionic zinquin acid would prevent the molecule from 
passing out through cell membranes. However, as the derivatives formed were 
membrane bound and uncharged,49 it was concluded that the cleavable ester 
function was not necessary for cellular zinc staining. 
In a study by O'Halloran,49 2-Me-TSQ, 23, and a series of TSQ analogues were 
synthesised and their properties characterised. Crystallographic studies49 showed 
that 2-Me-TSQ, 23, forms a neutral [Zn(2-Me-TSQh] complex with the coordination 
of the two nitrogen atoms from each ligand giving a highly distorted tetrahedral 
centre. The methyl group at the 2-position of the quinoline provides geometric 
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restrictions and along with the sulfonamide oxygens hinders the formation of both 
square planar and octahedral complexes, thus providing a steric selection for 
tetrahedral coordination that is not available in TSQ. 
Addition of zinc results in a greater than 100-fold increase of the fluorescence 
intensity for each of these quinoline sulfonamides. This is independent of pH. The 
fluorescence of the uncoordinated ligand is quenched by the presence of the 
sulfonamide proton and the effects of the hydrogen bonding of the solvent 
molecules to the quinoline nitrogen. Only the coordination of the diamagnetic zinc 
(11) to the quinoline nitrogen can suppress this quenching. 
However, despite the ability of these quinoline probes to image intracellular 
zinc (11),50 mixed complexes can form with partially coordinated zinc (11) in cells, 
generating uncertainty in the measurement of free zinc (11). Usefulness is also 
limited by their poor water solubility and requirement for potentially damaging UV 
radiation. A longer wavelength of light is required to prevent damage to living 
tissues. These quinoline probes have a limited range of dissociation constants (sub-
nanomolar), whereas the effective study of the numerous functions of Zn (11) 
requires many sensors with a wide array of binding affinities. 
1.4.4 Protein and Peptide Sensors 
In general, proteins do not show suitable fluorescence properties to be useful 
luminescent sensors. This problem has been overcome by covalently appending 
auxiliary fluorophores into the peptide sequence. The binding of zinc (II) causes a 
conformational change within the peptide, resulting in a change in the fluorophore 
environment, which in turn causes fluorescence to occur. The zinc binding affinity 
of protein and peptide probes can be optimised for selectivity and affinity, as well 
as water solubility, by variation of the overall amino acid sequence and the 
chelating residues. 
Imperiali and coworkers51'52 have used polypeptide architectures to make 
fluorescent chemosensors which are sensitive to zinc (11) in water at pH 7. 
Polypeptides have been prepared that include amino acid building blocks bearing 
16 
bipyridyl zmc (II) coordination sites, a cyanoanthracene chromophore, and an 
L-3,4-dimethoxy-DOPA donor unit which is able to quench the fluorophore 
fluorescence. This sensor works by undergoing a reversible metal induced 
conformation change. in the presence of micromolar concentrations of zinc. This 
results in PET luminescence quenching. This has the disadvantage that 
fluorescence is quenched in the presence of zinc (II). 
Zinc finger domains have been modified for use as sensitive and selective zinc 
receptors. 52'53 A dansylated p-aminoaniline amino acid derivative replaced a 
residue in the peptide sequence so the metal binding could be monitored. Metal 
binding caused the peptide to fold, resulting in the dansyl fluorophore becoming 
shielded from the solvent, leading to an increase in the fluorescence intensity. A 
linear and reversible response was observed with increasing zinc (II) levels between 
0.1 and 1.0 p.M. 
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Fluorophores 24, 25 and 26 have been incorporated into peptides based on zinc 
finger domains by Walkup and Imperiali.52 Fluorescent peptidyl sensor for zinc (11) 
with high oxidative stability and high selectivity and binding affinity (Kct 7 pM -
65 nM) were obtained. 
In order to be able to incorporate the fluorosensor onto a water-solvated resin to 
build a regenerable device, it was necessary to make the sensor smaller. Walkup 
and Imperiali43'51 incorporated 8-hydroxyquinoline into a peptide seven residues in 
length to form Fmoc-20xn-OH 27 and Fmoc-50xn-OH 28. 
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The sequence of peptides was designed to promote folding and cysteine was 
incorporated to favour zinc (11) selectivity. Under normal handling conditions, 
Fmoc-50xn-OH was found to undergo oxidation. Fmoc-20xn-OH formed 1 : 1 
complexes with Zn (II) leading to a 170 fold increase in fluorescence with a 
sensitivity that was sub micromolar (< 250 nm). This has been further developed to 
. lf 'd . 54 con tarn a su onam1 o mOiety. 
A ratiometric fluorescent probe for Zn (11) was reported by Godwin and Berg.55 It 
has a receptor based on a zinc finger consensus peptide which binds zinc tightly 
(Kct = 5.7 pM, pH 7) and selectively, resulting in a change in flexibility and 
structure. The peptide was modified to covalently link two fluorescent moieties 
with fluorescein 29 as the donor and lissamine 30 as the acceptor. 
0 
S02CI Oy,NyO 
u 
29 30 
In the unfolded conformation, the fluorophores are relatively far apart and do not 
interact much. In the presence of zinc (11) ions, a 1 : 1 complex forms and folding is 
induced. This brings the fluorophores close together and intramolecular energy 
transfer occurs. The fluorescence spectrum that occurs has two maxima 
corresponding to the fluorescein (521 nm) and lissamine (592 nm) emission. The 
relative intensity of the peaks changes with increasing zinc (11) concentration, 
resulting in a ratiometric chemosensor. As the emission occurs in the visible region, 
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it is not covered by other cellular components, so it is a good candidate for in vivo 
studies. 
A green fluorescent biosensor protein which binds zinc (11) (Kct =50 }1-M) enhancing 
fluorescence intensity two-fold has been developed by Barondeau et al. 56 The green 
mutant protein binds zinc to a tridentate chromophore resembling half a porphyrin. 
Unfortunately it also binds Cu (11) (Kct = 24 }1-M) but this quenches fluorescence. 
Copper (11) binds with a different coordination geometry resulting in a change in 
the absorption spectrum: the maximum moves from 379 to 444 nm when bound. 
The major disadvantage of using proteins and peptides as biological sensors is that 
peptides usually do not pass through cell membranes and are subject to 
degradation by peptidases. As a result, they must be introduced into the cell by 
microinjection. Introduction of the sensor molecules to cells by transinfection 
allows it to be targeted to specific tissues, organelles or cellular locations. 
1.4.5 Zinc Sensor Problems 
Many indicators for zinc (II) ions have been described in the recent literature.57 
However, very few of these have proved useful in addressing the problem of 
determining the biological function of zinc (II). This is for three main reasons. 
1. Biological systems contain an abundance of magnesium (II) and calcium (11) 
ions which can potentially interfere with the probe molecules. Most other 
potentially interfering metal ions e.g. Cu (11), Ni (II), Co (II) are open shell 
and paramagnetic so quench fluorescence, and Cd (II) and Hg (11) are 
typically present at very low concentrations in biological systems. 
2. Sensitivity: concentrations of free or weakly bound zinc (II) apparently 
range from the low millimolar within zinc secretory vesicles to femtomolar 
levels with in the cytoplasm of normal healthy resting cells. The probe must 
be able to bind to zinc (11) selectively and reversibly, therefore a selection of 
probes with different association constants would be useful to investigate 
the role of zinc (II) in different environments. 
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3. Quantification: it is difficult to relate fluorescence intensity to analyte 
concentrations. This can be overcome by the development of ratiometric 
indicators, where the ratio of intensities at two different excitation or 
emission wavelengths is related to the analyte concentration. 
There is still much scope for improvement in probes for the detecting biological 
zinc (II) species. Responsive lanthanide systems are a current area of interest. 
1.5 Emissive Lanthanide Complexes 
The world of chemical sensors is currently dominated by small fluorescent organic 
molecules but highly emissive lanthanide complexes are becoming more common 
and offer many advantages, including a more extensive excited state chemistry. In 
general, complexes have all the excited state levels associated with organic 
molecules along with the dd and ff transitions of metals. Analyte binding can cause 
a direct effect on the luminescence i.e. quenching or triggering. Alternatively, an 
alteration in the emission or excitation wavelength maxima may result.26 
1.5.1 Lanthanides 
Lanthanides have very different characteristics to transition metals because the 4f 
orbitals are well shielded from external fields by 5s2 and 5p6 shells. As a result the f 
orbitals interact weakly with ligand orbitals.18 This results in ligand field splittings 
being small (typically 100 cm-1). The forbidden nature of f-f transitions (Laporte or 
parity forbidden) means that absorption coefficients are very low and typically 
< 1 dm3mor1cm-1. The wavelengths of ff transition bands are nearly independent of 
coordination environment resulting in fixed emission wavelengths: the emission 
bands are very sharp and narrow even in solution. Vibrations of the ligands and 
accompanying changes in M-L distances have very little effect on the energy levels 
of the excited states?0 
1.5.2 Lanthanide Luminescence 
Many lanthanide (Ill) ions luminesce in solution including Sm(III), Eu(lll), Gd(III), 
Tb(III) and Dy(III). Absorption of light promotes the lanthanide (Ill) ion to an 
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excited state and luminescence occurs when the ion loses its energy and returns to 
the ground state.58 
Currently most research involves Eu (Ill) and Tb (III) as they have relatively large 
energy gaps and low rates of radiationless decay. Their excited energy levels are 
not too high in energy and so are relatively easy to populate, and they emit strongly 
in the visible region of the spectrum. 26 
1.5.3 Advantages of Lanthanides Complexes 
Lanthanide complexes have many advantages over conventional small fluorescent 
organic molecules as chemical sensors. These include: 26•58•70 
Very large Stokes shifts. The wavelength of emission is much greater than 
the excitation wavelength, typically 250 - 350 nm (compared to 28 nm for 
fluorescein). This allows the elimination of background fluorescence from 
cellular components, such as amino acids, because the lanthanide 
luminescence occurs where fluorescence from biological samples is 
minimal. These large Stokes shifts also mean that concentration dependent 
self-absorption problems do not arise. 
Long lived luminescence. The spin forbidden nature of lanthanide 
transitions leads to long luminescent lifetimes, typically 0.1 - 10 ms in the 
case of europium and terbium (compared to 1 -100 ns for organics). This 
allows the use of time resolved detection systems to discriminate against 
background fluorescence. A pulse excitation light source can be used to 
irradiate a sample and the long lived luminescence is monitored after 
suitable delay 
Emission spectra consist of narrow lines characteristic of the lanthanide 
ions. Luminescence can be monitored by observing specific Ln3+ emission 
lines. These lines shift no more than ± 2 nm with changing conditions. 
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There are various problems to be overcome with lanthanide (III) luminescence, 
including difficulties in populating the excited states. Absorption bands of 
lanthanide (Ill) ions are very weak because the transitions of interest involve the 
same fn configuration and electronic dipole. Transitions between such states are 
parity (Laporte) forbidden, leading to very low extinction coefficients, typically 
0.1 mor1dm3cm-1?0 The excited states can be achieved either by direct or sensitised 
excitation. 
1.5.4.1 Direct Excitation 
Lanthanide (III) ions have low molar absorption coefficients. As a result the excited 
states are not readily populated by direct absorption of light unless a very intense 
source is used?6 One solution is to use laser light to match the energy gap, another 
is sensitised emission. 
1.5.4.2 Use of Sensitising Chromophores 
Sensitised excitation has the advantage that lower intensities of light can be used. 
For energy transfer to occur efficiently, the distance between the chromophore and 
lanthanide ion must be small. This can be achieved by incorporating the 
chromophore into the same ligand as the lanthanide ion. The chromophore absorbs 
light energy and transfers it to the lanthanide excited state. 26' 70 This is illustrated by 
the antenna effect, Figure 1.3. 
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Figure 1.3 The Antenna Effect26 
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For energy transfer to occur efficiently, the energy of the excited state of the 
chromophore should exceed that of the emissive state of the lanthanide, as 
illustrated in the Jablonski Diagram, Figure 1.4. Efficient energy transfer requires 
that resonance of the emission band of the excited species (Sl) should overlap the 
absorption spectrum of the metal. However, if the energy gap is too small 
(<1700 cm-1), back energy transfer can occur, resulting in a decrease in lifetime and 
emission intensity. The donor excited state must be long-lived enough for energy 
transfer to compete effectively with other deactivation pathways. Singlet states are 
usually too short-lived for energy transfer to occur so triplet states dominate as the 
donor. If the energy gap between donor and acceptor is too small, it can lead to 
thermally activated back energy transfer from the metal to the chromophore, which 
competes with emission, leading to reduced lifetimes and quantum yields. 
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Figure 1.4 Jablonski Diagram for Sensitised Emission. 59 
1.5.4.3 Lanthanide Emission 
Once the lanthanide (III) has been excited there are three excited states that may be 
perturbed leading to emission (Figure 1.5). These are the singlet excited state of the 
sensitising chromophore, the intermediate triplet excited state of the chromophore 
and the excited state of the lanthanide itself. 58 
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Figure 1.5 Excited states that may be perturbed prior to lanthanide emission. 58 
1.5.5 Quenching Effects of Water on Lanthanide Luminscence 
Lanthanide (Ill) emissive states can be deactivated, or quenched, by vibrational 
energy transfer to the high energy 0-H stretching vibrations of coordinated or 
closely diffusing water molecules. This process is strongly dependent on the 
distance between the lanthanide and the OH oscillator. Water coordinated directly 
to the lanthanide centre has a much larger quenching effect. This reduces both the 
lifetime and the emission intensity and quantum yields. Lanthanide complexes 
must therefore be made to exclude water molecules. 60 
The stretching vibration energy of 0-D is much less than that of 0-H. This results 
in the lifetimes and luminescence intensity recorded in 0 20 being much greater 
than that in H 20/
1 
except where q = 0. 
1.5.6 Structure and Stability of Lanthanide Complexes 
Lanthanide (Ill) aqua ions are very toxic in vivo. As potential applications are 
concerned with biological samples and low concentrations, it is important that the 
lanthanide ion is chelated within a stable complex which does not dissociate at low 
concentrations in water over an appropriate pH range. 58 
1.5.7 Lanthanide Complexing Agents 
Lanthanide ions are most commonly 8 or 9 coordinate and form stable complexes 
with ligands with donor atoms which satisfy the demands of hard polarising ions.62 
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Lanthanide (Ill) ions favour polydentate ligands with nitrogen and/ or oxygen 
coordination. Suitable ligands include polyaminocarboxylate ligands based on 
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and DTPA 
(diethylenetriaminepentaacetic acid). These satisfy all Ln (III) ligand requirements 
and have been derivatised with a variety of sensitising groups in close proximity of 
the lanthanide ion. They form well defined 1 : 1 complexes with high formation 
constants and are kinetically inert to proton and cation mediated dissociation 
pathways. They are also water soluble and exclude all but one water molecule 
from the metal centre.26' 70 
1.6 Responsive Lanthanide Complexes 
Sensitised emission offers particular scope for controlled modulation of lanthanide 
luminescence. The excited state properties of the antenna chromophore can be 
designed to be perturbed in response to interaction with a specific analyte. This in 
turn can result in changes in the emission intensities and lifetimes. Alternatively, 
water bound to the lanthanide centre can be reversibly displaced leading to an 
increase in the intensity and lifetime of the emission?6'58 
1.6.1 PET Dependent Luminescence 
The first excited singlet state of aromatic fluorophores may be quenched by PET 
from oxidisable groups such as amines (Figure 1.2). Inhibition of this process by 
amine protonation or metal ion binding may lead to large increases in fluorescence 
intensity. If a fluorophore is being used to sensitise a lanthanide then the effect can 
be mirrored by a corresponding change in Ln (Ill) emission intensity.26 
1.6.2 Water Displacement from Lanthanide Centre 
Excited Ln (Ill) ions are subject to quenching by vibrational energy transfer (e.g. by 
H 20). If a species can reversibly bind directly to the Ln3+ centre, either 
intermolecularly or intramolecularly, displacing these water molecules, then the 
emission intensity and lifetime can increase markedly. Also, the spectral form will 
h all . . . ai . 636465 c ange, owmg ratiometr1c an ys1s. ' ' 
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Responsive lanthanide probes containing europium (Ill) or terbium (Ill) are useful 
in luminescence imaging. If the luminescent lanthanide ion is replaced with 
gadolinium (Ill), it is possible to generate a probe useful in magnetic resonance 
imaging. 
1. 7 Magnetic Resonance lmaging 
Magnetic resonance imaging (MRI) is a powerful medical diagnostic 
technique. 66'67'68'69 It is effectively a sophisticated NMR experiment which visualises 
water molecules within the human body. It allows a highly detailed, three 
dimensional image of the body to be generated in a non-invasive manner. 
MRI can be used to build up an image because the water protons within the body 
are in different chemical environments and concentrations. The image obtained can 
be made to have better resolution by use of a contrast agent. Contrast agents are 
currently used in over 30% of MRI investigations,68 with this percentage predicted 
to increase further with the development of more effective and target specific 
contrast agents. 
The intensity of the MRI signal obtained is dependent upon the longitudinal (T1) 
and the transverse (T2) water proton relaxation times. Increasing the relaxation 
rates of these water protons usually results in an increase in the intensity of the 
signals obtained. 
Contrast agents use a paramagnetic centre to increase the relaxation rate of water 
protons. When water is located close to a highly paramagnetic species such as Gd3+ 
or Mn2+, a substantial increase in the rate of relaxation of the water proton is 
observed. This is caused by a dipolar interaction between the electronic magnetic 
moment of the paramagnetic ion and the smaller magnetic moments of the 
proximate water molecules?0 Gadolinium (Ill) is one of the best paramagnetic ions 
for MRI as it has seven unpaired £-electrons, a large magnetic moment (5=7 /2) and 
a relatively slow electronic relaxation rate. 
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The efficacy of a contrast agent is described by its relaxivity (r1). Relaxivity is the 
enhancement of the total paramagnetic relaxation rate of the free water protons 
(R1p) per unit concentration of the paramagnetic species (units are mM-1s-1), 
equation (1.1) 
(1.1) 
The overall relaxivity of water protons Robs is described by equation (1.2), where R1d 
is the diamagnetic contribution to the rate of water relaxation, i.e. in the absence of 
any paramagnetic solute, and R1P is the paramagnetic contribution to the measured 
relaxation rate. 
Robs= R + R ld lp (1.2) 
The magnetic field generated around the paramagnetic centre decreases rapidly 
with increasing distance from the metal centre, so interactions that bring water 
protons into the proximity of the paramagnetic centre are important in the transfer 
of the paramagnetic effect to the bulk water. For Gd (Ill) complexes this interaction 
includes contributions from the water molecules bound in the first coordination 
sphere of the metal ion (inner sphere) R
1
1
:, in the second coordination sphere 
(second sphere) R1~ and also from those which diffuse in proximity to the 
paramagnetic complex (outer-sphere) Re;:, (Figure 1.6). 
··.k=l/tm 
~® 
Figure 1.6 Schematic representation of the three idealised hydration layers 
3+ 
around a Gd complex and the most relevant parameters of paramagnetic 
relaxation.71 
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The paramagnetic contribution is made up from these three terms, equation (1.3). 
R = RIS + Ros + Rss 
"lp lp lp "lp 
1.7.1 ~nner Sphere Relaxation 
(1.3) 
The inner-sphere contribution, Ri;, originates from dipolar interactions between 
the paramagnetic ion and the proton nuclei of directly bound water molecules. The 
paramagnetic effect is then transferred to the bulk through chemical exchange of 
the coordinated water with the bulk. 
Cq . 1 
55.6 T1M +rM 
(1.4) 
The inner sphere contribution is largest and provides the area of greatest control for 
change in relaxivity, equation (1.4), where C = molar concentration of the 
paramagnetic compound, q = number of bound water molecules, T1M = 
longitudinal relaxation time of the bound water protons and Tm = mean residence 
lifetime in the coordination site. Changing these parameters can lead to more 
efficient contrast agents.68 
The parameters determining T 1w the longitudinal relaxation time are expressed in 
Solomon, Bloembergen and Morgan theory,72'73' 74 through equations (1.5) and (1.6) 
(1.5) 
1 1 1 1 
-=-+-+- (1.6) 
'c rR 's rM 
YH is the gyromagnetic ratio of proton nuclei; g is the electronic Lande factor; p is 
the Bohr magneton; S is the electronic spin quantum number; r, the distance of the 
inner sphere water proton from the paramagnetic metal ion; -r0 the effective 
rotational correlation time; TR, the molecular reorientational correlation time; -r5, the 
electronic relation time and w5 and wH are the Larmor frequencies for the electron 
and proton respectively. 
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When proton exchange is very slow, TM;?: T1M, the rate of water exchange will be the 
determining factor for relaxivity. However, if the exchange rate is fast enough that 
T1M;?: Tw then the observed relaxivity will be determined by the relaxation rate of 
the coordinated protons, which in turn is dependent on the rate of proton exchange, 
rotation rate and electronic relaxation. In each of these limiting cases, the number 
of bound water molecules (q) and the Gd-H distance (r) are variables whose 
influence can be easily seen. Influences of parameters such as rotational correlation 
time and electronic relaxation are less predictable due to their dependence on 
magnetic field. 
1.7.2 Second Sphere and Outer Sphere Relaxation 
A significant proportion of the relaxation rate is a consequence of second and outer 
sphere relaxation. Water molecules that are not bound directly in the first 
coordination sphere may remain in the proximity of the paramagnetic ion for a 
relatively long time due to hydrogen bond bridges with the ligand. These water 
molecules give rise to the second sphere contribution and can play a significant role 
in the overall paramagnetic contribution to the water proton relaxation rate. Due to 
the difficulty in separating outer and second sphere effects, the second sphere 
contribution is rarely considered individually and is reported as part of the overall 
outer sphere contribution. 
The outer sphere relaxivity stems from modulation of dipolar proton interactions 
brought about by loosely diffusing water molecules from the bulk solvent and the 
paramagnetic centre. It is governed by a set of equations developed by Freed75 and 
depends on the electronic relaxation time of the metal ion, the distance of closest 
approach of the solvent and solute (a) and the sum of solvent and solute diffusion 
coefficients (D). cos is a constant (5.8 x 10-13 s-2M-1) and the dependence on the 
electronic relaxation times is expressed in the non-Lorentzian spectral density 
functions J(cuj, equation (1.7). 
(1.7) 
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1.8 Contrast Agents for MRI 
Gadolinium (III) is rather toxic (LD50 - 0.1 mmol kg-1 in rats)/9 so must be 
administered in a form that is highly stable in vivo especially as the administered 
dose is high (typically 0.1 mmol kg-1). Clinically approved contrasts agents are 
thermodynamically and kinetically stable, highly water soluble complexes of 
gadolinium (III) and based on polyaminocarboxylate systems, Figure 1.7. 
31 32 33 34 
Figure 1.7 Gadolinium complexes which are currently in clinical use for MRI. 
Gd(DOT Ar (DOTAREM) 31, and Gd(DTPA)2- (MAGNEVIST) 33, were the first 
complexes put into clinical use, Gd(DTPA-BMA) (OMNISCAN) 34 and 
GdHPD03A (PROHANCE) 32 were introduced later; as they are neutral complexes 
they have a reduced osmotic potential and are used for applications that require a 
higher dose of contrast agent. These are all examples of perfusion agents which 
distribute non-specifically through plasma and interstitial spaces and are excreted 
rapidly. 
Research is ongoing to develop the next generation of contrast agents which require 
a reduced administered dose. This can be achieved through 'smart' and high 
relaxivity contrast agents. 
1.8.1 'Smart' Contrast Agents 
'Smart' or responsive contrast agents have a relaxivity which is modulated by a 
h · th h · 1 · 1 · h H 63 76 77 78 79 8o 81 l . c ange m e p ys10 og1ca envrronment sue as p , ' ' ' ' ' ' meta 10n 
. 82,8384 . 1 f 858687 . . 888990 concentration, ' partia pressure o oxygen ' ' or enzyme activity. ' ' 
Changes in the environment result in a change in one or more of the parameters 
outlined in equation (1.5). 
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1.8.2 High Relaxivity Contrast Agents 
The relaxivity of a contrast agent can be enhanced maximally by optimising each of 
the inner, second and outer sphere contributions. 
Inner sphere relaxation is directly proportional to the number of bound water 
molecules ( q), therefore increasing the number of bound water molecules will 
increase the relaxivity. However, the gadolinium (Ill) ion is toxic and must be 
chelated in a thermodynamically and kinetically stable complex. Most attempts to 
make contrast agents where q = 2 have failed. This is usually because the inner 
sphere water molecules are displaced by anions64'91 or protein carboxylate side 
chains present within serum.72 
Another problem found with heptadentate ligands was that the derived complex 
was not sufficiently stable with respect to cation-mediated or acid dissociation to be 
safe for in vivo use. Furthermore TM, the water exchange lifetime tended to be too 
long, limiting the overall relaxivity.92 
One example of a q = 2 complex, 35, Gda003A, was recently synthesised by 
Messeri et al. 93 The anionic side chains inhibit the interaction with proteins and 
anions. A high relaxivity (12.3 mM-1s-1, (20 MHz, 298 K)), is reported in the 
presence of serum. 
0 0 
35 
GdaD03A 
The longitudinal relaxation time of bound water molecules T lM is dominated by the 
molecular reorientation (rotational correlation) time, TR, at 20 - 60 MHz (0.5 - 1.5 T), 
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the magnetic field strength used in MRI scanners. The more slowly the Gd (III) 
complex tumbles, the longer the reorientational correlation time, TR, the higher the 
relaxivity. Various approaches have been used to lengthen TR. Attaching the Gd 
(III) complex to a slowly tumbling macromolecule such as a polysaccharide,94 
protein95 or dendrimer96 has been used to reduce the tumbling rate of the Gd (III) 
complex. Complexes with hydrophobic groups form host-guest complexes with 
human serum albumin (HSA): this large protein tumbles slowly in solution with 
the small Gd (Ill) chelate compartmentalised within, also tumbling slowly. 
Significant increases in values of TR have been seen for 36, MS-325,97 TR 10.1 ns, 
r1 42.0 mM-
1s-1 when fully bound to HSA, compared to TR 115 ps, r1 6.6 mM-
1s-1 
when free at 20 MHz, 310 K. 
1.9 Responsive Lanthanide Metal(//) Signalling Systems 
Reany et al. 98'99 synthesised pentadentate europium (III) and terbium (III) complexes 
37 and 38 to signal changes in zinc (II) concentration. 
38 
These complexes show both a change in the form of the ligand emission and 
absorption spectra and also an increase in the intensity of delayed lanthanide 
emission with zinc (II) binding. The coordination of zinc to the pentadentate 
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sensitising group inhibits PET from the benzylic nitrogen to the aryl group. This is 
mirrored in enhancement of the lanthanide emission intensities. Zinc (II) sensitivity 
and selectivity is observed with 38, but its short excitation wavelength renders it 
unsuitable for cellular analyses. Ideally the system would exhibit a change in the 
emission spectrum of lifetime of the lanthanide reporter group. This would have to 
involve either a change in the rate of quenching of the lanthanide excited state or a 
change in the lanthanide coordination environment. 
Nagana and coworkers have made a MRI contrast agent84 and a luminescent 
lanthanide probe100 39 which responds to changes in zinc (11) concentration. 
The probe is a Ln(III) DTPA complex with an TPEN moiety to coordinate with zinc 
(11).84 This gadolinium complex shows a reduction in relaxivity upon coordination 
with zinc (11), the maximum decrease in relaxivity corresponds to the presence of 
one equivalent of zinc (II) {r1P 6.06 mM-1s-t, 25°C, 300 MHz, pH 8). The presence of 
more than one equivalent results in an increase in the relaxivity until it returns to 
its original value (r1P 3.98 mM-1s-t, 25°C, 300 MHz, pH 8) in the presence of two 
zinc equivalents. This complex does not complex to zinc (11) in a desirable range for 
biological systems and even if it did, then it would be difficult to apply it in a 1 : 1 
ratio to observe the maximum decrease in relaxivity. This relaxivity change can be 
ascribed to the binding of Zn (11) causing a change in the second sphere hydration 
state62 rather than the change in conformation and gadolinium hydration state, as 
suggested by Nagano.84 
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The europium and terbium (Ill) analogues of this complex100 show an linear 
increase in emission intensity with increasing zinc (II) concentrations up to a 1 : 1 
molar ratio of the lanthanide complex to Zn (II) (apparent Kct 2.6 nM), the intensity 
remained at a plateau upon the addition of more zinc (II) ions. This has been 
ascribed to a conformational change resulting in better energy transfer between the 
pyridyl moieties and the lanthanide centre. However, this is not in agreement with 
the decrease, followed by increase in relaxivity observed in the gadolinium 
analogue. 
Meade et al. 82'83 have developed a calcium responsive lanthanide complex. 
DOPTA-Gd, 40. This displays a relaxivity increase of 77% from 3.26 mM_\_1 to 
5.76 mM-1s-1 (25°C, 500 MHz) following addition of micromolar concentrations of 
calcium (II), Kct 0.96 11M. The change in relaxivity was seen to be most striking 
between the levels of 0.1 and 10 11M.83 As cellular calcium (11) is present in 
micromolar concentrations,1 this sensor will only be responsive when internalised 
inside a cell. A much higher Kct value is required. 
0 0 0 0 
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DOPTA-Gd 
The terbium analogue shows82 that an increase in calcium concentration leads to an 
increase in the hydration state of the lanthanide centre. In the absence of calcium, 
one water molecule may be present at a distance of about 3.3- 3.4 A. This could 
indicate the presence of one water proton hydrogen bonded to a carboxylate of the 
macrocycle. Alternatively, two second sphere water molecules could be 
coordinated at a distance of about 3.8 A from the metal ion, or a larger number of 
water molecules at larger distance.83 
After Ca2+ is bound to DOPTA-Gd 40, the molecule undergoes a substantial 
conformational change that opens up the hydrophilic face of tetraazacyclododecane 
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macrocycle. This change dramatically increases the accessibility of chelated Gd (Ill) 
ion to bulk solvent.82 
pH responsive lanthanide complexes 41, 42 and 43 (Figure 1.8) have been 
synthesised by Lowe et al. 63'77 
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Figure 1.8 pH Responsive lanthanide probe.63 
These sulfonamide appended D03A complexes63 exhibit a reversible change in 
hydration state over a defined pH range. The pH range was varied by using 
different substituents at the para position of the benzyl sulfonamide. At low pH, 
the sulfonamide is protonated and water binds to the lanthanide centre resulting in 
a luminescence inactive species. Increasing pH causes the deprotonation of the 
sulfonamide nitrogen which then binds to the lanthanide centre preventing water 
from binding. This results in a decrease in observed relaxivity and an increase in 
luminescence. The converse effect was seen with the gadolinium analogue; at low 
pH, water can bind to the gadolinium centre so a high relaxivity is observed. An 
increase in pH causes deprotonation of the sulfonamide, and the anionic nitrogen 
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binds to the gadolinium preventing water from binding, q = 0. This results in a 
significant decrease in observed relaxivity. 
1.10 Scope of Work 
Following the work of Lowe,63'77 the aim of this study was to synthesise and 
characterise ligands that selectively complex to zinc (11) at physiological pH, for 
possible application in luminescence sensors and as contrast agents in MRI. 
The initial task was to develop a simple pyridyl sulfonamide ligand which would 
selectively complex zinc (II) in a biological concentration and pH range. This 
ligand could then be appended to a macrocyclic lanthanide system which would 
exhibit a change in hydration state, and thereby lead to a switching on and off of 
luminescence and relaxivity, with changing zinc (II) concentration. 
In order to make this system work for clinical MRI applications, it would be 
necessary to have an appropriate association constant, such that the Zn[LnL] 
complex would form even though the complex (after introduction to the body by 
injection) would be present at very low concentrations. 
As zinc (11) is of a higher concentration in the hippocampus of the brain and central 
nervous system, a long-term aim would be to seek a zinc specific contrast agent that 
may be of use in brain imaging, providing it can cross the blood brain barrier. 
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Sim.ple Pyridyl-sulfonan1ide 
Ligands 
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2 Simple Pyridyl=sulfonamide ligands 
2. 1 Introduction 
Initial work was directed towards the synthesis and characterisation of some simple 
pyridyl-sulfonamide ligands L\ L2, L3, and L4, to examine their binding to zinc (11) 
and to compare the structure and solution behaviour of the zinc complexes formed 
with those of neighbouring transition metals, namely Co (11), Ni (11) and Cu (II). 
A model ligand system was sought from this series, capable of forming a well-
defined neutral complex with zinc (11) under ambient pH conditions, when the zinc 
(II) concentration is within the range 100 - 0.1 nm. The most appropriate ligand 
was then to be incorporated into a related system suitable for MRI and luminescent 
applications. 
2.1.1 Electronic Control 
The electron donating ability of the sulfonyl nitrogen atom was varied by altering 
the sulfonamide substituent from tolyl to trifluoromethyl. A neutral secondary 
sulfonamide is a weak acid that may be deprotonated in basic media to generate an 
anionic conjugate base. The protonation constant characterising this equilibrium 
(pKa) is primarily determined by the nature of the sulfur substitutuent. For 
example, arylsulfonamides typically have pKa values around 12/01 while 
CF3S02NH2 has a pKa of 7.
102 Thus the donor ability of the sulfonamide N may be 
controlled by variation of the sulfur substituent. 
2.1.2 Steric Control 
An a-methyl substitutent was introduced to sterically inhibit the formation of 
square planar ML2 complexes. The simple ligand L
1 
may act as a mono-anionic 
bidentate donor through chelation of each nitrogen. In ML2 complexes, limiting 
square planar or tetrahedral geometries may be adopted at the metal centre whose 
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relative stability can be varied by introduction of a substituent at the 6-position of 
the pyridyl ring e.g. e. The more bulky this substituent, the more a tetrahedral 
geometry is expected to be favoured. Such an analysis is well established in 
coordination chemistry. For example, whilst 2,2-bipyridine forms well-defined 
square planar complexes with Cu(II), introduction of an a-methyl substituent in 
each ring destabilises this coordination mode and favours formation of a 
tetrahedral complex - as revealed in the stabilisation of the Cu(I) complex with the 
ligand neocuproin.103 An a-methyl substituent was introduced into the fluorescent 
zinc probe 'TSQ'49 to inhibit the formation of square planar and octahedral 
complexes and thus disfavour the binding of the ligand to Cu (11). 
2.2 Synthesis 
2.2.1 Ligand synthesis 
The sulfonarnide ligands e and e were prepared by the reaction of 2-(arnino-
methyl)pyridine with toluenesulfonyl chloride or trifluoromethanesulfonyl 
chloride, in dry pyridine (Scheme 2.1). 
~ 0 ~ 11 pyridine + CI-S-R 11 0 0 11 R = tolyl, CF3 L1: R = tolyl N-S-R NH2 L2: R = CF3 H 11 0 
Scheme 2.1 Synthesis of ligands L 1 and L 2 
The related 6-Me derivatives e and L 4 were prepared from 6-methyl-2-
pyridinecarboxaldehyde. Reaction with hydroxylamine hydrochloride following 
the method of Fuentes and Paudler/04 yielded the imine 44. Hydrogenation of the 
imine using a palladium on carbon catalyst gave the amine 45. Initially, an attempt 
was made to synthesise the amine 45 using a zinc/ acetic acid reduction.105 This 
route was abandoned as it gave rise to a mixture of the desired amine 45 and an 
hydroxylamine. Ligands L3 and L 4 were then prepared by sulfonylation of the 
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amine 45 with toluenesulfonyl chloride and trifluoromethanesulfonyl chloride in 
53% and 30% yields respectively (Scheme 2.2). 
~H 
0 
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hydrochloride 
K,co,JH,o H2, Pd/C 
losyl chloride 
pyridine 
-10C 
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-40C 
no ~N~ 11 
N-S-CF 
H 11 3 Ll 0 
Scheme 2.2 Synthesis of ligands L3 and L 4 
2.2.2 Metal Complex Synthesis 
l 1 R = p-MePh, R' = H 
l 2 R = CF3, R' = H 
L3 R = CF3, R' = Me 
l 4 R = p-MePh, R' =Me 
M =Co2+, Ni2+, Cu2+ or Zn2+ 
The ML2 complexes were formed by mixing two molar equivalents of ligand with 
one of the metal acetate salt in boiling methanol. In the case of [Ni(eh] and 
[Co(e)J, it was found to be necessary to form the potassium salt of the ligand prior 
to complex formation. On cooling, crystals of the neutral complex were deposited, 
usually over the course of several days. It was then possible to recrystallise each of 
the complexes from hot methanol or ethanol. 
Attempts were made to prepare the corresponding iron (11) and manganese (11) 
complexes of e using this procedure but this was not successful; only manganese 
(IV) oxide and iron (III) hydroxide were obtained. 
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2.3 X-ray Analysis 
Single crystal X-ray diffraction experiments were carried out by Dr Horst 
Puschmann, using SMART CCD area detectors and graphite-monochromated 
MoK0 radiation. The structures were solved by direct methods and refined against 
F2 of all data, using SHELXTL programs.106 
Each of the sixteen neutral complexes had its structure determined by X-ray 
crystallography at 100 -120 K. Table 2.1 shows views of each of the crystal 
structures and Table 2.2 details the unit cell and crystallographic information. 
41 
ligand 
0('N R-o-VN -g ~ /; 
l1 
crN-M+F F 11 0 F 
l2 
Y 
OF N-M+ 11 F 
0 F 
LJ 
~N R-o-
"f" -g u 
l4 
Co 
Table 2.1 
Ni Cu Zn 
View of the crystal structures of the Co(II), Ni (II), Cu (11) and Zn(II) complexes of L 1 - l 4 
Complex a/A b/A c/A aJO wo y/0 • 3 System S.Gr z w -1 T/K Rin/Ofo Rw/% R/% Volume/A mm 
L1 26.831(4) 5.958(1) 16.576(2) 90 99.967(3) 90 2610.1(6) Monoclinic C2/c 8 0.249 110 3.05 9.20 3.84 
Zn(L1)2 30.505(2) 8.010(1) 27.309(1) 90 123.815(3) 90 5543.8(9) Monoclinic C2/c 8 1.081 100 8.30 10.94 4.83 
Zn(L2)2 8.296(1) 9.721(1) 13.035(1) 93.193(4) 95.817(4) 107.145(4) 995.27(17) . Triclinic P"1 2 1.529 100 2.06 6.64 2.72 
Zn(L3)2 7.973(1) 9.432(1) 14.746(1) 81.984(1) 81.130(1) 81.744(10) 1076.38(5) Triclinic P"1 2 1.419 105 2.56 8.35 2.99 
Zn(L4)2 28.129(1) 12.033(1) 16.726(1) 90 91.701(1) 90 5658.54(17) Monoclinic 12/a 8 1.057 120 2.48 6.65 2.69 
Cu(L1)2 7.293(1) 17.089(1) 9.912(7) 90 99.176(4) 90 1219.56(15) Monoclinic P21/c 2 1.11 100 4.14 8.99 3.31 
Cu(L2)2§§ 9.04(5) 10.29(5) 20.70(5) 90 91.71(5) 90 1923(10) Monoclinic Pc 4 1.442 100 5.60 36.05 14.10 
Cu(L3)2 10.450(1) 14.023(1) 15.197(1) 90 106.221(1) 90 2138.19(10) Monoclinic P2Ifc 4 1.301 105 5.26 8.17 3.45 
Cu(L4)2 26.673(1) 14.539(1) 14.980(1) 90 102.051(1) 90 5680.9(3) Monoclinic C2/c 8 0.96 110 15.03 18.56 7.32 
Ni(L1)2 7.335(1) 17.058(1) 9.822(1) 90 99.139(1) 90 1213.25(8) Monoclinic P2J!c 2 1.015 120 5.46 20.24 6.99 
Ni(L2)2 10.458(1) 16.052(2) 29.546(4) 90 90 90 4960.1(11) Orthorhombic Pbca 8 1.038 100 4.21 15.38 5.89 
Ni(L3)2 7.936(1) 9.450(1) 14.716(1) 80.519(0) 80.609(1) 81.548(1) 1065.77(6) Triclinic P"1 2 1.191 100 2.42 9.33 3.36 
Ni(l4)2 32.016(1) 11.932(4) 16.782(8) 90 118.86(2) 90 5615(4) Monoclinic C2/c 8 0.881 120 4.23 11.8 4.35 
Co(L1)2 29.967(6) 7.977(1) 26.183(5) 90 121.349(5) 90 5345.2(17) Monoclinic C2/c 8 0.838 100 5.23 9.00 3.73 
Co(L2)2 8.270(1) 9.801(1) 13.050(1) 93.015(1) 95.599(1) 108.418(1) 994.84(6) Triclinic P"1 2 1.158 110 3.19 9.47 3.69 
§Remaining solvent electron density was refined to 0.13 molecules of water. 
§§These crystals were badly twinned, despite appearing perfectly well formed. Satisfactory anisotropic refinement was not possible. 
Table 2.2 Unit Cell and Crystallographic Data for Zn, Cu, Ni and Co Complexes of 11 -14 
Octahedral: 6-coordinate [Ni(12b.2EtOH] Distorted Tetrahedral [Co(eh] 
Square planar [Cu(eb], also [Ni(eh] Distorted Tetrahedral [Cu(12h] 
Table 2.3 Highlighting the three different structures of the complexes. Each complex, with the exceptions of [Cu(eh] (square planar), [Ni(eh] 
(square planar) and [Ni(eh.2EtOH] (octahedral), adopted a distorted tetrahedral conformation. 
2.3.1 Coordination Geometry 
Each of the complexes was found to form 2 ligand : 1 metal systems with the 
ligands coordinating in a bidentate manner. With three exceptions, they were four-
coordinate and adopted a distorted tetrahedral geometry (Table 2.3). 
The coordination geometry at the zinc and cobalt centres was invariably distorted 
tetrahedral. This arrangement minimises the steric congestion around the metal 
and offers a slightly favourable ligand field stabilisation effect in the case of cobalt. 
A similar distorted tetrahedral arrangement was found in the case of copper with 
ligands e, e and L4 . However, the less sterically demanding ligand e allowed the 
formation of a square planar complex. Nickel was found to form the same 
distorted tetrahedral arrangement with the a-methyl substituted ligands, e and L 4. 
[Ni(L 1)z] adopted a square planar arrangement, while [Ni(L 2)z] adopted an 
octahedral arrangement with two ethanol molecules cis-coordinated and the 
sulfonamide nitrogens trans-related. 
During the course of this study, a related square planar complex was reported by 
Gutierrez et al. 107'108 
2.3.2 Bond Angle Analysis 
Two extreme geometries exist for four-coordinate complexes; square planar and 
tetrahedral. In an ideal tetrahedral complex, the angles between adjacent donor 
atoms and the central atom are 109°. Square planar complexes have 90° angles 
between adjacent coordinated atoms. Only [Ni(e)z] and [Cu(e)z] can be described 
as square planar and with the exception of the octahedral complex, [Ni(L 2)~, each 
of the other complexes adopted a distorted tetrahedral geometry (Table 2.4). 
The degree of distortion of these complexes is primarily related to the 5-ring chelate 
bite angle, which averaged 82°. This is imposed by the bidentate ligand structure. 
The intra-ligand N-M-N' bond angles in the series average 83° and 82° for the set of 
zinc and cobalt complexes respectively. This relatively constant bite angle is also 
maintained (83 ± 3 °) in the square planar and octahedral nickel complexes. 
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Table 2.4 Bond angles, in degrees between the central metal ion and the 
coordinating nitrogen atoms. 
Complex N11-M-N12 Nu-M-N2t N11-M-N22 N12-M-N2t N12-M-N22 N21-M-N22 
[Zn(L1);] 82.96(11) 122.40(10) 121.54(11) 117.73(11) 134.92(11) 82.59(10) 
[Zn(L2h] 83.12(6) 124.98(6) 124.75(6) 114.93(7) 131.99(7) 82.44(6) 
[Zn(ehl 82.81(6) 113.20(6) 125.79(7) 123.81(7) 131.73(7) 83.32(6) 
[Zn(L4h] 82.8(2) 113.3(2) 129.8(3) 117.47(8) 134.01(8) 82.01(7) 
[Cu(L1)J 83.23(6) 180.00(8) 96.77(6) 96.77(6) 180.00(7) 83.23(6) 
[Cu(L2)i 82.3 147.3 105.6 105.6 154.7 81.0 
[Cu(L3)J 84.07(8) 150.57(9) 112.72(8) 103.40(8) 131.34(9) 83.92(8) 
4 [Cu(L )Ja 83.0(2) 140.66(19) 109.3(2) 107.2(2) 145.0(2) 84.2(2) 
[Cu(L4)Jb 82.2(2) 128.82(19) 115.0(2) 110.6(2) 145.4(2) 82.7(2) 
[Ni(L1)J 94.4(2) 180.00(17) 85.6(2) 85.6(2) 180.0(3) 94.4(2) 
[Ni(L2)J 79.48(12) 91.01(12) 94.27(13) 97.31(13) 173.27(13) 80.18(13) 
[Ni(L3)J 82.13(7) 108.20(7) 124.26(8) 124.25(7) 137.32(8) 82.23(7) 
[Ni(L 4) 2) 81.82(8) 110.69(8) 116.45(8) 133.00(8) 134.63(8) 81.64(7) 
[Co(L1h] 81.85(9) 122.08(9) 119.28(10) 119.19(10) 137.24(10) 82.59(9) 
[Co(L2)J 82.25(8) 125.16(8) 122.17(8) 116.01(9) 135.44(8) 81.83(8) 
[Co(L3)J 82.88(8) 115.13(8) 124.51(8) 127.66(9) 129.35(9) 82.12(8) 
[Co(L4)J 81.97(8) 114.45(8) 119.17(8) 128.57(8) 134.20(8) 81.94(7) 
§Twinned Crystal. Structure of poor quality. SU's are estimated at ± 5 in the last 
digit. 
2.3.3 CSD Bond Angle Analysis. 
There are two limiting geometries for four-coordinate complexes; square planar 
and tetrahedral. To quantify the deviation from these extremes in the complexes 
being examined here, a search of the CSD109 was undertaken, examining all of the 
four-coordinate first row transition metal complexes with nitrogen or oxygen 
donors. In the April 2001 version, 284 of these were zinc complexes. The bond 
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angles around the central metal ion, which determine the overall geometry of the 
complex, were obtained from the database. The sum of these angles is 656° in a 
tetrahedral complex and 720° in a square planar system. However, the sum itself is 
not a sufficient measure of geometry; in the case of a perfect tetrahedron all the 
angles must be identical, whilst for a perfect square planar arrangement, two of the 
angles must be 180° and the others must be 90°. A measure of distortion is obtained 
from the average deviation of all six angles; in the case of a perfect tetrahedron, this 
should be oo and for a square planar complex, it should be 40°, [(2x60)+(4x30)]/6. 
A plot of the average angular deviation (y axis) versus the sum of the six angles is 
given for all the CN = 4 first row transition metal complexes where the donor atoms 
are nitrogen or oxygen only (Figure 2.1). In this plot, the square planar complexes, 
[Cu(L1)] and [Ni(e)], appear in the top right hand corner. [Cu(e)~ has an angular 
deviation of ~25° whereas the rest of the structures examined (with the exception of 
octahedral nickel which has been excluded as CN = 6) form a cluster around 18-
20°. The degree of distortion examined here can be primarily related to the 5-ring 
chelate with constant bite angle of approx. 82°. This method may be extended to 
related polyhedron such as octahedron and trigonal bipyramids. 
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Figure 2.1 Plot of the sum of the six bond angles versus the average deviation of 
these angles for all four-coordinate first row transition metal complexes 
involving N and 0 donors (CSD 2001). The squares represent the complexes of 
Lt-L4. 
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An alternative method of 1-D analysis exists for the unique case of tetrahedral 
distortion. Analysis involves the examination of the dihedral angle between the 
two ML2 planes with limits of 0 and 90° for ideal square planar and tetrahedral 
geometry respectively. The advantage of this system is that it gives the absolute 
configuration for chiral systems. Such an analysis has been carried out on the four-
coordinate systems described here. For each of the tetrahedrally distorted cobalt 
(11), nickel (11) and zinc (11) systems examined, the deviation from the tetrahedral 
limit was not more than 10°. Distortion was more evident with the copper systems. 
For [Cu(L 2)z:J the dihedral angle was 45° whereas for [Cu(L3)z1 and [Cu(L 4)z1, the 
angles were 29° and 33° respectively. The 2-D plot in Figure 2.1 provides additional 
information. For example, tetragonal distortion of a square planar complex gives 
an angle sum of 720° and an angular distortion of > 40°; no cases were found of this 
for first row transition metals with N or 0 donors. 
2.3.4 Bond Length Analysis 
Table 2.5 Bond Lengths, in A, from the metal ion to the coordinating pyridyl 
(N1 ) and sulfonamide (N2) nitrogens and average distances. 
Complex M-N11 M-Ntz M-N21 M-N22 avM-N1 avM-N2 AvM-N 
[Zn(L\] 2.049(3) 1.942(3) 2.049(3) 1.956(3) 2.049 1.949 1.999 
[Zn(L2)z) 2.023(2) 1.972(2) 2.043(2) 1.967(2) 2.033 1.969 2.001 
[Zn(e)zl 2.048(2) 1.965(2) 2.057(2) 1.966(2) 2.052 1.965 2.009 
[Zn(L4)zl 2.050(7) 1.954(2) 2.089(2) 1.929(2) 2.069 1.941 2.004 
[Cu(L1)zl 1.996(1) 1.998(1) 1.996(1) 1.998(2) 1.996 1.998 1.997 
[Cu(e)zl 1.949 1.939 1.998 1.916 1.974 1.928 1.951 
[Cu(L3)zl 1.979(2) 1.973(2) 1.962(2) 1.969(2) 1.971 1.971 1.971 
4 [Cu(L )zla 2.067(5) 1.920(5) 2.019(5) 1.944(5) 2.043 1.932 1.988 
[Cu(L4)zlb 2.067(5) 1.914(5) 2.058(5) 1.918(5) 2.063 1.916 1.989 
[Ni(L1)zl 1.924(5) 1.960(5) 1.924(5) 1.960(5) 1.924 1.960 1.942 
[Ni(L 2)zl 2.090(3) 2.123(3) 2.060(3) 2.099(3) 2.075 2.111 2.093 
[Ni(L3)zl 2.021(2) 1.941(2) 2.028(2) 1.946(2) 2.025 1.944 1.9845 
[Ni(L 4)zl 2.040(2) 1.905(2) 2.014(2) 1.929(2) 2.027 1.917 1.972 
[Co(L1)zl 2.031(2) 1.960(2) 2.037(2) 1.937(2) 2.034 1.949 1.9915 
[Co(L2)zl 2.028(2) 1.962(2) 2.031(2) 1.968(2) 2.030 1.965 1.9975 
[Co(L3)zl 2.040(2) 1.972(2) 2.035(2) 1.965(2) 2.038 1.969 2.0035 
[Co(L4)zl 2.061(2) 1.934(2) 2.052(2) 1.960(2) 2.056 1.947 2.001 
a) In CN=4, mean ionic radii for Zn, Cu, Ni and Co(II) ions are 0.60, 0.57, 0.55 and 0.58A.19 
b) [Cu(L 4)zl This complex has two independent molecules per unit cell. 
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Within the series of zinc and cobalt complexes, average bond lengths (Table 2.5) 
from the metal centre to the sulfonamide nitrogen were marginally longer with the 
more electron-poor trifluoromethyl substituted ligands L 2 and L3. Also, the 
6-methyl substituted ligands form complexes with slightly longer M-NPY bond 
lengths. Bond lengths to pyridyl and sulfonamide nitrogens were in line with 
l.t tu 1 f f d f' d' t . 1 110111112113 F 1 era re va ues or our an 1ve-coor ma e zmc comp exes. ' ' ' or 
example, in tl1e 2,2-bipyridyl zinc complex of cyclohexane-1,2-diylbis(methane-
sulfonamide) the sulfonamide N-Zn bond length was 1.94 A with a bpy-N-Zn 
0 110 length of 2.05A. With the copper (11) complexes, average bond lengths were 
slightly longer for the square planar example. 
The X-ray structure of [Cu(L1)~ has recently been reported at 273 K:107' 108 structural 
details echo those reported herein. 
Overall, there is a remarkable constancy in the M-N bond lengths. This can again 
be related to the fixed chelate bite angle associated with each ligand, and the 
similarity of the ionic radii of four-coordinate Co2+, Ni2+, Cu2+ and Zn2+ ions. 
2.4 Mercury Complexes 
Mercury (II) complexes of e and e were synthesised in an analogous manner, and 
the crystal structures of complexes [Hg(L 1)~ and [Hg(L 2)~ were obtained (Figure 
2.2). The crystallographic information is summarised in Table 2.6. 
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figwre 2.2 Structure of mercury (H) complexes of ligands l 1 and l 2• 
C13 
Table 2.6 Unit Cell and Crystallographic Data for Complexes [Hg(l1h] and [Hg(l2)~. 
Complex a; A b/A c/A a)O wo y/0 0 3 Volume/A System S.Gr z w'mm-1 T/K Rintf/o Rw/% R/% 
Hg(l1)2 9.227(1) 9.227(1) 31.966(1) 90 90 90 2721.2(1) Tetragonal P-4 4 5.848 120 3.80 3.25 1.43 
Hg(l2h 10.908(1) 10.008(1) 18.044(1) 90 96.522(1) 90 1957.0(1) Monoclinic P2(1)/n 4 8.165 120 2.88 4.25 1.77 
2.4.1 Bond Lengtlhs and Angies of [Hg(L 1)2] and [Hg(L 2)2] 
The mercury (11) complexes of L1 and e crystallised with a distorted tetrahedral 
geometry. The angles and bond lengths between the central mercury (11) ion and 
the coordinating nitrogens are summarised in Table 2.7 and Table 2.8. 
Table 2.7 Bond angles (0 ) between the mercury ion and the coordinating 
nitrogens. 
Complex N11-M-N12 N11-M-N21 N11-M-N22 N12-M-N21 N12-M-N22 N21-M-N22 
[Hg(L\J 73.78(7) 101.48(9) 114.57(7) 114.57(7) 167.62(11) 73.78(7) 
[Hg(L2h,] 74.12(7) 122.92(7) 129.20(8)) 110.31(8) 150.89(8) 73.82(7) 
Table 2.8 Bond lengths (A) between the mercury ion and coordinating 
nitrogens. 
Complex M-N11 M-N12 M-N21 M-N22 avM-N1 avM-N2 
[Hg(Llh,] 2.460(1) 2.073(1) 2.460(1) 2.073(1) 2.460 2.073 
[Hg(L2h,] 2.350(2) 2.165(2) 2.376(2) 2.135(2) 2.363 2.150 
In the complexes of the first row transition metals, the angle between the central 
metal ion and the coordinating nitrogens of the same ligand (e.g. N11-M-Nn), were 
constrained by the bite angle of the five-membered chelate ring to approximately 
82°. In both of the mercury complexes, this bite angle is drastically reduced to 74°. 
Although four-coordinate mercury has a greater ionic radius (1.10 A)/9 the metal to 
nitrogen bond lengths do not increase proportionally. In the first row transition 
metal complexes, the average metal to pyridyl (M-N1) bond length was 2.0 A and 
the average metal to sulfonamide nitrogen (M-N2) bond length was 1.95 A. In the 
mercury complexes, it can be seen that M-N2 bond increases by approximately 8% 
in length whereas the M-N1 bond increases by approximately 18% in length. This 
indicates that the sulfonamide nitrogen anion is a much stronger donor to the 
mercury ion than the pyridyl nitrogen. This difference in the donor ability and thus 
the bond lengths from the two coordinating nitrogens results in a distortion of the 
bite angle of the chelate ring. 
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2.5 Absorption Spectra. 
Absorption spectra were recorded for each of the soluble coloured complexes in 
acetonitrile solution at 1 mM concentration. Absorption maxima and extinction 
coefficients are summarised in Table 2.9. 
Table 2.9 Absorption Spectral Data (MeCN, 295 K) for cobalt, copper and 
nickel (11) complexes (A1nax; r/M-1cm-1 in parenthesis) 
Co(ll) Ni (11) Cu (11) 
Lt 513 (300), 579 (290) Insoluble 639 (70) 
L2 500 (45) 367 (50), 597 (3) 672 (230) 
L3 533(400), 564 (380) 544 (190), 733 (50) 410 (405), 764 (70) 
L4 532 (580), 564 (540) 544 (70), 760 (30) 448 (2020), 784 (215) 
2.5.1 Absorption Spectra of Cobalt (11) Complexes 
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Figure 2.3 Absorption spectra of neutral cobalt (11) complexes of L1 - L 4• (1 mM 
2 
complex), (2 mM for L ), MeCN) 
For the series of Co (11) complexes (Figure 2.3), the absorption spectra were similar, 
with the exception of [Co(L2)z_) which was much more pale coloured in solution. 
Molar absorption coefficients, £, increased in the sequence [Co(L2hl << [Co(ehl < 
[Co(L3)z) < [Co(L 4)z]. It is generally appreciated that the visible transitions in 
tetrahedral cobalt (11) complexes are an order of magnitude more intense than for 
equivalent octahedral systems.114 Absorption spectra tend to be dominated by the 
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4A2 -7 
4T1(P) transition for tetrahedral systems and the 4T1g(F) -7 4T1g(P) transition 
for octahedral examples. Fine structure is imposed by a number of transitions to 
doublet excited states, which gain intensity by spin orbit coupling. Thus for 
[Co(L 2}z:J, the complex must be octahedral in solution, binding two additional 
solvent molecules, as revealed in the X-ray analysis of [Ni(eh(EtOH)~. The 
reflectance spectra for each cobalt complex, obtained from crystalline samples, were 
more or less identical in form and intensity, in support of this idea. 
2.5.2 Absorption Spectra of Copper (11) Complexes 
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Figure 2.4 Absorption spectra of neutral copper (11) complexes of L1 - L4, the inset 
highlights the position of the 2E2g 7 ~ 2g transition. 
Complexes of copper (11) with N4 donors typically give rise to two main transitions, 
associated with a d-d transition in the range 500 - 700 nm and with an LMCT band 
to shorter wavelength. 
The tetrahedrally distorted copper complexes, [Cu(e)~ and [Cu(L4)~, were lime-
green and orange-brown in solution, reflecting the intensity of the relatively intense 
LMCT bands at 410 and 448 nm respectively (Figure 2.4). The position of the d-d 
transition was shifted in the sequence [Cu(L1)~ > [Cu(L2)~ > [Cu(L3)~ > [Cu(L 4)~ 
associated with the increase in LFSE for square planar complexes, with the more 
polarisable NTs ligand in e affording the greatest crystal field splitting. 
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2.5.3 Absorption Spectra of Nickel (11) Complexes 
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Figure 2.5 Absorption spectra of neutral nickel (11) complexes of L 2 - L 4• 
The complexes [Ni(L3)z) and [Ni(L 4)z] have a much more intense absorption than 
[Ni(e)z). The crystallographic information shows that [Ni(e)z] and [Ni(L 4)z] 
adopt a distorted tetrahedral configuration, whereas [Ni(L 2):z] adopts an octahedral 
arrangement. Whilst a relatively intense absorption typically arises from the 3T1(F) 
-7 ~1(P) transition in tetrahedral d8 complexes, the transition from 3 A2g -7 ~lg in 
octahedral d8 complexes results in a much weaker absorption.18 Such features are 
evident in the spectra obtained here (Figure 2.5). It was not possible to measure the 
absorption spectrum for complex [Ni(L1)~ as it was insoluble in acetonitrile. 
2. 6 Cyclic Voltammetry 
Cyclic voltammetry is a controlled potential sweep technique, which applies a 
triangular waveform of potential to the working electrode (WE) of an 
electrochemical cell. A cyclic voltammogram is produced: this is a plot of the 
current through the electrode as the potential is increased linearly (Figure 2.6).115 
54 
e 
Epruusm E:u' 
--. Potential E 
Figure 2.6 Cyclic voltammogram for a reversible redox system in unstirred 
solution for a single triangular potential excursion: for fast electron transfer, the 
115 peaks are separated by 57 m V at 298 K 
The applied waveform is controlled by a potentiostat. It sweeps at a constant scan 
rate, from a negative start potential up to a positive limit, and then returns to the 
initial potential. The driving of the electrode to more positive potentials, with 
respect to the reference electrode, causes an oxidation current to flow from the 
solution to the electrode. Similarly, driving the electrode to negative potentials 
causes a reducing current to flow from the electrode to the solution. At a critical 
point, the analyte will oxidise or reduce and cause the peak current (ip) to flow 
resulting in a peak in the voltammogram. These critical potentials are referred to as 
standard potentials and are unique to the analyte.115 
A background electrolyte of tetrabutylammonium perchlorate, TBAP, was used in 
these experiments. This reduces the resistance of the cell and carries most of the 
current between the electrodes. This allows the effects of migration on the 
electroactive species of interest to be ignored. 
2.6.1 Cyclic Voltammetry Studies of Copper Complexes 
The Cun/Cu1 redox couple was examined by cyclic voltammetry (MeCN, 0.1M 
Bu4NC104, 295K) for each of the four complexes Figure 2.7 and Table 2.10. 
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Figure 2.7 Cyclic voltammogram of copper (11) complexes of L1 - L4 (295 K, 0.1 M 
Bu4NC1041 100 scans per minute) 
Table 2.10 Cyclic voltammetry data for copper (11) complexes of ligands e - L 4• 
Scan rate Peak Peak Peak Peak 
Complex (scans per current voltage current voltage !J.V !J.V /2 
minute) oxidation oxidation reduction reduction (m V) (m V) (~A) (m V) (~A) (m V) 
50 -13.24 -532 11.27 -322 210 105 
1 Cu(L h 100 -8.50 -514 9.30 -346 168 84 
150 -17.26 -532 8.546 -346 186 93 
200 -20.90 -546 15.24 -300 246 123 
50 -10.12 -196 12.482 -72 124 62 
Cu(L2) 2 100 -15.68 -202 10.549 -72 130 65 
150 -20.13 -206 16.27 -68 138 69 
200 -24.13 -224 23.43 -60 164 82 
50 - 9.82 -0.0007 9.379 120 120 60 
3 Cu(L h 100 -14.86 -8.001 13.466 118 126 63 
150 -19 -12.0 17.37 128 140 70 
200 -22.5 -18.0 18.7 128 141.7 70.8 
50 -13.75 -338 
Cu(L ~2 100 -15.95 -352 7.308 68 420 210 
150 -20.57 -354 9.227 116 470 235 
200 -23.77 -354 9.767 120 474 237 
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The E~1, values (Table 2.11) for [Cu(e)z] reflect the larger stabilisation energy of the 
Cu(II) state as provided in a square planar configuration in the tosylamide complex. 
The complexes with the a-methyl substituents, [Cu(L 2)z] and [Cu(e)~, are much 
more readily reduced. This is consistent with the destabilisation of the Cu(II) state 
in a distorted tetrahedral conformation.115'116 In each of the cases of e, e and ea 
quasi-reversible behaviour was exhibited (ip ziai ia ex: V'). The tetrahedrally distorted 
complex [Cu(L 4)~ exhibited more complex redox behaviour with an apparent redox 
couple at ea. -240m V. 
Table 2.11 Ev2 values (vs AW'AgCl) for copper complexes of ligands e- L 4• 
Complex Ev, vs Aw' AgCl (m V) 
1 Cu(L h -430 
2 Cu(L h -137 
3 Cu(L h +55 
Cu(L4) 2 -240 
2. 7 pH Dependent Cyclic Voltammetry 
For the Cu(II)/e system, it was possible to vary the pH over the range 4 - 10 in 
order to control the relative proportion of [Cue] and [Cu(e)~ species. Thus, for a 
ligand concentration of 10 mM at pH 5, the predominant species is [CuL1], whereas 
at pH > 7, [Cu(L 2)~ is the major species. With this in mind, cyclic voltammetry was 
used to examine the Cu(II)/Cu(I) redox couple as a function of pH. These 
measurements were undertaken by Mark Knell in Durham. 
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Figure 2.8 Left: Species distribution plot for Cu2+/L 1 (10 mM L 1, 5 mM Cu2+, 298K, 
80% MeOH, 20% H20, 0.1 M NMe4N03). Right: cyclic voltammograms recorded 
under the same conditions at pH 4.9, 5.65 and 8.81 (u = 100 m Vs-\ 
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Figure 2.8 shows that at pH 4.9 (10 mM L1; 5 mM Cu(CF3S03h; 298 K; 0.1 M 
NMe4N03, 80% MeOH/ H20), the reversible wave observed at ea -10 m V may be 
ascribed to [Cue], whereas at pH 8.8, the redox couple shifts to -315 m V and is 
associated with the square planar complex [Cu(eh]. 
At the intermediate pH of 5.65, both species are present in nearly equal amounts, 
and the observation of separate redox waves for each species is consistent with the 
rate of electron transfer being faster than any associative ligand exchange process 
involving [Cue] and [Cu(eh]. Given that different redox active ML species may 
be observed simultaneously, for example using different pulse voltammetry, and 
that their relative concentrations is pH dependent, such work suggests that by 
immobilizing ligands related to L1 at an electrode surface, the selection detection 
and assay of a mixture of metal ions may be expedited using sensitive stripping 
voltammetric techniques. 
2.8 Ligand and Complex Speciation in Solution 
2.8.1 Ligand Protonation Constants 
Equilibrium constants associated with stepwise protonation of the anionic ligands 
L \ e and e were measured by Mark Knell in Durham using standard pH-metric 
methods in 80% MeOH/H20 in a background of 0.1 M NMe4N03• Data were 
corrected117 to allow for the variation of water dissociation constant at this solvent 
composition and analysed using the programme HYPERQUAD.118'119'120 
Table 2.12 Ligand Protonation Constants. 
Ligand pKa1 pKa2 p2 
Ll 3.31(3) 12.23(6) 15.54 
L2 2.69(3) 7.51(3) 10.20 
L3 3.23(3) 7.61(3) 10.84 
L4 2.92 12.55 10.88 
The successive ligand protonation constants are summarised (Table 2.12) and are 
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The log K1 values measured for L
2 
and L3 were 7.51 and 7.61 respectively, similar to 
the literature values for simple trifluoromethylsulfonamides.121 The p-toluene-
sulfonyl analogue, L\ possesses a much more basic sulfonamide N, log K1 = 12.23, 
in line with published data for related arylsulfonamides.122 
The pyridyl nitrogen is much less basic in each case, with a pKa in the range 2.7 to 
3.3. The introduction of the 6-methyl substituent slightly enhances proton affinity. 
Thus, around ambient pH conditions, the ligands e and L3 exist as almost 50% of 
the monoanionic species. 
2.9 Metal complex formation constants 
Metal complex formation constants were measured by Mark Knell for Cu(II) and 
Zn(II) complexes of ligands L \ L 2 and e, taking into account metal ion 
hydrolysis.118'119'120 Separate titrations at 1: 1 and 1 : 2 metal: ligand ratios were 
undertaken in order to measure both the ML and ML2 formation constant. 
Table 2.13 Selected Metal Complex Formation Constants (298 K, I = 0.1 M 
NMe4N03, 80% MeOH - 20% H20) 
logKznL IogKznL2 IogKcuL IogKcuL2 logKcaL IogKcoL2 
Lt 7.66(6) 6.91(7) 11.40(5) 9.16(7) 
L2 5.25(5) 5.12(7) 6.74(5) 6.42(8) 5.11(6) 5.19(5) 
L3 precipitate formed precipitate formed 6.26(4) 6.09(8) 
From the data summarised in Table 2.13 it can be seen that ligand L2 formed 
slightly more stable complexes with copper than zinc in accord with the lrving-
Williams series,21 although a direct comparison of the tetrahedrally distorted Cu-L3 
/ ZnL3 systems is not possible here, owing to the insolubility of the zinc complex 
under the standard conditions used. The difference in the stability of the copper 
and zinc complexes is much greater with L\ as the copper complex in that case is 
square planar and the zinc complex is tetrahedral. 
The relative magnitude for the stepwise formation constants (log KML vs log KML2) 
for zinc, copper and cobalt was very similar, although there was no evidence for 
positive cooperativity in the formation of the ML2 species. 
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The harder trifluoromethanesulfonamide N favours binding to Cu (II) less than the 
more basic and softer tosylsulfonamide N in L1. Systems favouring tetrahedral 
coordination should also enhance the relative stability of zinc (11) compared to 
copper (II), as the LFSE contribution is significantly diminished for Cu (11) when 
deviations from planarity or square pyramidal geometry occur. 
2.9. ~ Complex Spec nation Plots 
Species distribution diagrams as a function of pH and M/L concentrations were 
obtained from the data in Table 2.12 and Table 2.13 in which the percentage of the 
insoluble metal hydroxide is calculated by extrapolation. Considering the Zn2+ /L1 
and L2 systems, the pH-dependent distribution of complex species has been 
calculated at fixed ligand concentrations of 10 mM, 1 mM and 0.1 mM with varying 
[Zn2+] values. 
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With the L2 system (Figure 2.10) a particular feature is that the [Zn(L2hl species 
predominates at ambient pH and even with [e]101 = 0.1 mM and [Zn2+] = 0.1 p.M, 
more than 80% of all Zn bound species is in the form of the neutral 2: 1 complex 
[Zn(e)~. However, for the tosylamide ligand L1 (log K1 = 12.2), even when [e] 101 = 
10 mM and [Zn2+] 101 = 1 mM, the major species at pH 7.4 is the metal hydroxide, 
with significant [ZnL1] formed (Figure 2.9). At lower ligand concentrations, only a 
very small amount of the [ZnL 1] species is present. In summary, it can be seen that 
e and e offer scope as the basis for practicable Zn(II) probes in neutral aqueous 
media, possessing sufficient affinity for the Zn2+ ion at ambient pH to form a major 
2 : 1 species, even with low total ligand concentrations. 
2.10 Conclusion 
Ligands L2 and L3 are suitable basic ligand systems that form neutral ML2 
complexes at ambient pH when the free zinc (11) concentration is in the micro to 
nanomolar range. Based on these ligands, appropriately conjugated variants were 
then considered for potential use as pZn sensitive MRI or luminescence probes, and 
are discussed in the following chapters. 
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Chapter 3 
Si111ple Macrocyclic Ligands 
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3. 1 Introduction 
Once the most appropriate zinc (11) binding ligands had been identified as the 
pyridyl trifluoromethanesulfonamides, e and e, a suitable linkage group to attach 
it to a macrocyclic system had to be established. 
Macrocyclic ligands based on triacetate (e.g. D03A: N,N',N" -tris(carboxymethyl)-
1,4,7,10-tetraazacyclododecane) and triacetate-monoamide derivatives of cyclen 
(1,4,7,10-tetraazacyclododecane) have been shown to form well-defined and 
kinetically robust complexes with lanthanide (Ill) ions in solution.62 Therefore, 
D03A-type complexes with appended pyridyl amide groups were designed and 
synthesised, with both ethyl and propyl chains linking the amide group to one 
nitrogen of the 12-N4 ring. 
The europium (Ill) and gadolinium (Ill) complexes of ligands L5 and L6 were 
synthesised and characterised as model complexes for the trifluoromethane-
sulfonamide systems e and L8, which are potentially pZn MRI probes or 
precursors of luminescent probes. 
The amide carbonyl group was anticipated to ligate intramolecularly to the central 
lanthanide ion. Enlarging from a seven membered chelate ring (L5) to an eight 
membered chelate ring (L6) was expected to disfavour amide carbonyl binding. If 
65 
this intramolecular ligation was rendered reversible, it would then be possible to 
create a responsive system, sensitive to the presence of added metal ions, provided 
that the binding of the carbonyl group to the lanthanide centre also prevented 
water from binding to the lanthanide ion. The result was hypothesised to be a 
switching between q = 0 and q = 1 or 2 system, following the addition of metal ions 
(Scheme 3.1). 
N 
~ I 
q=O q=n 
@ = added metal ion 
Scheme 3.1 
3.2 Synthesis 
The synthesis of ligand L5 (Scheme 3.2), commenced with the EDC coupling of 2-
pyridine carboxylic acid with ethanolamine to give the corresponding amide 46. 
The terminal alcohol was then brominated using carbon tetrabromide and 
triphenylphosphine to give 47 which was then used to alkylate 1,4,7-tris(tert-
butoxycarbonylmethyl)-1,4,7,10-tetra-azacyclododecane, 48, in the presence of base 
in hot acetonitrile. The resulting tetrasubstituted cyclen, 49, was deprotected with 
trifluoroacetic acid to afford the desired ligand L5 as the TF A salt. Lanthanide 
complexes were prepared in aqueous solution following reaction of the ligand with 
hydrated LnC13 at pH 5.5 (90°C, 18 hours). 
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Scheme 3.2 Synthesis of Lanthanide (Ill) Complexes of L5• 
Ligand L6 was prepared in a similar fashion: EDC coupling of 2-pyridine carboxylic 
acid with n-propanolamine yielded the amide 50. Carbon tetrabrornide and 
triphenylphosphine were used to brominate the alcohol, and the resulting 
bromoalkane 51 was reacted with 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane 48 in the presence of base. The t-butyl protecting groups 
were then removed from the tetra-substituted cyclen 52 with TF A, and the desired 
ligand L6 was complexed with the lanthanide ion (Scheme 3.3). 
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Scheme 3.3 Synthesis of Lanthanide (Ill) Complexes of L6• 
These four complexes were then studied using various physicochemical techniques 
to establish the speciation and constitution of the complexes in solution and 
determine whether the ethyl or propyl linkage gives rise to more appropriate 
properties in the desired lanthanide complex. 
3.3 Emission excited state lifetimes of Eu (Ill) 
complexes: evaluation of hydration state, q. 
The number of water molecules (q) coordinated to the europium ion was assessed 
by measuring the rate constants for the depopulation of the Eu 50 0 excited states in 
H20 (kH20) and D20 (k020) and applying equation (3.1), where x is the number of 
exchangeable amide NH groups bound to the europium (Ill) ion.61'123 
(3.1) 
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Table 3.1 Rate decay constants and number of bound waters at pH 7 of 
complexes [EuL5] and [EuL6l The values of q obtained assumes that 
the amide nitrogen is not bound to the europium centre. 
Complex kH2o (ms-1) kv2o (ms-1) qEu 
(EuL5] 1.65 0.47 1.11 
[EuL6] 0.87 0.58 0.04 
The hydration state of the europium (Ill) centre changes with ligand. The q values 
obtained (Table 3.1), show that there is one water molecule bound to the europium 
(Ill) centre in [EuL5] whereas [EuL 1 has no bound water. The parent systems 
[EuDOT Ar and [EuD03A] are known to form q = 1 and q = 2 complexes 
respectively.92 As the hydration state for [EuL 1 is q = 0, the pyridyl amide group 
must be binding to the europium (Ill) centre giving rise to considerable steric 
demand at the Eu (Ill) centre, thereby preventing water from binding. It is also 
worth noting that in the 14-N4-tetraacetate complex, [EuTETAL no water is bound to 
the Eu (Ill) ion.124 This has been ascribed to the increased steric demand imposed by 
the introduction of the two six-ring chelates of the macrocyclic ring (Table 3.2). 
Table 3.2 [EuTET Ar, [EuDOTAr and [EuD03A] are q = 0, q = 1 and q = 2 . 
[EuTETAr [EuDOTAr [Eu003A] 
ot?" 0 0 tO OH2 -E~~OH, -6~~0 0 E"!_ 0 hc!J OH, 
0 0~ oJ-:/"{1--{ O NO~ 
0 0 0 
q=O q=1 q =2 
Caravan et al.92 found that alcoholic oxygen, pyridyl nitrogen and amide oxygen 
donor atoms (X) gave rise to the greatest contribution to the increase in stability to 
lanthanide (Ill) chelation of the neutral donors that they investigated (Scheme 3.4). 
Table 3.3 details the relative affinities of different donor atoms for Ln(III) ions; here, 
L11og K refers to the free energy difference in binding after taking into account the 
difference in ligand basicity. 
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Table 3.3 Relative affinity of different donor atoms for Ln(III) ions.92 
i'x L\ log K 
j\s- 0.0 
j\0_ 1.6 
00H 2.9 
rD 3.3 
NH2 
00 3.38 
Although pyridyl nitrogen and amide oxygen have been shown to have a relatively 
high affinity for lanthanide (Ill) ions, this is in a 5-membered ring chelate system. 
The ligands L5 and L6 cannot form 5-membered chelate rings between either the 
pyridyl nitrogen or the amide oxygen. In the case of [EuL 1, a seven-membered 
chelate ring could exist between the amide oxygen or an eight membered ring with 
the pyridyl nitrogen; and in the case of L6, an eight-membered chelate ring would 
have to form between the amide oxygen or a nine membered ring with the pyridyl 
nitrogen. Nevertheless, the lifetime studies are consistent with the intramolecular 
coordination, in each case. The nature of this coordination was therefore studied 
further. 
3.3.1 Variation of Lifetime with pH. 
The lifetimes of the europium (Ill) complexes L5 and L6 were measured in water at 
pH 4 and 7. If the pyridyl nitrogen were reversibly bound to the lanthanide centre, 
protonation at low pH would result in the pyridyl group no longer being ligated to 
the europium and an increase in the hydration state would be expected to result. 
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Table 3.4 Rate decay constants (kH20, ms-1) of [EuL5] and [EuL6] at pH 4 and 7 
pH 
kH,o (ms-1) 
[EuL5) [EuL~ 
4 1.73 0.92 
7 1.65 0.87 
From the lifetime values given in Table 3.4, it can be seen that there is no significant 
variation of lifetime with pH. Thus it can be concluded that the number of water 
molecules bound to the europium (Ill) centre ( q) does not vary with pH over the 
range studied, and the pendant group does not bind to the europium (Ill) centre in 
a pH dependent manner. 
3.3.2 Effect of Zinc (11) Concentration on Lifetime 
Pyridyl and amide groups can each coordinate to zinc (II) either independently or 
as a chelate. If zinc (II) coordination occurred in [EuL 1, a 5-membered chelate ring 
system would form, similar to that observed in the zinc (11) complexes of L 1 - L 4. 
Zinc (11) acetate was added to solutions of the europium complexes [EuL 1 and 
[EuL6]. Formation of a zinc complex, Zn[EuLlz, was postulated as in Scheme 3.5. 
The bound zinc (11) might then inhibit the pyridyl amide from binding to the 
europium (Ill) centre and instead allow water to bind to the europium. The 
increase in the number of bound water molecules, in turn, would result in an 
decrease in the measured Eu (Ill) excited state lifetime. 
o~N+jo 
Zn2• o-f3UJElJ3oH2 HyQI 
-=..:........:: ~N N~N "' 
.._..- 1 N 0 0 o--ox·,n I 00 
0 N" N~/',li~N 
I A H H,Or~~o 
0 0 
Scheme 3.5 Proposed mechanism for the binding of Zn (11) to [EuL6), resulting in 
the coordination of water to the europium centre and so causing a decrease in 
excited state lifetime. 
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The lifetimes of the europium complexes [EuL5) and [lEuL 6) were measured at pH 4 
and 7 in the presence of 10 equivalents of zinc (11) acetate. 
Table 3.5 Rate decay constant of [EuL 1 and [EuL6) in the presence of 10 
equivalents of Zn (H) at pH 4 and 7. 
pH 
kH2o (ms-1) 
[EuL5] [EuL~ 
4 1.76 0.96 
7 1.64 0.91 
The kH
2
o values obtained at different pH values (Table 3.5) in the presence of zinc 
(11) show that the lifetime does not vary with changing zinc (11) concentration. The 
[EuL5) complex remains a mono-aqua species and [EuL6) remains q = 0. This 
suggests that in the case of [EuL6], the pyridyl amide group must be strongly 
coordinated to the europium centre in an irreversible manner, preventing 
coordination of water to the europium centre. 
3.4 Luminescence studies of [EuL 5] and [EuL 6]. 
Examination of the form and relative band intensity in europium (Ill) emission 
spectra following direct (Aexc 397 nm) or sensitised (Aexc 268 nm) excitation can be 
used to provide further information about the coordination environment at the 
lanthanide centre.125'126 
Comparison of the emission spectra of [EuL5) and [EuL6) (Figure 3.1) reveals an 
increase in the relative intensity of emission of the £1] = 2 transition, centred at 
616 nm, for [EuL 1 in comparison with [EuL 1. The !lJ = 2 band provides 
information about the nature of the axial donor binding to the europium. In 
general, the more polarisable the axial donor, the greater the ratio of the intensity of 
the L'l/ = 2/11/ = 1 bands. This increase in intensity is consistent with the different 
hydration states in the two complexes. An enhanced relative intensity of emission 
would be expected for [EuL 1 as there are no water molecules bound to the 
europium (Ill) centre. In contrast [EuL5) has one bound water molecule, which 
would not only quench the overall Eu (Ill) emission, resulting in a decrease in the 
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total emission intensity, but also has been characterised by a low L'lJ ::: 2/ L'lJ ::;: 1 
intensity ratio for several related mono-aqua complexes.125 
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Figure 3.1 Emission spectra of [EuL ~ and [EuL ~, Xexc = 268nm. 
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3.4.1 Effec~ o~ !PH ollll h.nmollllesceu-uce 
Measurements of lifetimes at various pH values had shown that there was no 
change in the hydration state of [EuL 1. This was confirmed by changing the pH 
and recording the emission spectrum. No change in the spectral form was 
observed between pH 4 and 9 with direct or sensitised excitation, confirming that 
the europium (III) coordination environment was not changed. 
3.4.2 !Effect of Zinc (11) on luminescence 
Emission spech·a were also used to confirm that there was no change in the 
hydration state of [EuL6] with increasing added zinc (11) concentration. Zinc (11) 
acetate solution was added in small aliquots containing one equivalent, until 10 
equivalents had been added. No change was observed in the spectral form with 
direct or sensitised excitation at either pH 4 or pH 7. It can therefore be concluded 
that [EuL6] remains q = 0, i.e. unhydrated, in the presence of an excess of Zn (11) 
ions. 
3.4.3 Dilution Effects 
For [EuL 6] to be a q = 0 complex, part of the pyridyl amide subsituent must be 
binding to the europium (Ill) centre. As seven (C=O) or eight (pyridyl N) 
membered chelate rings are not usually formed, intermolecular binding was 
considered to be a possibility. 
Recording the emission spectra with sensitised emission at increasingly dilute 
concentrations might result in a change in the spectral form when the concentration 
fell below the binding affinity of the pyridyl amide of one complex to the europium 
(Ill) centre of another. 
Dilution of a solution of [EuL 1 from 250 ]1M to 7.3 ]1M resulted in a decrease in the 
overall intensity of the observed emission spectrum, but no change to the spectral 
form was observed. This suggests that the antennae group is bound to the 
europium (Ill) centre intramolecularly. If the antennae group was bound 
intermolecularly, a change in the spectral form might have been expected. 
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Electrospray mass spectrometry suggests that it is possible that a high affinity 
dimer has formed. However, this is seems unlikely as the dissociation constant 
would be Kct < 10-6 M; anions have been to have a much lower affinity than this for 
lanthanide centres, ea. 104 M.64 
3.4.4 Sensitised [EuD03A] emission with a pyridyl chromphore 
Compound 50, which contains the chromophore in [EuL5] and [EuL 1, was added to 
a solution of [EuD03A] and the sensitised emission spectrum was recorded. If 50 
is a good donor for europium (Scheme 3.6) then it was hypothesised that it might 
coordinate in solution and sensitised emission would occur when the excitation 
wavelength matched the absorption spectral profile of the chromophore. 
Oy~~OH 
0 
Scheme 3.6 Proposed method of coordination of pyridyl chromophore 50 to 
[EuD03A) allowing sensitised emission (.\exc = 268 nm) to occur. 
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Figure 3.2 Emission spectrum of [EuD03A] sensitised with one equivalent of 
pyridyl amide (50) scaled to compare with [EuL6] • .\exc = 268nm, 315 nm filter. 
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The spectrum obtained for the sensitised emission of [EuD03A] and one equivalent 
of 50, when put on the same scale as the emission spectra of [EuL6] (Figure 3.2), 
shows that there is a striking similarity in the spectral form of [EuL 1 and 
[EuD03A] sensitised with 50. However, the spectrum for [EuD03A] is of poorer 
resolution. The L1] = 2 band, which is most sensitive to axial coordination, is of a 
similar form and relative intensity suggesting that the pyridyl amide group 
coordinates to the europium centre in the same way, irrespective of whether it 
binds intermolecularly or intramolecularly. 
3.5 Relaxivity Behaviour of the Gadolinium Complexes 
The relaxivity (r1p) of the gadolinium (Ill) complexes describes the bulk water 
proton relaxation rate per mmol of complex. The magnitude of the measured 
relaxivity gives an indication of the number of water molecules bound to the 
gadolinium (Ill) centre. Information on water exchange rates is usually deduced in 
separate studies measuring the 17 0 transverse relaxation rate as a function of 
temperature. 
The relaxation rate (R1p) was determined from the measured T1 values via 
equations 3.2 and 3.3. Proton T1 values were measured using either a Bruker 
Minispec mq60 NMR analyser, which operates at 37.0°C and 60 MHz, or using a 
homemade 65 MHz NMR machine, which operates at ambient temperature (22°C). 
1 Robs R R 
T,obs = I = lp + Id 
I 
(3.2) 
R =-~-- 1 
I p T, obs T, diamag 
I I 
(3.3) 
The diamagnetic contribution to water relaxation was determined from a dilution 
series of a gadolinium standard and the values used were 0.26 s-1 (60 MHz, 37°C) 
and 0.38 s-1 (65 MHz, 22°C). 
The concentration of the relaxivity samples were determined by digesting them in 
2.5 M nitric acid. The relaxivity of gadolinium (Ill) in 2.5 M nitric acid was 
determined to be 8.74 mmor\-1 with a diamagnetic correction factor of 0.24 s-1 at 
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60 MHz, 37oc, compared to 11.66 mM-1s-1 with a diamagnetic correction factor of 
0.40 s-1, at 65 MHz, 22°C). 
The relaxivity was determined by equation 3.4. 
Rir 
r =--
Ip [Gd] 
3.5.1 Relaxivity of [Gdl5] and [Gdl6] 
(3.4) 
The relaxivities of [GdL5] and [GdL6] were determined at both 60 MHz and 65 MHz 
(Table 3.6). 
Table 3.6 Relaxivities of gadolinium (Ill) complexes at pH 7. 
Complex 
Relaxivity (mM-1s -l) 
60MHz,37°C 65 MHz,22°C 
[GdL) 2.89 3.50 
[GdL~ 2.18 2.45 
The relaxivity values obtained for [GdL 1 are higher than those obtained for [GdL6], 
which is consistent with the higher hydration state of [GdL5]. The values obtained 
at the measured field and temperatures lie within the expected range for low 
molecular weight gadolinium systems with q = 1 and q = 0 hydration states for 
[GdL 1 and [GdL6] respectively.92 
The relaxivity values obtained at 37°C are consistently lower than those obtained at 
22oc because under conditions of fast water exchange, relaxivity is inversely 
proportional to temperature, as it depends primarily on the rotational correlation 
time, TR, of the whole complex. 
3.5.2 Variation of Relaxivity with pH 
The relaxivity of gadolinium (Ill) complexes [GdL 1 and [GdL 1 was measured at 
pH 4, 7 and 9 at 37°C and 60 MHz using the Bruker Minispec mq60. 
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Table 3.7 Variation of relaxivity (60 MHz, 37°C) of complexes [GdL 1 and [GdL6] 
with pH. 
pH 
[GdL5] 
Relaxivity (s -1mmor1I) 
[GdL6] 
4 3.14 3.16 
7 2.89 2.30 
9 2.83 2.25 
The relaxivity of both [GdL5] and [GdL 1 increased slightly at low pH (Table 3.7). 
This could be caused by the onset of protonation of the pyridine, resulting in an 
increased second sphere of hydration around the gadolinium centre and hence an 
increase in the observed relaxivity. 
3.5.3 Zinc (11) !Dependence of Relaxivity 
The relaxivity of both [GdL 1 and [GdL 1 was measured in 0.1 M MOPS buffer at 
pH 7.4, in the presence of increasing zinc (II) concentration, using the Bruker 
Minispec mq60 (Table 3.8). 
Table 3.8 Relaxivity (60 MHz, 37°C) of complexes [GdL5] and [GdL6] in the 
presence of 1 and 10 equivalents of Zn(II) acetate at pH 7.4. 
Relaxivity (mM-1s -1) 
[GdL5] [GdL~ 
1 equiv Zn 10 equiv Zn 1 equiv Zn 10 equiv Zn 
2.89 2.96 2.24 2.38 
The [GdL5] complex shows no change in the relaxivity with increasing Zn (II) 
concentration. As the complex is a q = 1 species, the observed relaxivity is 
dominated by the itmer sphere effect. 
A small but significant increase can be seen in the relaxivity of [GdL6] with 
increasing zinc (II) concentration. Titration of small aliquots of zinc acetate solution 
(1.88 pl, 5 mM), containing one equivalent of zinc (II), into a solution of [GdL6] 
(200 pl, 0.47 mM) in 0.1 M MOPS buffer at pH 7.4 (Figure 3.3), shows that the 
relaxivity (60 MHz, 37°C) increases most significantly with the addition of between 
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one and five zmc (11) equivalents and then reaches a saturation value. Such 
behaviour may be associated with weak binding between [GdL 1 and Zn (II). By 
assuming a 1 : 1 binding model, an estimated apparent binding constant of 
0.53 mM-1 was calculated by iterative least squares fitting. 
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Figure 3.3 Increase in relalaxivity of [GdL6] (0.47mM) with increasing zinc (11) 
concentration. (60 MHz, 37°C). 
The 65 MHz NMR machine at 22 oc was also used to determine the relaxivity of 
[GdL 1 at 0.5 mM and 11.5 mM concentration in the presence of 10 equivalents of 
zinc (II). At each concentration investigated, the relaxivity of [GdL6] increased 
from 2.4 mM-1s-1 (65 MHz, 22 oq to 4.3 mM1s-1 in the presence of 10 equivalents of 
zinc (II) acetate. As a control, 10 equivalents of sodium acetate were added to 
another sample of [GdL 1. The relaxivity was relatively unchanged at 2.5 mM-1s-1 
(65 MHz, 22 aq. The [GdL 1 complex shows a 75% increase in relaxivity at this 
temperature in the presence of zinc (II). As the addition of sodium acetate caused 
no change in the relaxivity, it can be concluded that there is no anion binding effect. 
The increase in relaxivity can be ascribed to outer sphere binding of zinc (II) to the 
complex, which markedly changes the local hydration of the complex, resulting in 
an increase in the relaxivity. From studies with the europium analogue, it was 
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5 
earlier shown that the q value does not change in the presence of added Zn (II) ions. 
The increase in the relaxivity is therefore most likely to be an outer sphere effect. 
The relaxivity increase in the presence of zinc (11) is greater than that shown by the 
only published zinc (11) sensitive contrast agent, 39, which has a maximum decrease 
in relaxivity of 33% in the presence of one equivalent of Zn (11).84 This relaxivity 
change has also been ascribed to the binding of Zn (II), presumable caused by a 
change in the second sphere hydration state.62 
Large changes in relaxivity have been reported for other cases of q = 0 complexes, 
as a consequence of 'outer sphere' binding. Examples of this include the 
tetrabenzylphosphinate 53127 in which the steric bulk of the phosphinate groups 
above the complex prevents the coordination of water molecules to the gadolinium 
centre, rendering it a purely outer sphere complex. The relaxivity has no inner 
sphere component and the NMRD profile represents the archetypal case of a 
complex exhibiting only 'outer sphere' relaxivity. 
53 54 
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Substitution of one of the phosphinate groups with a less bulky carboxamide e.g. 54 
favours the access of water to the paramagnetic centre.128'129 The NMRD profile 
obtained has a shape typical of a q = 1 complex but the magnitude is significantly 
lower. A small hump in the NMRD profile at 100 MHz characterises a dependence 
of the relaxivity on the rotational dynamics (TR) of the complex. The increase in the 
relaxivity on passing from the pure outer sphere system 53 to 54 can be assigned to 
the presence of a tightly bound water molecule in the second coordination sphere 
with a long coordination lifetime.128 The water molecule was proposed to be 
hydrogen bonded to the carboxamide oxygen atom, resulting in a metal proton 
distance that is sufficiently short to markedly affect the relaxivity. 
A divalent calcium-sensitive MRI contrast agent DOPT A-Gd 40 developed by 
Meade and co-workers,83 has a relaxivity increase of 77% from 3.26 mM-1s-1 to 
5.76 mM-1s-1 (25°C, 500 MHz) following addition of micromolar concentrations of 
calcium (II). 
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It has been proposed that the metal ion chelation perturbs the second sphere rather 
than the inner sphere water molecules, causing the increase in relaxivity,62 although 
Meade et al. were unaware of this in their original publications83 where they 
postulated changes in the coordination environment at the gadolinium centre, 
without any experimental proof. 
3. 6 NMRD Profiles of Complexes [GdL 5) and [GdL 6]. 
Nuclear Magnetic Resonance Dispersion (NMRD) profiles which record the 
magnetic field dependence of relaxivity were recorded in Durham at 25°C (Figure 
3.4) and at 37°C using a Stelar field-cycling relaxometer. The NMRD profiles were 
fitted (Table 3.9) by Professor Mauro Botta and Dr Eliana Gianolio at the Universita 
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di Torino based on the following theoretical arguments, and using 170 data to 
determine TM (Section 3.7). 
The relaxation rate of inner sphere water, R1~is, arises from the exchange of the 
metal-bound waters and is given by: 
R His= Cq 1 
lp 55.6 ~~ + r;: (3.5) 
where C is the concentration of the Gd (III) complex in mM; q is the number of 
metal bound water molecules and d} is their residence lifetime. 
r/tt is the longitudinal relaxation time of the inner-sphere water protons and is 
given by: 
(3.6) 
where S is the electron spin quantum number (7 /2 for Gd(III); YH the proton nuclear 
magnetogyric ratio; JiB the Bohr magneton; ge the Lande factor for the free electron; 
rH the distance between the metal ion and the inner-sphere water protons; OJH and 
w5 the proton and electron Larmor frequencies ( w5 = 658 wH) respectively and rei 
(i = 1,2) the correlation times related to the modulation of the electron-proton 
dipolar coupling. The modulation may occur by the reorientation of the 
paramagnetic species, rR, by the water exchange with a rate kex = 1/ rM and by the 
electron relaxation, TiE: 
-1 -1 + -1 +T-1 
rei = r R rM iE (3.7) 
For Gd(III) complexes T1E and T2E are related to the modulation of the zero field 
splitting (ZFS) of the electronic spin states due to the dynamic distortions of the 
ligand field interaction and, according to the Bloembergen-Morgan theory/4 their 
magnetic field dependence is given by the following equations: 
( 
1 J ZFS 1 2 ( 1 4 J 
- =-~ rv{4S(S+l)-3 2 2 + 2 2 ~e 25 l+wsrv 1+4wsrv (3.8) 
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- 1 1 2 [ ( 5 2 J T2 E =-/j. r v 4S(S+ l)-3 3+ 2 2 + 2 2 
50 1 + w5 r v 1 + 4w5 r v 
(3.9) 
where L12 is the the square of the average (transient) ZFS tensor and 'v the 
correlation time related to its modulation. The outer sphere term, R~os , describes 
the contribution arising from the water molecules diffusing near the paramagnetic 
chelate and, according to the Freed model/ 5 may be related to the minimum 
distance between the metal and the diffusing water molecules, a, the relative solute-
solvent diffusion coefficient, D, and the electronic relaxation times, TiE: 
(3.10) 
where CS is a constant (5.8 x 10-13 s-2M-1) and the dependence on the electronic 
relaxation times is expressed in the non-Lorentzian spectral density functions J(wJ 
Figure 3.4 Experimental NMRD profiles for [GdL5) (solid squares) and [GdL ~ 
(open squares) in aqueous solution (pH 6) The values were all obtained at 25°C 
with the exception of the 65 MHz values which were obtained at 22°C. The solid 
lines through the data are best-fitting curves obtained using the above theory, 
using parameters given in Table 3.9. 
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Table 3.9 Best fitting parameters obtained from the analysis of the NMRD 
profiles for the gadolinium (Ill) complexes [GdL5] and [GdL6] at 25°C 
and pH 6. 
Complex q A 2 (s -2x1019) T0 (ps) TR (ns) r (A) a (A) D(cm2s -1x10-5) 
[GdLl 1 5.6 16 54 3.13 4 2.24 
[GdL6] 0 4 12.9 54 - 3.7 2.24 
[GdL5] has an NMRD profile (Figure 3.4) typical of a small Gd3+ complex 
possessing a single coordinated water molecule. Fitting of the data (Table 3.9) 
shows that the gadolinium (III) to water proton distance is quite long, 3.13 A. The 
gadolinium (III) to outer water distance is 4 A, which is consistent with the inner 
and outer sphere water molecules being hydrogen bonded together. 
Fitting of the data for [GdL6] shows the complex to be q = 0, whilst the profile 
obtained for [GdL5] has a shape characteristic of a low molecular weight Gd (III), 
q = 1 complex. However, the magnitude of relaxivity across the entire magnetic 
field range, is lower than typically expected for a q = 1 complex. The relaxation 
behaviour of [GdL 1 is however inconsistent with purely outer-sphere properties. 
The Gd-H distance of coordinated water molecules has been estimated as 3.7 A, 
which is shorter than the distance that would be expected in a purely outer sphere 
complex.69'92 It can probably be accounted for by hydrogen bonding of the water 
molecules in the second hydration sphere to the pyridyl amide group. This would 
result in the water being bound at an equilibrium distance from the metal that is 
longer than in inner sphere complexes, but the residence lifetime, Tw is 
significantly longer than the time necessary for the solute and solvent to diffuse 
apart. Such behaviour is reminiscent of the monoamide triphosphinate gadolinium 
complexes described in section 3.5.3. 
3. 7 Variable Temperature 17 0 NMR Studies 
The temperature dependence of the solvent water 170 transverse relaxation rate can 
provide information about the hydration number and the water exchange 
rate.60'128'129 The residence lifetime of a water molecule directly coordinated to a 
paramagnetic metal ion ( £~) may be evaluated by measuring the temperature 
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dependence of the paramagnetic contribution ( R?P) to the observed 170 water 
solvent transverse relaxation rate: 
(3.11) 
where, by analogy with the relaxivity, R£t is the diamagnetic term. R?P is related 
tor~ through the values of L1m~ (the 170 chemical shift difference between 
coordinated and bulk water resonances) and R? M (the transverse relaxation rate of 
the coordinated water oxygen): 
(3.12) 
The temperature dependence of L1m~ is given by the following equation: 
(3.13) 
where B0 is the magnetic field strength and A I 1i is the GdYo scalar coupling 
constant which, for polyaminocarboxylate Gd(III) complexes, may be reasonably 
fixed to -3.8 x 106 rad s-1. 
For relatively small-sized Gd(III) chelate R?M is dominated by the electron-
nucleus scalar interaction: 
( ) 2 [ J 0 1 A r £ 2 R2M = - - s(s + 1) r El + 2 2 3 1i l+msrE2 
_, r-' ( o )-' 
TEi = iE + TM 
(3.14) 
(3.15) 
Finally, the temperature dependence of R?P is expressed in terms of the Eyring 
relationship for r~ and r v: 
(3.16) 
where j refers to the two different dynamic processes involved (j = v, M) and L1Hj is 
the corresponding activation enthalpy. 
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The 170 linewidths were measured in Durham at 500 MHz and pH 6 over the 
temperature range 275 - 365 K for 21 mM and 32 mM solutions of complexes 
[GdL 1 and [GdL 1 respectively. The 170 data were fitted (Figure 3.5 and Table 3.10) 
by Professor Mauro Botta and Or Eliana Gianolio at the Universita di Torino 
according to equations 3.11- 3.16. 
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Figure 3.5 Temperature dependence of 17 0 transverse relaxation rate at 500 MHz 
and pH 6 of [GdL 1 (21 mM) and [GdL 1 (32 mM). The line for [GdL5] shows the 
fit to the experimental data. 
Table 3.10 17 0 NMR best-fitting parameters obtained from the analysis of the 
temperature dependence of R2P for 21 mM aqueous solution of [GdL 1 
Complex 
13.2 Tu TM TR r /3.Hu /3.HM q (s -2x1019) ( ps) (ns) (ps) (A) (kJmor1) (kJmor1) 
[GdLl 1 5 14 8.6 55 2.50 2 21 
[GdL 1 has no water molecules directly coordinated to the gadolinium (Ill) centre 
so the 17 0 profile obtained for this complex is almost flat, i.e. no bound water is 
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present. The form of the 170 profile (Figure 3.5) of [GdL5] is consistent with fast 
water exchange. The calculated value of the mean residence lifetime, TM (25°C) for 
[GdL5] is 8.6 ns which is very fast, indeed it is two orders of magnitude faster than 
occurs for [Gd(DOTA)H20r (TM 244 ns, 25°C) and [Gd(DTPA)H20t (TM 303 ns, 
25°C).130 This suggests that the sterical demands of the pyridyl amide moiety result 
in a steric destabilisation of the Ln-water binding interaction which in turn causes 
fast water exchange to occur. 
Systems with increased steric demands at the water binding sites have been shown 
b M b h d k 131132133 hib' · d h B y er ac an cowor ers ' ' to ex It mcrease water exc ange rates. y 
the replacement of one five-membered NCCN ring of DOT A or a pendant arm of 
DTP A, by a more sterically demanding six-membered analogue they have 
synthesised systems that exhibit an exchange rate which is an order of magnitude 
faster than the parent system. 
The fitted data also is consistent with the presence of a relatively long Gd-OH2 
bond (2.50 A). This is in agreement with the long Gd-H bond lengths derived from 
the fitting to the NMRD data. 
3.8 Infra Red Spectroscopy 
Infra red (IR) spectra of lyophilised samples of [LnL 1 and [LnL6] were recorded in 
a KBr matrix and compared. The infra red spectra of the complexes of ligands L5 
and L6 shows them to be virtually identical in the region 1750 - 1500 cm-\ with a 
(coordinated) amide stretch at 1636 cm-1 (cf. 1660 cm-1 for the unbound amide 
carbonyl stretch). This would suggest that the amide carbonyl coordinates to the 
lanthanide centre in the same manner in each case. The pyridine ring vibrations 
have been tentatively assigned at 1591 and 1560 cm-1. This is consistent with the 
absence of pyridine nitrogen ligation.134 
3.9 Conclusions 
Pyridyl amide groups in the studied complexes of L5 and L6 bind very well to both 
europium and gadolinium centres. In the case of [LnL 6], the pyridyl amide binds 
irreversibly to the lanthanide centre, forming a kinetically stable q = 0 complex 
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which resists protonation and binds the central lanthanide ion more strongly than 
Zn (11). Inspection of molecular models confirms that the mode of binding is 
through the carbonyl oxygen, is relatively unstrained and accords with IR and 
emission luminescence studies. 
Reducing the alkyl chain length linking the pyridyl amide to the macrocyclic ring 
nitrogen from propyl to ethyl, reduces the steric demand at the lanthanide centre, 
giving rise to a q = 1 complex. Molecular models confirm that because of the 
rigidity of the amide group it is not possible for the pyridyl nitrogen to bind to the 
lanthanide ion, but it is possible for the amide carbonyl oxygen to bind. The steric 
demands of this seven-membered chelate ring results in a steric compression of the 
water ligand binding site, causing the Ln-water bond to be long and the water 
exchange rate to be fast. 
The relaxivity of [GdL6] (65 MHz, 22°C) shows a 75% increase in the presence of 
excess added zinc (11). This increase is not an anion effect, a pH effect nor a result 
of a change in the gadolinium (Ill) inner sphere hydration state. The increase can 
be tentatively ascribed to the binding of zinc (11) to the complex resulting in an 
increase in the extent of complex hydration and thus an increase in the measured 
relaxivity. 
Although neither of the complexes [LnL5] or [LnL6] showed a change in lanthanide 
coordination environment with changing pH or Zn (11) concentration, the presence 
of carboxyalkyl subsituents on the cyclen nitrogens instead of a D03A type system 
along with a trifluoromethanesulfonamide group in the six position of the pyridine 
may prevent the pyridyl amide from binding so strongly to the lanthanide ion. 
Both the ethyl and propyl linkage groups were therefore used to link the pyridyl 
sulfonamide to the central macrocycle for use in potentially pZn sensitive MRI 
probes and the results of these studies are discussed in the following chapter. 
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pZn Responsive Lanthanide 
Systen1 
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4 pZn Responsive lanthan~de System 
4. 1 Introduction 
Having established the parent macrocyclic system with either ethyl or propyl 
amide groups linking the pyridyl moiety to the macrocyclic core, the parent zinc (11) 
binding trifluoromethanesulfonamide ligand, L3, was incorporated into pyridyl 
sulfonamide appended macrocyclic system with the aim of providing a greater 
affinity for zinc (11), Figure 4.1. 
0 
11 
0 N-S-CF H 11 3 
0 
Figure 4.1 Pyridine trifluoromethanesulfonamide appended lanthanide complex. 
This pyridyl trifluoromethanesulfonamide appended macrocyclic complex was 
intended to have pZn (11) responsive properties for potential MRI and luminescence 
applications. The amide carbonyl group had been shown in the parent systems 
[LnL5] and [LnL6] (Chapter 3) to ligate intramolecularly the lanthanide centre 
forming q = 1 and q = 0 systems respectively. Although these parent systems 
exhibited no reversible pZn dependent binding properties, it was hypothesised that 
the addition of the trifluoromethanesulfonamide group to the system would 
significantly increase the affinity of the pendant group for zinc (11). 
The proposed mechanism through which [LnL8] responds to increased 
concentrations of zinc (11) is illustrated in Scheme 4.1. The amide carbonyl was 
hypothesised to bind to the lanthanide (Ill) centre in a reversible manner in 
response to changes in zinc (11) concentration. 
In the absence of Zn (11), the lanthanide (Ill) ion is eight coordinate and binding of 
water is inhibited by the presence of the carbonyl group. 
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Addition of zinc (II) to the system could result in the formation of a [Zn(L3h_] type 
complex between the pendant arm and the free zinc (11) ions; the resulting complex 
will have 2 Gd3+: 1 Zn2+. The amide carbonyl was anticipated to participate in 
octahedral zinc (11) binding leaving a co-ordination site free on the lanthanide (Ill) 
ion for water to bind. The result was hypothesised to be a switching between a 
q = 0 and a q = 1 or 2 system, following the addition of zinc (11) ions. 
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Scheme 4.1 Proposed mechanism through which [LnL8) binds zinc (11) ions. The 
amide carbonyl participates in the octahedral ligation of Zn (11) resulting in an 
increase in the hydration state of the lanthanide centre. 
The initial target complexes prepared to prove the concept were the Eu (Ill) and Gd 
(Ill) complexes of 003A-derived ligands, L7 and L8. It was appreciated that when 
the complex was not intermolecularly ligated, then the binding of endogenous 
anions64'77 or proteins might displace the bound waters and suppress the relaxivity 
of the Gd (Ill) complexes.135 Therefore, the related ligands L9 and L10 were also 
prepared (Figure 4.2). The presence of the carboxyalkyl subsituents had earlier 
been demonstrated to inhibit intermolecular anion binding at a coordinatively 
unsaturated lanthanide centre.64 
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4.2 Synthesis 
The synthesis of ligands L7, L8, L9 and L10 was more complicated than initially 
anticipated; many different routes were investigated before one was found which 
led to the production of the desired products. 
The synthetic pathway started with the synthesis of pyridine-2,6-dicarboxylic acid 
diethyl ester 55, which was prepared by esterification of commercially available 2,6-
pyridinedicarboxylic acid with ethanol. Following the method of Bretonierre/36 the 
ester was reduced using sodium borohydride to give the monoalcohol 56. A one-
pot reaction was used to convert the alcohol 56 into azide 57.136 The alcohol was 
first mesylated using methanesulfonyl chloride in the presence of triethylamine in 
toluene. When the reaction was shown to be complete by TLC, it was heated under 
reflux in a two phase system with sodium azide in water using tetrabutyl 
ammonium bromide as a phase transfer reagent. The reaction proceeded with an 
overall yield of 63%. Azide 57 was then hydrogenated using a palladium on carbon 
catalyst, under 30 psi hydrogen gas using Parr's hydrogenator apparatus to 
produce amine 58. The amine was acidified using trifluoroacetic acid, prior to 
concentration, to prevent polymerisation from occurring. 
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The trifluoromethanesulfonamide 59 was then prepared by the reaction of 58 with 
trifluoromethanesulfonyl chloride in dry pyridine. The ester functionality of 59 
was then converted into an amide by stirring, at room temperature, with the 
desired amine; in this case ethanolamine or 3-aminopropan-1-ol. However, this 
resulted in the cleavage of the sulfonamide, resulting in the production of amines 
60 and 61 respectively (Scheme 4.2) . 
EtOH/H' 
~ NaBH4 
........__..o'("N~O-..._/ _E.....;tO_H--'.,. 
0 55 0 
67% 
HfPd/C ~ 
EtOH ........__..o'("N~N3 
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Scheme 4.2 Synthesis of 60 and 61. 
As the hydrolysis of the sulfonamide was not desirable at this stage, it was decided 
to BOC protect amine 58, then form the amide, deprotect the amine and then form 
the sulfonamide. 
The BOC protected amine 62 was formed by stirring 58 with di-tert butyl 
dicarbonate in methanol. It was later discovered that the BOC protected amine 
could be formed in a one-pot reaction from the azide 57. Following the method of 
Saito and coworkers,137 the azide and di-tert butyl dicarbonate were dissolved in 
ethyl acetate and the solution was shaken under a hydrogen atmosphere (40 psi) in 
a Parr's hydrogenator. The BOC protected amine 62 was formed cleanly in 91% 
yield (Scheme 4.3). 
93 
Scheme 4.3 Alternative route for the production of BOC protected amine 62. 
The ester functionality of 62 was converted into an amide by stirring with ethanol-
amine or 3-aminopropan-1-ol at room temperature to give 63 and 64 respectively. 
The BOC protecting group was then removed with TFA to give 65 (66). The 
sulfonamides 61 and (67) were then formed under anhydrous conditions with 
trifluoromethanesulfonyl chloride in the presence of Hunig' s base (Scheme 4.4). 
H~H HO~N ~ N, 
N S02CF3 
0 67 
Scheme 4.4 Formation of sulfonamides 
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Difficulties arose in attaching a leaving group to the hydroxy sulfonamides 67 and 
61 so that they could be joined on to the cyclen core. Carbon tetrabromide and 
triphenyl phosphine were used in an attempt to brominate the alcohol. However, 
under a variety of conditions, no reaction occurred. Attempts were then made to 
sulfonylate the alcohol using trifluormethanesulfonyl chloride and trifluoro-
methanesulfonyl anhydride under different conditions, but the desired product 
was never isolated. 
As it was surprisingly tricky to attach a leaving group to 61 (67), it was decided to 
attach the BOC protected pyridyl amide to the cyclen core and then deprotect it and 
try to form the trifluoromethane sulfonamide derivative at a later stage. 
The hydroxy amides 63 and 64 were therefore converted into the corresponding 
bromides, 68 and 69 respectively following the reaction of the alcohol with 
triphenyl phosphine and carbon tetrabromide in dichloromethane. Attempts were 
made to substitute these bromides on to trisubstituted cyclen 48 in dry acetonitrile 
in the presence of base. Unfortunately, this did not result in the production of 
tetrasubstituted cyclen as desired. The bromide molecules instead underwent an 
intramolecular reaction, resulting in the production of aziridine 70 and azetidine 71. 
A similar result was obtained on reacting the bromides with tri-adipate substituted 
cyclen 72 (Scheme 4.5). 
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Scheme 4.5 Attempt to alkylated tri-substituted cyclen ring with BOC protected 
bromo amides. 
With this disappointing result, a new approach was attempted. Ester 59 was 
hydrolysed in lithium hydroxide solution, yielding acid 73. Attempts were made to 
undertake an EDC coupling of 73 and 74, an ethylamine appended D03A 
compound which had been prepared independently by Luca Frullano in the 
laboratory (Scheme 4.6). 
0~0- 0~0- AI (n~NH, A Eoc.Host.H,o.pH7 (n~~ ""N o 
-e
N NJ HO ""' --X -eN NJ 11 ? L_N N + N ~ 9 L N N o ~-w-cF, 
o0v ~~ 0 ~-rCF, O~ ~~ 0 
74 0 73 0 
Scheme 4.6 Attempted EDC coupling of 73 and 74. 
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Unfortunately Scheme 4.6 was not successful so the coupling was attempted again, 
this time using the methyl ester of 74. The D03A compound was converted into 
the methyl ester by refluxing in dry methanol in the presence of a catalytic amount 
of acid to give 75. The coupling reaction was then undertaken as outlined in 
Scheme 4.7. This reaction also did not lead to the isolation of the desired product. 
0 0 
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Scheme 4.7 Attempted EDC coupling of 73 and 75. 
The next plan of attack involved the monoalkylation of cyclen with the bromo BOC 
protected amine 68 (69), followed by the addition of the three other N-substituents, 
either carboxymethyl or a-dimethyl adipate 76, on to the cyclen core. 
It was found possible to monoalkylate cyclen quantitatively with both 68 and 69 in 
dry chloroform in the presence of excess cyclen to give 77 and 78 respectively 
(Scheme 4.8). To prevent over alkylation, the reaction was carried out in a dilute 
solution, with the excess of cyclen which also acted as a base. The reaction 
proceeded more rapidly with 69 possibly because it has a C3 spacer separating the 
electron withdrawing C-N bond. 
69 
78 
Scheme 4.8 Alkylation of cyclen in dry chloroform. 
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Following the production of the monoalkylated cyclen, the product was split into 
two batches. One batch was to undergo substitution with t-butylbromoacetate to 
then go on and form the D03A type system fore and L8. The other batch was to 
be substituted with dimethyl a-bromoadipate, to form the basis for the 
carboxyalkylligands e and eo. 
The D03A system was synthesised first in order to establish a synthetic route for 
the more synthetically challenging carboxyalkyl ligands. For this reason the 
synthesis of the D03A system will be discussed first. 
Alkylation of the three remaining cyclen amines of the monosubstituted system 
was achieved by stirring 77 (or 78) with t-butylbromoacetate at 60°C in dry 
acetonitrile under argon in the presence of base to yield 79 (or 80). The BOC 
protection group was then removed using trifluoroacetic acid; this also resulted in 
the removal of the t-butyl protecting group on the acetate arms resulting in 81 and 
L11 respectively (Scheme 4.9). 
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Scheme 4.9 Alkylation and deprotection of 77. 
The resulting ligand L 11 was then complexed with europium (III) under standard 
conditions and attempts were made to sulfonylate the complex [EuL11] in a two-
phase system. The europium complex was dissolved in water and layered on top 
of trifluoromethanesulfonyl chloride and Hi.inig' s base dissolved in dichloro-
methane. The reaction mixture was stirred gently and the reaction was anticipated 
98 
to occur at the interphase of the two solvents. No reaction occurred (Scheme 4.10). 
It was concluded that nothing happened because trifluoromethanesulfonyl chloride 
reacts too rapidly with water with the production of hydrochloric acid and 
trifluoromethanesulfonic acid. The reaction was then repeated with trifluoro-
methanesulfonic anhydride, as this reacts more gently with water. Similarly, the 
desired product was not isolated, only unreacted starting material. From this is it 
was concluded that sulfonylation using trifluoromethanesulfonyl chloride must be 
undertaken in a dry non-polar organic solvent. 
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Scheme 4.10 Complexation of L11 and subsequent attempt to sulfonylate complex. 
As complex (EuL11] was not soluble in non-polar organic solvent, it was necessary 
to find a different route to the target complex. Following the removal of the t-butyl 
protecting groups from the acetate arms of the D03A system with TFA, L11 was 
also insoluble in dichloromethane. The ligand was rendered soluble in 
dichloromethane by converting the acetate arms to the methyl ester. This was 
achieved by heating the acid 81 (L 11) in dry methanol under reflux, in the presence 
of dry HCl, generated in situ from acetyl chloride. In hindsight, it would have been 
more efficient to transesterify the t-butyl ester into a methyl ester, by heating under 
reflux in methanol, and then removing the BOC protecting group with TF A. 
The triester 82 (83) was soluble in dichloromethane and able to react with trifluoro-
methanesulfonyl chloride under anhydrous conditions. Amine 82 (83) was 
99 
sulfonylated with trifluoromethanesulfonyl chloride in the presence of Hunig's 
base in dichloromethane resulting in the production of the desired sulfonamide 84 
(85). The methyl esters were subsequently hydrolysed in 0.5 M lithium hydroxide 
solution to give ligand L7 (L8) which was complexed by heating at 90°C with the 
lanthanide chloride salt in aqueous solution at pH 5.5 (Scheme 4.11). 
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Scheme 4.11 Final steps leading to the production of [EuL7] and [GdL7] 
Having finally established a route to the target complexes, the carboxyalkyl 
substituted analogue was prepared by a similar route. The monosubstituted cyclen 
77 (or 78) was alkylated with dimethyl a-bromoadipate 76 in the presence of base to 
form 86 (and 87). This reaction took approximately one week to reach completion 
whereas the equivalent t-butylbromoacetate reaction reached completion overnight. 
This difference in rate was probably caused by the dimethyl adipate groups being 
bulkier and their addition being more sterically hindered. The BOC protecting 
group was then removed from the tetrasubsituted cyclen 86 (87) using trifluoro-
acetic acid, to give 88 (89). As this was done under anhydrous conditions, the 
100 
methyl ester protecting groups were not affected. Trifluoromethanesulfonyl 
chloride was then used to form the sulfonamide 90 (91). Lithium hydroxide 
solution was used to remove the methyl ester protecting groups and the resulting 
ligand L9 (L 10) was complexed with the lanthanide (Ill) chloride salt in aqueous 
solution at pH 5.5 (Scheme 4.12). 
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Scheme 4.12 Final steps in the synthesis of the carboxyalkyl subsitituted 
complexes. 
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The synthesis of the desired complexes was therefore finally achieved in thirteen 
steps, as outlined in Scheme 4.13 and Scheme 4.14 . 
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Scheme 4.13 Overall successful synthesis of europium (Ill) and gadolinium (Ill) 
complexes of L7• L8 was synthesised in an analogous manner using 3-amino-
propan-1-ol instead of ethanolamine. 
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Scheme 4.14 Overall successful synthesis of europium (Ill) and gadolinium (Ill) 
complexes of L10• L9 was synthesised in an analogous manner using ethanol-
amine instead of 3-aminopropan-1-ol. 
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4.3 Luminescence Studies of Europium Complexes 
4.3.1 Emission Excited State Lifetimes of Eu (Ill) Complexes: 
Evaluation of q 
The number of water molecules ( q) coordinated to the europium (Ill) ion was 
assessed by measuring the rate constants for the depopulation of the Eu 5D0 excited 
Table 4.1 Radiative rate constants k and derived hydration states (q) for decay of 
europium luminescence at pH 7. 
[EuL5] [EuL6] [EuL7] [EuL8] [EuL9] [EuL1~ [EuL11] 
kHzO 1.65 0.87 1.57 1.69 2.05 1.84 1.91 (ms-1) 
kDzO 0.47 0.58 0.503 0.49 0.26 0.22 0.62 (ms-1) 
qEu 1.11 0.04 0.98 1.14 1.85 1.65 1.24 
Assessment of the radiative rate decay constants obtained for the europium 
complexes (Table 3.1) shows that D03A type complexes [Eue], [EuL8] and [EuL11] 
possess only one coordinated water molecule, whereas each of the carboxyalkyl 
substituted complexes, [EuL9] and [EuL1~, possess two water molecules bound to 
the europium (III) centre. This suggests that the presence of the carboxyalkyl 
substituents prevents the coordination of the pyridyl amide moiety to the europium 
centre, thus allowing the coordination of a second water molecule. 
Comparison of the q values obtained for the three C3 appended D03A complexes 
[EuL6], [EuL8] and [EuL11] (Table 4.2) reveals that while [EuL8] and [EuL11] have one 
water molecule coordinated to the europium centre, whereas [EuL 1 has no 
coordinating water molecules. From this observation, it can be concluded that the 
presence of the trifluoromethanesulfonamide, or of just a free methylamine group 
on the 6' position of the pyridyl group, provides sufficient steric bulk to prevent the 
amide carbonyl from coordinating to the europium (Ill) centre. This also sterically 
inhibits water from binding. 
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Table 4.2 Comparison of q values of C3 appended ligands 
[EuL6] [EuL8] [EuL11] 
0~0 yO o<:rnrv~A o\+,rv~A o __ 0 ~ I retN) ~ N £"'~ ~ )S~Jo", o ""' tL?e__;--NH J5 ~ 0 ~-~-CF 3 0 oQ OH2 0 ~0 0 0 0 
q=O q=1 q =1 
4.3.2 Effect of Zill'Dc (11) Concentratioll'D 0111 Excited State Lifetime 
It was anticipated that as ligand L3 has been shown to have a high affinity for zinc 
(II), the pyridyl sulfonamide moieties of the europium complexes would become 
coordinated to any free zinc present in an octahedral fashion involving amide 
carbonyl ligation. This would leave a coordination site free on the europium ion, 
allowing the binding of another water molecule, resulting in a switching from a 
q = 1 to q = 2 complex (Scheme 4.15). 
Scheme 4.15 Proposed mechanism through which [EuL ~may bind zinc (11) ions. 
The amide carbonyl participates in the octahedral ligation of Zn (11) resulting in 
an increase in the hydration state of the europium centre. 
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The europium complexes [Eue], [EuL8], [EuL9] [Eue0], and [EuL11] were dissolved 
in 0.1 M MOPS buffer (pH 7.4). The excited state lifetimes (kH~) were measured in 
the presence of 0, 0.5 and 1 equivalents of zinc. A pH of 7.4 was chosen because the 
speciation plots (section 2.9) showed that at this pH, zinc was bound as an ML2 
complex. 
Table 4.3 Excited state lifetimes of Eu (Ill) complexes in the presence of Zn (II). 
No. of zinc (11) Lifetime T (ms) 
equivalents 
[EuL7) [EuL8) [EuL~ (Eul10) [EuL11] added 
0 0.70 0.59 0.16 0.29 0.52 
0.5 0.72 0.64 0.16 0.29 0.44 
1 0.79 0.65 0.16 0.30 0.45 
The excited state lifetimes (Table 3.5) reveal that none of the trifluoromethane-
sulfonamide complexes show any significant change in lifetime in the presence of 
added zinc (11) ions. This proves that there is no change in the hydration state of 
the europium (III) centre with increasing free zinc (11) concentration. 
4.3.3 Emission Spectra of [Eul7], [Eul8], [Eul9], [Eul 10] and 
[Eul 11] 
The emission spectra of the europium complexes were recorded both in water 
(pH 5.5) and in 0.1 M MOPS buffer (pH 7.4). The spectra recorded were identical, 
suggesting that the MOPS buffer had no effect on the coordination environment of 
the europium (Ill). 
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Figure 4.3 Emission spectra of 
the europium complexes in 
0.1 M MOPS solution, pH 7.4. 
Aex = 271 nm, 315 nm filter. 
Comparison of the emission spec tra of the eu ropium complexes [EuL7] , [Eu L8] , 
[EuL9] , [Eue0] and [EuL11], (Figure 4.3) shows that the coordination environment at 
the europium centre is significantly different for each of these complexes . The poor 
signal to noise ratio and resolution of the [EuL9] and [EuL 1~ spectra is a result of 
the complexes being dihydrated; coordinated water molecules quench europium 
0 0 kdl 26 emiSSIOn mar e y. 
The emission spectrum of [Eue] has a very similar form to that of the pyridyl 
amide complex [EuL 1 . This suggests that the amide carbonyl group coordinates to 
the europium centre in a similar manner in each complex. 
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Figure 4.4 Sensitised europium emission spectra of [EuL7) and [EuL 1. These 
spectra have a very similar form suggesting a similar europium coordination 
environment. 
The sensitised europium emission spectra of the three C3 appended 003A type 
complexes [EuL6] , [EuL8] and [EuL11] , differ in their spectral form. This is in 
agreement with the measured differences in hydration state, as revealed by 
examination of their excited state lifetimes (Section 4.3.1). The complex [EuL6], has 
no group attached to the 6' position of the pyridine ring. This allows the amide 
carbonyl to coordinate to the europium centre in such a way as to prevent water 
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from coordinating as well. The trifluoromethanesulfonamide and aminomethyl 
group on the pyridyl 6' position in complexes [EuL8] and [EuL11] respectively, 
increase the apparent steric demand of the aryl moiety. This prevents the 
coordination of the amide carbonyl to the europium centre and in addition inhibits 
the direct coordination of a second water molecule to the lanthanide centre. Seven-
coordinate monohydrated systems have also been synthesised by Bretonniere et 
al.65 In these systems the presence of a sterically demanding acridone moiety 
prevents the lanthanide centre being dihydrated. 
4.3.4 Effect of Zinc (11) on Emission Spectra of Europium (Ill) 
Complexes 
The sensitised emission spectra of the europium complexes [Eue], [EuL8], [EuL9], 
[EuL1~ and [EuL11] were recorded in 0.1M MOPS buffer (pH 7.4) in the presence of 
0, 0.5 and 1 equivalents of zinc (11). 
The trifluoromethanesulfonamide complexes showed no change in either spectral 
form or intensity with the increase in zinc concentration. This is in agreement with 
the absence in variation in excited state lifetimes, consistent with no change in the 
hydration state of these complexes with added zinc (11) ions. It also shows that 
there is no change in the coordination environment at the europium centre. Such 
behaviour suggests that in the case of the q = 1, D03A complexes, possessing a 
coordinated amide carbonyl group, the affinity of the amide carbonyl for the 
proximate lanthanide (Ill) centre is greater than its affinity for zinc (11). These 
results show that the pyridyl trifluoromethanesulfonamide moieties do not bind as 
hypothesised to free zinc (11) in an octahedral fashion. However, it does not rule 
out the possibility that free zinc (11) is bound in a four-coordinate complex, leaving 
the europium coordination environment unaffected. 
As complexes [EuL9] and [EuL10] have two bound water molecules, it is unlikely 
that the coordination of zinc (11) to the trifluoromethanesulfonamide moiety would 
result in any change in the coordination environment of the europium (Ill) centre. 
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4.3.5 Effect of Zinc (li) on Excitation Spectra of Europium 
Complexes 
Information about the europium coordination environment can also be ascertained 
from the excitation spectrum.126 The excitation spectra of [Eue], [EuL8], [EuL9] 
[EuL1~, and [EuL11] were recorded as a function of zinc (11) whilst observing the 
616 nm emission band. 
The form of the excitation spectrum of all of the Eu (Ill) complexes remained 
unchanged with increasing zinc (11) concentration. This proves that there is no 
change in the coordination environment of europium, i.e. no reversible ligation, 
with changing zinc (11) concentration. 
4.3.6 Effect of Zinc (11) Concentration on Pyridyl Emission and 
Absorption Spectra 
The pyridyl emission spectra and absorption spectra of the europium complexes 
[EuL7], [EuL8], [EuL9] [Eue~, and [EuL11] were recorded in the presence of 0, 0.5 
and 1 equivalents of zinc (11) (Aex = 271 nm). No change in the absorption or the 
spectral form or intensity of the pyridyl emission was observed. This strongly 
suggests that the pyridyl coordination environment of all of these complexes 
remains unchanged in the presence of excess zinc (11). 
4.4 Re/axivity Behaviour of Gadolinium Complexes 
The behaviour of the gadolinium (Ill) complexes [Gde], [GdL '1, [GdL ~ and 
[Gde0] was assessed by 1H NMR relaxivity studies. The relaxivity values were 
determined from the measured T1 values and were calculated as described in 
Section 3.5. 
4.4.1 Relaxivity of [Gdl7], [Gdl8], [Gdl9] and (Gdl10] 
The relaxivities of [Gde], [GdL8], [GdL9] and [GdL1~ were determined at both 
60 MHz, 22°C and at 65 MHz and 37°C (Table 4.4). 
110 
Table 4.4 Relaxivities of Gadolinium Complexes, pH 6. 
Relaxivity Complex 
(mM-1s-1) [GdL7] [GdL8] [GdL9] [GdL1~ 
65 MHz,22°C 6.74 6.56 13.40 19.9 
60 MHz,37°C 4.34 4.35 8.71 13.6 
The relaxivity values obtained for complexes [Gde] and [GdL8] lie within the 
expected range for low molecular weight gadolinium complexes with one water 
molecule coordinated to the Gd (Ill) centre.92 
[GdL9] and [GdL1~ have high relaxivity values, even for q = 2 complexes. The 
relaxivities are significantly higher than the value shown by the parent GdaD03A 
system,93 which exhibits a relaxivity of 12.3 mM-1s-1 (20 MHz, 298 K). 
High relaxivity values result from the concomitant effect of two inner sphere water 
molecules and the increase in molecular size. A linear relationship has been 
observed between the relaxivity and the molecular weight of diaqua gadolinium 
complexes.138 consistent with the expected effect of an increasing TR, under 
conditions of fast water exchange. 
The relaxivity values obtained for each of the gadolinium complexes studied, i.e. 
[Gde], [GdL8], [GdL9] and [Gde~ are in agreement with the hydration states 
observed for the related europium complexes. 
4.4.2 Effect of Zinc (11) on Relaxivity 
Although the presence of an excess of zinc (II) ions showed no effect in the related 
europium complexes, it is possible that the trifluoromethanesulfonamide moiety 
binds to zinc but without any change in the lanthanide coordination environment. 
In the europium complexes, only a change in the coordination environment or 
hydration state would result in a change in the sensitised europium emission of 
excited state lifetime. 
Addition of zinc (II) to the gadolinium system may result in the formation of a 2 : 1 
complex with 2 Gd3+: 1 Zn2+. The increased size of this molecule will cause it to 
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tumble more slowly in solution; slower tumbling in solution results in an increase 
in -rR138 and consequently the relaxivity will increase (Scheme 4.16). In the case of 
the q = 1 D03A complexes, [Gde] and [GdL8], it would be possible that the free 
zinc was bound in a four coordinate manner between the sulfonamide and pyridyl 
nitrogen atoms, while the amide carbonyl remains bound to the lanthanide centre. 
This would cause no change in the lanthanide coordination environment. 
Scheme 4.16 The coordination of the trifluoromethane sulfonamide pyridyl 
moiety of [GdL1~ to zinc may result in the formation of a 2:1 complex, resulting 
in an increase in molecular size and consequently an increse in relaxivity. 
The gadolinium (Ill) complexes [Gde], [GdL8] and [GdL1~ were dissolved in 0.1 M 
MOPS buffer (pH 7.4). Due to problems with solubility, possibly due to 
oligomerisation at high pH, [GdL9] was dissolved in water at pH 5.5. Small 
aliquots containing 0.5 equivalents of zinc (11) acetate were added to the solutions of 
the complexes. The T1 values were determined at 60 MHz, 37°C. 
Table 4.5 Effect of zinc (11) on the relaxivity of gadolinium complexes [Gde], 
[GdL8], [Gde] and [GdL10]. 
No. of zinc 
Relaxivity (mM-1s -1) 
(11) [GdL7] [GdL~ [GdL9] [GdL1~ equivalents 
added (60MHz, (65MHz, (65 MHz, (60 MHz, 
37°C) 22oC) 22oC) 37°C) 
0 4.34 6.56 8.70 13.63 
0.5 4.35 6.50 8.71 12.89 
1 4.45 6.76 8.72 12.45 
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It can be seen from Table 4.5 that the presence of free zinc (II) results in no 
significant increase in the measured relaxivity for each of the gadolinium 
complexes. From this information it can be concluded that the pyridyl trifluoro-
methanesulfonamide moiety does not have a sufficiently high affinity for zinc (II) 
under the conditions of the present study. 
The slight decrease in relaxivity observed for [Gde0] at increased zinc 
concentrations may be a result of the acetate anion perturbing the second sphere of 
hydration. 
4.5 Protein Binding Studies 
Human serum albumin (HSA) is the most abundant protein in blood plasma and is 
the major transport protein for zinc (II).139 Blood plasma has a zinc concentration of 
ea. 19 p.M, most of which is bound to HSA with an affinity constant of 
logKd = -7.53.140 
The interaction of gadolinium chelates with proteins has been widely investigated 
in recent years.69 Research has focussed on gadolinium chelates which will bind to 
HSA either through a covalent or non-covalent interaction resulting in a ternary 
macromolecular paramagnetic complexes. HSA tumbles slowly in solution with 
the small Gd (III) chelate compartmentalised within, also tumbling slowly. 
At the magnetic field strength used in MRI scans (20- 60 MHz), the longitudinal 
relaxation time of bound water molecules T1M is dominated by the rotational 
correlation time (-rR)· If the gadolinium complex tumbles more slowly, TR increases 
and this leads to an increase in the relaxivity. The length of TR for a small Gd 
complex is usually in the picosecond range (typically 50- 200 ps) whereas TR for 
albumin is in the nanosecond range (ea. 50 ns).68 
Many gadolinium chelates have been synthesised which contain a hydrophobic 
moiety which binds to HSA,69 this is then attached to the gadolinium chelate 
through a rigid linker so that the motion of the protein is coupled to that of the 
gadolinium, leading to an increase in TR of Gd (Figure 4.5). 
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Slowly Tumbling Protein 
~ 
Figure 4.5 Schematic representation of a Gd (Ill) chelate binding to HSA leading 
• • 69 to an mcrease 1n Tw 
As well as providing increased relaxivity values through the increase in TR, contrast 
agents which bind HSA target the blood pool allowing selective enhancement of 
veins and arteries. They also have an increased half-life in vivo allowing higher 
1 . . b b . d 141 reso ution rmages to eo tame . 
The high affinity of the pyridine trifluoromethanesulfonamide moiety for zinc (II) 
coupled with the hydrophobic nature of this group suggested that this might make 
a good HSA binding system. With this in mind, HSA was added to solutions of the 
gadolinium (III) complexes and relaxivity was measured as a function of added 
HSA. 
4.5.1 Binding Affinity of Gd Complexes to Human Serum Albumin 
The binding interaction of gadolinium complexes [Gde], [GdL ~' [GdL ~ and 
[GdL10] to human serum albumin (HSA) were assessed by measuring the water 
proton relaxation times of solutions containing the paramagnetic complex in the 
presence of increasing concentrations of the protein. These titrations were carried 
out in collaboration with Nicola Thompson using the Bruker Minispec mq60 
(60 MHz, 37°C). 
In addition to yielding an estimate of the binding strength KA (by assuming one 
binding site on the protein) by iterative least squares fitting, these measurements 
also provide a direct assessment of the relaxivity of the putative macromolecular 
adduct. 
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The relaxivity values obtained in these protein binding studies have been quoted in 
terms of molality (mMolal-1s-1). Defining relaxivity in terms of mM_\_1 in protein 
solution, such as human serum albumin, can be misleading as high concentrations 
of protein are usually dissolved. As a result, more than 20% of the volume is 
occupied by protein and hence less than 80% by water. 92'142 
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Figure 4.6 Increase in relaxivity of [GdL7] (0.32 mM) with increasing HSA 
concentration (60 MHz, 37°C). 
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Figure 4.7 Increase in relaxivity of [GdL8] (0.40 mM) with increasing HSA 
concentration (60 MHz, 37°C). 
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Figure 4.8 Increase in relaxivity of [GdL9) (0.05 mM) with increasing HSA 
concentration (60 MHz, 37°C). 
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Figure 4.9 Increase in relaxivity of [GdL1~ (0.12 mM) with increasing HSA 
concentration (60 MHz, 37°C). 
The binding curves for the gadolinium complexes to HSA, Figure 4.6- Figure 4.9 
and the association constants (Table 4.6) reveal that the complexes with carboxy-
alkyl substituents, [GdL ~ and [GdL10], show a much higher binding affinity and 
greater increase in relaxivity with the addition of HSA compared to the charge 
neutral 003A analogues. 
116 
The q = 1 D03A complexes show approximately 60% increase in relaxivity on 
binding to HSA. Whereas the relaxivity of the q = 2 [Gde~ system doubles and 
[GdL9] shows approximately a 700% increase in relaxivity. 
Table 4.6 Binding constants (KA) for the gadolinium complexes to HSA. 
Complex KA (M-1) 
[GdL7] 1.15 X 104 
[GdL8] 1.45 X 104 
[GdL9] 2.71x 105 
[GdL1~ 8.55 X 104 
The concentration of HSA in the blood is 0.6 mM.139 From the experimental binding 
affinities, it can bee seen that complexes [GdL9] and [Gde0] have reached the 
maximum saturated relaxivity value at this concentration. 
The tri-negative charge on the [GdL9] and [Gde0] complexes may have caused an 
increase in the electrostatic interaction between the gadolinium chelate and the 
HSA resulting in the carboxyalkyl substituted complexes having a higher affinity 
for HSA compared to the neutral complexes. 
The greater relaxivity enhancement shown by [GdL9] compared to [GdL 1~, is 
probably caused by the C2 linker being more rigid than the C3 analogue. Free 
rotation about the alkyl chain could result in the slow tumbling rate of HSA not 
being transferred efficiently to the gadolinium chelate in [Gde~.69 
It is likely that hydrogen bonding between the pyridyl nitrogen and the amide 
proton will result in the [GdL9] and [GdL1~ adopting different conformations in 
solution, Figure 4.10. This hydrogen bonding between a pyridyl nitrogen and 
amide proton has been observed in a 2,6-diamide substituted pyridine system 
synthesised by Hunter and Purvis.143 The different conformations of the two 
analogues may be associated with the different binding affinities to HSA. 
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Figure 4.10 Proposed conformation of [GdL9] and [Gde~ 
The affinity constant of [GdL9] for HSA is in line with the affinity constant shown 
by L2 for zinc (11). This suggests that a complex may form between [GdL9] and a 
zinc (11) ion present within the HSA protein. 
In previous examples of diaqua gadolinium complexes, the expected relaxation 
enhancement on binding to a macromolecule such as HSA has not been observed. 
This is generally because the inner sphere water molecules are displaced by a donor 
atom either from the protein (e.g. a carboxylate group) or through the coordination 
of a bidentate anion (e.g. carbonate or phosphate).138 
4.5.2 NMRD Profiles of Gadolinium Complexes bound to HSA 
NMRD profiles are highly diagnostic of the formation of adducts between 
gadolinium complexes and slowly tumbling substrates such as proteins, as they 
show a characteristic relaxivity peak centered at about 20- 30 MHz. 130 
NMRD profiles of the gadolinium complexes were recorded in Durham and will be 
fitted according to the theoretical arguments presented in Section 3.6. The profiles 
were recorded at 25°C in the presence and absence of a saturated level of HSA, 
Figure 4.11- Figure 4.14. 
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From the NMRD profiles of the D03A complexes [Gde] and [GdL ~ (Figure 4.11 
and Figure 4.12) it can be seen that the addition of HSA causes a doubling of the 
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observed relaxivity. The appearance of a relaxivity peak at the high field end of the 
spectrum is characteristic of an increased TR. The effect on TR is more pronounced in 
[GdL7] than in [GdL8]. This is probably because the C2 spacer is less 
conformationally mobile than the c3 spacer. Thus, the c3 spacer allows free 
rotation between the HSA-pyridylsulfonamide moiety and the gadolinium chelate, 
the C2 spacer is more rigid so the protein and gadolinium chelate tumble coherently 
and the increased TR of the HSA is effectively transferred to the gadolinium ion. 
This effect is also apparent in the behaviour of carboxyalkyl analogues [GdL ~ and 
[Gde0], Figure 4.13 and Figure 4.14. The relaxivity increase in the high field region 
caused by the increased TR is much greater in the C2 example, again suggesting that 
the C3linkage group allows more rotational freedom. 
The relaxivity enhancement exhibited by [GdL9] is quite remarkable. Previous 
examples of q = 2 gadolinium chelates have always displayed a much lower 
relaxivity value than expected. This is usually caused by the displacement of the 
bound water molecules by protein side chains (e.g. aspartate or glutamate 
carboxylate groups) or anions, or free rotation occuring in the spacer group so that 
the long TR of the HSA is not effectively transferred to the gadolinium centre.138 
Complex [GdL ~ is unique in that it maintains its q = 2 hydration stae in the 
presence of HSA and apparently tumbles coherently with the protein. This results 
in an unprecedented relaxivity value and has a relaxivity value92 close to the 
calculated maximum value for such a system.69 
As these results were so unexpected, the complex was sent to Turin for 
independent verification. The relaxivity value at 40 MHz was also measured as this 
appeared, from the NMRD profiles, to be the frequency at which the maximum 
relaxivity value would occur. 
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Figure 4.15 NMRD Profile of [GdL9) in the presence of HSA, measured in Turin. 
Figure 4.15 shows the relaxation rate of [Gde] in the presence of HSA. This data is 
in agreement with that obtained in Durham and suggests that the maximum 
relaxivity is obtained at ea. 40 MHz. This value appears to be approximately 20% 
higher than the relaxivity at 20 MHz suggesting a maximum relaxivity value of 
- 90 mM.1s-1 (40 MHz, 25°C) 
4.5.3 Effect of Human Serum on Relaxivity 
Complex [GdL ~ exhibits high relaxivity in the presence of HSA, suggesting that it 
binds very well to the protein and this reduces its rate of tumbling in solution. 
Also, the complex retains its dihydrated state in the presence of HSA. 
Most q = 2 contrast agents which have been synthesised so far exhibit a binding of 
the protein carboxylate side chains to the lanthanide centre resulting in the water 
molecules being displaced with a subsequent reduction in the observed relaxivity. 
Although the relaxivity was maintained in GdaD03A, the relaxivity did not 
increase so markedly in the presence of either HSA or human serum.93'142 
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The relaxivity of [GdL9] was determined in the presence of human serum (60 MHz, 
Table 4.7 Relaxivity (60 MHz, 37°C) of [GdL9] in the presence of human serum. 
Relaxivity (mM"V1) (60 MHz, 37°C) 
[GdL9] 8.7 
[GdL9] in 0.6mM HSA 67.5 
[GdL9] in human serum 14.1 
The relaxivity of [GdL9] is shown to be much smaller in serum than in serum 
albumin, Table 4.7. This suggests that anions from the serum bind to the 
gadolinium centre displacing the water molecules leading to a significant reduction 
in relaxivity. Although [GdL9] has a high affinity for HSA in serum, leading to an 
increase in relaxivity through an increase in TR, the loss of the dihydrated state of 
the gadolinium leads to a feeble relaxivity enhancement. 
The relaxivity of [GdL9] in human serum was monitored as a function of pH over 
the range 9 to 4. N-Alkylation of the macrocyclic ring is known to lead to a higher 
affinity for anion binding at lanthanide centres.64 It was hypothesised that a 
reduction of pH might prevent anions such as bicarbonate or phosphate from 
binding. However, no significant change in relaxivity was observed with 
decreasing pH, suggesting that lactate, as well as phosphate and bicarbonate is a 
likely competeing ion. 
4.5.4 Effect of Anions on Relaxivity 
As the binding of anions to the gadolinium centre was hypothesised as the cause 
for the reduction in relaxivity observed in serum, the relaxivity of [Gde'] was 
recorded as a function of the concentration of biological anion background. 
Aliquots of a simulated anion background solution containing carbonate (30 mM), 
phosphate (0.9 mM), citrate (0.13 mM) and lactate (2.3 mM) were added to a 
solution of [Gde'] and the transverse relaxation time (60 MHz, 37°C) was 
recorded. 
123 
16 .................... ········-······-······-- ·········-----··········-·-··-·--··---------------···--··-···----·····-·------------
14 
12 
.. 
~~ 10 
.§. • 
... 8 
:t= 
> 
·;c 
6 
'" a; 
a: • 
4 
2 
0 
0 20 40 60 80 100 120 140 180 
Anion Background Addition (Ill) 
Figure 4.16 Relaxivity of [Gdej as a function of biological anion concentration. 
From Figure 4.16 it can be seen that the relaxivity decreases significantly as the 
biological anion concentration increases. This suggests that it is the binding of 
extra-cellular anions which cause the decrease in relaxivity in serum. The relaxivity 
of [GdL1~ in anion background was monitored as a function of pH The relaxivity 
remained constant between pH 3 and pH 9. This is in agreement with the 
observations made in serum. 
4.5.5 Effect of Anions and pH on Luminescence of [Eul9] 
Further to the observation that relaxivity of [Gde~ did not vary with pH in an 
extra-cellular anion background; the sensitised emission spectrum of [EuL ~ was 
recorded in an extra-cellular anion background as a function of pH. 
Europium luminescence is effectively quenched by the OH oscillators in bound 
water molecules.61 The displacement of these water molecules by coordinating 
anions can be detected by an increase in the emission intensity, Scheme 4.17. 
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Figure 4.17 Effect of pH on sensitised emission (.\ex 271 nm) of [EuL9) in an 
extracellular anion background. 
The sensitised europium emission spectrum (Figure 4.17) of [EuL9] in an extra-
cellular anion background shows that as the pH decreases there is a change in the 
125 
spectral form but the intensity of emission remains constant. This suggests that 
anions are bound to the europium centre over the whole pH range investigated, 
unlike in the parent GdaD03A system where the anions only bound at pH>7.5.142 
At high pH (>7.5), the hypersensitive .t1J = 2 band is very sharp and intense and the 
.t1J = 1 band is broad. A decrease in pH results in a change in the spectral form at 
-pH 7.5. The intensity of the .t1J = 2 band decreases and resolves into two distinct 
bands and the intensity of both the .t1J = 4, .t1J = 1 and .t1J = 0 bands increase, with the 
.t1J = 1 transition displaying three bands. This suggests that the anion coordinated 
to the europium centre varies with pH. 
In order to unequivocally prove which anion is bound to the europium centre, the 
sensitised emission spectrum of [EuL9] was recorded in solutions containing only 
one anion. 
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Figure 4.18 Effect of lactate, phosphate and carbonate on the sensitised emission 
of [EuL9). 
The sensitised emission spectra of [EuL9] in the presence of lactate, phosphate and 
carbonate show significant differences in spectral form, (Figure 4.18). The 
displacement of the water molecules bound to the europium centre by the anions 
results in a large increase in emission intensity. 
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Comparison of Figure 4.17 with Figure 4.18 reveals that at high pH (>pH 7.5), 
carbonate is bound to [EuL9] and as the pH decreases the carbonate is displaced by 
phosphate. 
4.6 Conclusions 
Pyridine trifluoromethanesulfonamide appended lanthanide complexes [Lne], 
[LnL8], [LnL9] and [LnL1~ did not show any behaviour, either emissive or 
relaxometric, which was responsive to zinc (11) ions in the range investigated. A 
zinc (II) binding group with a higher affinity at physiological pH must be sought. 
Protein binding studies revealed that [GdL9] has a very high affinity (KA = 
1.4 x 105 M-1) for HSA. The binding of [GdL9] to HSA results in the formation of a 
ternary adduct with a very high relaxivity: unbound r1P = 8.7 mM-
1
s-
1 (60 MHz, 
37°C) compared to r1P = 67.5 mM_\_1 (60 MHz, 37°C) when bound to 0.6 mM HSA. 
This increase in relaxivity shows that [GdL ~ remains q =2 even when bound to 
protein and the increase in TR of the protein increases the observed relaxivity. 
However, this relaxivity is not maintained in the presence of serum. The presence 
of anions in the serum displaces the inner sphere water molecules from the 
gadolinium, resulting in a significant reduction in relaxivity. Sensitised emission 
spectra of the europium analogue have revealed that at pH > 7.5, carbonate anions 
bind to the gadolinium whereas at pH < 7.5 phosphate anions displace the water 
from the lanthanide centre. 
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5 pH and pZn Responsive Lanthanide System 
5. 1 Introduction 
The pyridyl trifluoromethanesulfonamide ligand L2 was incorporated into a D03A-
type macrocyclic complex [LnL12], which was destined to have pH and pZn (11) 
responsive properties for potential MRI and luminescence applications. The 
complex has an anionic sulfonamide donor which was hypothesised to bind to the 
lanthanide (Ill) centre in a reversible manner in response to changing pH and zinc 
(11) concentration. 
t no_" I w o'}.-o 0. N~N~N, ( th;£~---~-CF 
__ei. I J.::::+-N-S-CF e_N, I ,N-=:L H 11 3 0YJ~~ 8 ' O~~_f(OH,~ 0 
(1) 0 ~Zn2• 0 Zn2• f [G(d2L)12] 0 
Low relaxivity ,I' 
No bound Water 'Y-( { 0 High relaxivity 
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Scheme 5.1 Proposed mechanism for the responsive behaviour of (GdL 12) with 
variation of pH and pZn (11). 
The proposed mechanism through which [GdL 12] enhances the water relaxation rate 
in response to increased concentrations of zinc (11) and pH is illustrated in Figure 5.1. 
At high pH and in the absence of Zn (II), complex (1), the gadolinium (Ill) ion is 
eight coordinate, and binding of water is inhibited by the presence of the 
coordinated trifluoromethanesulfonamide group, leading to a complex with low 
relaxivity. 
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In the presence of acid, the sulfonamide nitrogen will be protonated and the binding 
of the sulfonamide nitrogen to gadolinium is suppressed; complex (2) may then 
form. This leaves a co-ordination site free on the Gd (Ill} for water to bind, leading 
to an increase in the relaxivity of the complex. The pH dependence of this process 
has been defined in recent work by Lowe et al. 63'77: the pH at which complex 
protonation occurs may be controlled by variation of the sulfonamide group or by 
changing the substituent a to the ring nitrogen. Complexes with pKaH values in the 
range 5.7 to 7.2 have been characterised in Lowe's work. 
Addition of zinc (II) ions to the system will disturb this equilibrium, resulting in the 
stepwise formation of (3), which is a 2: 1 complex with 2 Gd3+: 1 Zn2+. The 
increased size of this molecule will cause it to tumble more slowly in solution; 
slower tumbling in solution results in an increase in TR and consequently the 
relaxivity will increase. 
The europium analogue [Eue2] was also synthesised. It is proposed that at high 
pH, no water will be coordinated to the europium centre, so the intensity of 
emission will be high. As pH increases, the sulfonamide nitrogen will protonate 
and water will be able to bind to the europium centre, leading to a quenching of the 
emission. Similarly, at high concentrations of zinc (II) ions, the sulfonamide 
nitrogen will bind to zinc, allowing water to bind to the europium, again resulting 
in a decrease in the intensity of emission. 
5.2 Synthesis 
Many different routes were investigated in an attempt to synthesise ligand e2. 
Initially, work was directed towards the synthesis of enantiomerically pure 2-
pyridylglycine, Scheme 5.2. 
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Scheme 5.2 The first target in the overall sequence requires the synthesis of 
enantiometrically pure 2-pyridylglycine 
Early attempts that were made to synthesis 2-pyridylglycine are shown in Scheme 
5.3. The initial intention was to prepare the N-acetyl derivative and use hog renal 
acylase144 to resolve it. 2-Pyridinecarboxaldehyde was converted into the oxazole 92 
. h B h B . 145 usmg t e uc erer- urgs reaction. Subsequent hydrolysis with 2M sodium 
hydroxide solution145,146 yielded a mixture of 2-pyridylgycine 93 and pyridine-2-
ylmethyl-urea 94 in variable ratios and yields. Strong cation exchange resin was 
used to remove the salt from the products. However, the liberation of protons in 
exchange for Na + resulted in the decarboxylation of the amino acid and the 
production of unwanted 2-aminomethylpyridine 95. 
OyH 
0 
Strong cation ~ exchange res;n 
95 
NH2 94 
1
2M NaOH 
120C 
~COOH 
93 
NH2 
Scheme 5.3 Initial attempt to synthesise 2-pyridyl glycine 93. 
An alternative route, Scheme 5.4, was therefore devised for the synthesis of N-acyl 
2-pyridylglycine 96. The oxime 97 was formed by reacting sodium nitrite with 
ethyl(2-pyridyl)acetate as described by Van Zyl et al. 147 Following the method of 
Kolar and eo-workers, 148 97 was reduced using zinc dust and acetic anhydride to 
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form the racemic amide 98. Hydrolysis of the ethyl ester was achieved with 0.02 M 
sodium hydroxide solution to yield N-acyl 2-pyridylglycine 96. 
~0 w~o w~o OJ NaNO,J • Oyt--< Zn/(CH,CO),O N--< O~ NaOH(aq) N--< OH /"o..CH3COOH N 0....-........:: N o· -.... HNY HNY 
NOH 
97 98 0 96 0 
Scheme 5.4 Synthesis of N-acyl2-pyridylglycine. 
Hog renal acylase was then used in an attempt to make enantiomerically pure 
2-pyridyl glycine from 96. Unfortunately both enantiomers were obtained, with no 
significant resolution. 
a-Chymotrypsin was then used in an attempt to hydrolyse ester 98 to 
enantimerically pure N-acyl protected 2-pyridyl glycine. This also resulted in the 
isolation of unresolved material. 
As the ligand was more challenging than expected to synthesise, it was decided to 
concentrate on the chemistry of the racemic mixture. The target could be then 
synthesised subsequently in an enantiomerically pure form. 
Initial efforts to reduce ester 98 to the alcohol used borane.THF at low temperatures. 
This proved to be too powerful a reducing agent, reducing both the ester and the 
amide functional groups. Lithium borohydride proved to be more gentle, and 
reduced only the ester functionality to the alcohol to give 99 in 41% yield. The 
amide protecting group was then removed by hydrolysis in 6M hydrochloric acid to 
give 100 quantitatively. Trifluoromethanesulfonyl chloride in the presence of 
Hiinig's base was then used to prepare the sulfonamide 101. 
Problems arose in attaching a leaving group to 101 so that it could be linked to the 
protected 003A core. Triphenyl phosphine and carbon tetrabromide were used in 
an attempt to brominate the alcohol. However, under a variety of conditions no 
reaction occurred. Attempts were made to sulfonylate the alcohol 101 with 
trifluormethanesulfonyl chloride, trifluoromethanesulfonic anhydride, and 
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trifluoromethanesulfonyl imidazole under different conditions, but the desired 
product was never isolated. 
As it did not seem possible to attach a leaving group to 101, it was decided to go 
back to the protected amine stage (99), and endeavour to join the pyridyl amide on 
to the D03A core and then sulfonylate it. It was found possible to brominate 99 
using triphenyl phophine and carbon tetrabromide. The bromide 102 was then 
used to alkylate protected D03A 48, but this led directly to the formation of the 
aziridine 103. Attempts were made to alkylate the protected D03A using the 
aziridine, which was produced by stirring the bromide in potassium hydroxide 
solution. The aziridine proved to be very stable and resisted ring opening even 
when heated to 160°C (Scheme 5.5). 
Scheme 5.5 Formation of stable aziridine 103. 
As joining the pyridyl moiety with the protected amine group onto D03A was 
difficult, further attempts were pursued using the sulfonamide 101. This time it 
was decided not to isolate the product with the leaving group as this was probably 
causing intermolecular reactions to occur. Instead, attempts were made to react it 
on in situ. 
Methanesulfonyl chloride was then used to mesylate the alcohol of 101. The 
disappearance of the alcohol was monitored by TLC and a single spot, presumed to 
be 104, was formed. This was then reacted in situ with the addition of 1,4,7-tris(tert-
butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane 48, in hot acetonitrile, in the 
presence of potassium carbonate. The resulting tetrasubstituted cyclen 105 was 
deprotected with trifluoroacetic acid to afford the desired ligand L12 as the TFA salt. 
Lanthanide (Ill) complexes, [Eue2] and [Gde2] were prepared in aqueous solution 
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following reaction of the ligand with hydrated LnC13 at pH 5.5 (90°C, 18 hours), 
Scheme 5.6. 
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Scheme 5.6 Successful overall synthesis of lanthanide (Ill) complexes of ligand L12• 
5.3 Luminescence Studies of [EuL 12] 
5.3.1 Effect of pH on Emission Spectrum of [EuL 12] 
Information about the nature of the lanthanide (Ill) coordination environment as a 
function of pH was provided by examination of the europium emission spectrum 
following sensitised excitation (262 nm). It was anticipated that as the pH 
decreased, the sulfonamide nitrogen would become protonated, resulting in the 
sulfonamide nitrogen ceasing to bind to the lanthanide centre (Scheme 5.7). This 
would then allow water to bind to the lanthanide centre, resulting in a change in 
spectral form and a decrease in the intensity of emission. Also, the increased 
distance between the pyridyl chromophore and europium (Ill) centre would result 
in less efficient energy transfer between the sensitising group and the lanthanide 
ion. 
Scheme 5.7 Hypothesised effect of pH on the constitution of [EuL12). 
The pH of a solution of [Eue2] was adjusted to pH 10 using sodium hydroxide 
solution. Small aliquots of 0.1 M HCI were added and the luminescence spectra 
were recorded at each point following excitation at 262 nm. 
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Figure 5.1 Effect of pH on the Sensitised Emission (Xexc 262 nm) of [EuL12] 
(315 nm filter). 
The emission spectrum (Figure 5.1) shows no change in spectral form between pH 3 
and pH 10. As the pH decreases, the intensity of emission can be seen to increase 
slightly although the ratio of the .t1J = 2: .t1J = 1 bands remains constant. This 
suggests that there is no change in the europium coordination environment over the 
pH range investigated. It can therefore be concluded that there is no reversible 
ligation of the europium centre with changing pH 
If the pyridyl nitrogen were irreversibly bound to the europium (Ill) centre, then the 
protonation of the unbound sulfonamide nitrogen with decreasing pH may result in 
the slight increase in intensity of the spectrum, as it would be less hydrated than in 
an anionic form. 
5.3.2 Variation of Excitation Spectra of [Eul 12] with pH 
Information about the europium coordination environment can also be ascertained 
from the excitation spectrum. The excitation spectrum was also recorded as a 
function of pH whilst observing the 616 nm emission band. 
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Figure 5.2 Excitation of [EuL 12] as a function of pH. 
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Although the intensity increases slightly, the form of the excitation spectrum of 
[Eue2] remains unchanged with decreasing pH (Figure 5.2). This suggests that 
there is no change in the coordination environment of europium, thus no reversible 
ligation, with variation in pH. 
5.3.3 Variation of [Eul 12) Absorption Spectra with pH 
The absorption spectrum of [EuL12] was also monitored as a function of pH. No 
significant variation in spectral form and intensity was observed with changing pH 
(A.max 262 nm), suggesting that the coordination environment of the pyridyl 
chromophore was not changed. 
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5.3.4 Emission excited state lifetimes of Eu (Ill) complex: 
evaluation of q. 
The number of water molecules (q) coordinated to the europium centre of [EuL12] at 
pH 4 and 7 was assessed by measuring the rate constants for the depopulation of 
the Eu 5D0 excited states in H20 (kH20) and D20 (k020) as discussed in Section 3.3.61 
Table 5.1 Rate constants for decay of Eu excited state and number of bound 
water molecules bound to [Eue2] at pH 4 and 7. 
[EuL12] pH4 pH7 
kHzO (ms-1) 1.50 1.35 
kvzo (ms-1) 0.54 0.53 
qEu 0.8 0.7 
Table 5.1 shows that there is one water molecule bound to [EuL 12] and the hydration 
state of the europium (Ill) centre does not change with increasing pH. This is also in 
agreement with the absence of pH dependent ligation of the europium (Ill) centre. 
The value of q obtained is less than one, but the hydrophobic nature of the pyridyl 
and trifluoromethyl moieties may result in the outer sphere contribution being low, 
resulting in a decreased q value. The slight increase in the q value at pH 4 can 
probably be attributed to the protonation of the sulfonamide nitrogen resulting in 
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5.3.5 Effect of Zinc (11) on Luminescence of [Eul 12] 
Information about the nature of the lanthanide (Ill) coordination environment as a 
function of zinc (11) concentration was provided by examination of the europium 
emission spectrum following sensitised excitation (262 nm). It was anticipated from 
the speciation plots of the model ligand (Section 2.9.1) that, as the concentration of 
zinc increased at neutral pH, the pyridyl and sulfonamide nitrogens would bind to 
the free zinc (11), Scheme 5.8. A consequence of this zinc (11) binding would be that 
the sulfonamide nitrogen could no longer bind to the lanthanide centre; this would 
result in the chromophore being further from the europium centre and allow more 
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water to bind to the lanthanide centre resulting in a change in form and decrease in 
the intensity of europium emission.63 
Zn2+ 
0 to o 
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Scheme 5.8 Hypothesised Effect of Zinc (11) on [EuL12]. 
The excitation and emission of [EuL12] were monitored as a function of added zinc 
(II) while keeping the pH constant (pH 7.1). Zinc (11) acetate solution was added in 
small aliquots containing one equivalent of zinc until 10 equivalents had been 
added. EDT A was added to a sample of the [EuL 12] solution before the titration was 
undertaken to confirm that the complex had not already become bound to a metal 
ion. No change in the spectrum was observed so it was concluded that the sample 
was free from transition metal ions. 
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Figure 5.3 Sensitised emission (-"ex 262 nm) of [EuL 12] as a function of zinc (II) 
concentration. 
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The emission spectrum (Figure 5.3) shows that there is no change in form or 
intensity as a function of zinc (II) concentration. There is similarly no change in the 
form or intensity of the excitation spectrum. It would be expected that if the pyridyl 
sulfonamide moiety bound zinc (II) as hypothesised, the binding of zinc would lead 
to an increase in the hydration state of the complex and thus a change in the 
europium (III) emission and excitation. This suggests that there is no change in the 
ligation or hydration state of the europium (III) centre as a function of added zinc 
(II). 
5.4 Ligation of Pyridine? 
Although it was predicted that the sulfonamide nitrogen would ligate the 
lanthanide (III) centre with a five-membered chelate ring, it would also be possible 
for a six-membered chelate ring to form between the lanthanide (Ill) centre and the 
pyridyl nitrogen atom (Figure 5.4). 
Figure 5.4 Possible ligation configurations of [LnL12]. The sulfonamide nitrogen 
binds with a five-membered chelate ring or the pyridyl nitrogen could bind in a 
six-membered chelate ring. 
A related EuD03A complex appended with a pyridyl chromophore, synthesised by 
Lowe, 106 forms a five-membered chelate ring between the pyridyl nitrogen and the 
europium (III) centre.149 The pyridyl nitrogen proved to be a very good donor for 
the europium centre and binds irreversibly in an equatorial position. The crystal 
structure obtained of the complex shows there to be one water of hydration in an 
axial position; this is in agreement with the relaxivity and kH2o data obtained. 
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Figure 5.5 Emission spectrum (Aex 264 nm) of 106 (315 nm filter) The llJ = 2 and 
fl.J = 1 bands have a similar relative intensity. The spectral form is similar to that 
of [Eue2]. 
An emission spectrum (Figure 5.5) was recorded of europium complex 106 which 
had been synthesised by Or Mark Lowe. The emission spectrum shows that a 
pyridyl nitrogen bound to a Eu003A type complex in an equatorial position results 
in a llJ = 2 band of similar relative intensity to the llJ = 1 and llJ = 4 bands. The 
emission spectrum of [Eue2] also has llJ = 2, llJ = 1 and llJ = 4 bands of similar 
relative intensity. This effect suggests that the pyridyl nitrogen of [EuL 12] binds to 
the europium centre in an equatorial fashion while the water is bound in an axial 
position. 
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Europium (III) complex 107 synthesised by Maffeo and Williams150 has a quinoline 
moiety which forms a five-membered chelate ring between the quinoline nitrogen 
and the europium (Ill) centre. The complex has no bound water molecules as the 
space normally occupied by the water molecules is occupied by the benzyloxy 
group. 
The europium emission spectrum obtained of complex 107 is of similar form, 
although the relative intensities of the LlJ bands increases in the order LlJ = 4 > LlJ = 2 
> LlJ = 1. This change in the relative intensities of the LlJ bands is probably a 
function of the change of hydration state. 
107 108 
Another example of a EuD03A complex with an aromatic nitrogen coordinated to 
the europium (Ill) centre in a five-membered chelate ring 108 was synthesised by 
Quici and coworkers.151 The complex has a phenanthroline chromophore and no 
water is bound to the europium centre. The emission spectrum obtained is very 
similar in form to that obtained for 107. 
In summary, a comparison of the emission spectrum of [EuL 12] with that of other 
examples of EuD03A complexes, with an aromatic nitrogen donor coordinated to 
the europium centre in a small chelate rings, shows the greatest similarity between 
[Eue2] and 106. This suggests that the pyridyl nitrogen is coordinated to the 
europium centre in an equatorial position and there is one water molecule 
coordinated in an axial position. The lack of change of the emission spectrum and 
excitation specta as a function of pH and increasing zinc (11) concentration suggests 
that the pyridyl nitrogen is an excellent donor for the europium (Ill) ion in such 
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tribasic N50 3 octadentate ligands, and is not susceptible to protonation, remaining 
irreversibly bound, as was the case for 106. 
5.5 Relaxivity Behaviour of [GdL 12} Complex 
The behaviour of the gadolinium complex (GdL12] was confirmed by relaxivity 
studies. The relaxivity values were determined from the measured T1 values and 
calculated as described in Section 3.5. 
The relaxivity of (Gde2] was determined at both 60 MHz, 37°C and 65 MHz, 22°C 
(Table 5.2). 
Table 5.2 Relaxivity of (Gde2] at pH 7. 
Relaxivity (mM-1s-1) 
Complex 
60MHz,37°C 65MHz,22°C 
[GdL12] 2.67 3.73 
The relaxivity values obtained for (Gde2] at the measured field and temperatures 
lie within the expected range for low molecular weight gadolinium systems with a 
q = 1 hydration state.92 
5.5.1 Effect of pH on Relaxivity 
The relaxivity of (GdL12] was determined at pH 4, 7 and 9 using the Bruker 
Minispec mq60 (60 MHz, 37°C). The system was designed to increase in relaxivity 
with a decrease in pH. However, if the gadolinium and europium complexes 
behave in the same manner, with the pyridyl nitrogen being a very good donor for 
the lanthanide centre, no change in relaxivity would be expected with a decrease in 
pH. 
Table 5.3 Relaxivity of (Gde2] at pH 4, 7 and 9 (60 MHz, 37°C). 
Relaxivity of [GdL12] (mM-1s-1) 
pH4 pH7 pH9 
2.83 2.52 2.30 
The relaxivity values (Table 5.3) show that there is no significant change in 
relaxivity with pH. This suggests that there is no change in the hydration state at 
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the Gd (Ill) centre. This is in agreement with the hypothesis that the pyridyl 
nitrogen is tightly bound to the lanthanide centre in an irreversible manner. 
The slight increase in relaxivity value at low pH is probably caused by the 
protonation of the sulfonamide nitrogen, causing an increase in the hydration state 
of the complex, resulting in an increase in the second sphere contribution. 
5.5.2 Effect of Zinc (11) on Relaxivity of [Gdl 12] 
The lumiscence studies suggested that the pyridyl nitrogen was bound tightly to the 
lanthanide ion centre and did not respond to the presence of zinc (11) ions. It was 
hypothesised that even if the pyridyl nitrogen remained bound to the lanthanide 
ion it still may be possible for a complex to form between the sulfonamide nitrogens 
and zinc (11) and possibly the bound pyridyl nitrogens. Although a change in the 
hydration state was not expected, a dimer would form with two gadolinium 
complexes per zinc (11) ion (Scheme 5.9). This increase in molecular size would lead 
to an increase in TR and thus an increase the relaxivity. 
Small aliquots containing 0.25 equivalents of zinc (11) acetate were added to a 
0.38 mM solution of [GdL12], the pH was kept constant at pH 7.4. The T1 value was 
determined at both 65 MHz, 22°C and 60 MHz, 37°C. 
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Table 5.4 Relaxivity of [GdL12] in the presence of various zinc (11) concentrations. 
Number of zinc (II) Relaxivity (mM-1s -1) of [GdL 12] 
equivalents added. 60 MHz, 37°C 65 MHz,22°C 
0 2.67 3.71 
0.25 3.98 
0.5 3.74 
1 2.60 3.59 
Table 5.4 shows that the presence of zinc (11) has no effect on the relaxivity of 
[GdL12]. This would suggest that a dimer does not form between the gadolinium 
complex and zinc (11). This is in agreement with the hypothesis that the pyridyl 
nitrogen irreversibly binds to the gadolinium centre. 
5.6 NMRD Profiles of Complex [GdL 12} 
An NMRD profile of [GdL12] was recorded and fitted in Durham according to the 
theoretical arguments presented in Section 3.6. 
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Figure 5.6 Experimental NMRD profile for (GdL 12] in aqueous solution (pH 6). 
The values were all obtained at zsoc with the exception of the 65 MHz value 
which was obtained at 22°C. The solid lines through the data are best fitting 
curves obtained using the parameters given in Table 5.5. 
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Table 5.5 Best fitting parameters obtained from the analysis of the NMRD 
profiles for the gadolinium (HI) complex [Gde2]. 
Complex 
1'12 Tu 
TR (ns) TM r a D q (s -2x1018) (ps) (ns) (A) (A) (cm2s -\10-5) 
[GdL12) 1 9.9 28 56 2.4 3.13 4 1.72 
[GdL12] has an NMRD profile (Figure 5.6) typical of a small gadolinium (III) 
1 . . 1 d' d 1 1 128129 comp ex possessmg a smg e coor mate water mo ecu e. ' 
5.1 Conclusions 
The octadentate N50 3 ligand ez contains a coordinating pyridyl group that forms 
kinetically stable complexes with europium (III) and gadolinium (III) that resist 
protonation. The pyridyl group binds the lanthanide centre irreversiby, even in the 
presence of Zn (11) and Cu (11) ions, notwithstanding the putative high affinity of the 
pyridylsulfonamide moiety for the zinc (11) ions. 
Lifetime and relaxivity studies show that the complex [LnL 12] has one water 
molecule coordinated to the lanthanide centre. The emission spectrum suggests 
that the water molecule is coordinated in an axial position while the pyridyl 
nitrogen coordinates to the lanthanide centre in an equatorial position. 
As the pyridyl nitrogen is such an excellent donor for the lanthanide centre in this 
tribasic N50 3 octadentate ligand, the complex is rendered inappropriate for use as a 
pH and pZn responsive system. A more appropriate donor group with less 
strongly lanthanide ligating substituents is required. 
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Conclusions and Suggestions for Further Work 
Although it was first shown that the trifluoromethanesulfonamide moieties in L2 
and L3 have a high affinity for zinc (11), subsequent studies revealed that when this 
moiety was incorporated into a macrocyclic lanthanide complex, this affinity was 
lost. Zinc responsive lanthanide systems were not obtained. It may be possible to 
increase the affinity of the complex for zinc (11) by altering the sulfonamide to 
something with a greater number of zinc (II) donor atoms, Figure 7.1, giving a 
pentadentate binding site for Zn2+. 
Figure 7.1 
Investigations into D03A systems with an appended pyridyl amide group revealed 
that the steric bulk introduced to the sytem by a seven-membered chelate ring 
between the amide carbonyl and lanthanide centre resulted in a very fast water 
exchange rate. Whereas the increased steric demands of an eight-membered chelate 
resulted in the lanthanide centre being unhydrated. This approach of increasing 
steric demand to promote rapid water exchange could be considered as a precursor 
for new higher molecular weight constrast agents in which a fast-water exchanging 
site at gadolinium is a prerequisite for maximal relaxivity enhancement.69 
A remarkably high affinity and relaxivity enhancement in the presence of HSA was 
displayed by [GdL9]. Unlike previous q = 2 systems, the binding of protein did not 
result in the displacement of water from the gadolinium centre and an 
unprecedented 700% enhancement in the relaxivity was observed. However, this 
system has the disadvantage that this relaxivity increase was not maintained in the 
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presence of anions or serum. The anions displaced the water bound to the 
lanthanide centre giving a small enhancement in relaxivity. Further work could try 
to understand which parts of the pyridyl sulfonamide moiety lead to this high HSA 
affinity, for example, by changing the sulfonamide group. As the formation of the 
sulfonamide occurs in the final stages of the ligand synthesis, it should be 
straightforward to form a variety of sulfonamide analogues, Figure 0.2. These 
analogues should exhibit different pKa values at the sulfonamide nitrogen and so 
should have different hydrogen donor/ acceptor properties leading to variation in 
the affinity for HSA. Also, the free amine and unsubsituted pyridylamide 
compounds may exhibit some interesting properties in the presence of albumin. 
0 
0 
Figure 0.2 Possible target molecules. 
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Furthermore, the anion affinity of the lanthanide complex could perhaps be reduced 
by the addition of anion repelling phosphate groups, as in the structure below. 
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Chapter 6 
Experin1en tal 
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6 Experimental 
6. 1 Synthetic Procedures and Characterisation 
Reactions requiring anhydrous conditions were carried out using Schlenk-line 
techniques under an atmosphere of dry argon. Solvents were dried from an 
appropriate drying agent where required.152 Water was purified by the "PuritesrrLL 
plus" system and has a conductivity :5; 0.04]1Scm-1. Reagents were used as supplied. 
Thin layer chromatography was carried out using fluorescent (254 nm) silica plates 
(Merck Art 5554) and visualised by UV or iodine staining. Preparative column 
chromatography was carried out using silica (Merck silica gel60, 230-400 mesh). 
Mass spectra (ES MS) were recorded using a VG 11 Platform spectrometer (Fisons 
Instruments) with methanol as the carrier solvent. El (El MS) spectra were 
recorded on a Micromass AutoSpec. F AB spectra were recorded by the EPSRC 
Mass Spectrometry Service at the University of Wales at Swansea. Accurate mass 
spectra (Acc.Ms) were recorded at the University of Durham using a Micromass 
LCT at 5000 resolution using sodium iodide as the reference. Accurate mass 
spectra (Acc.Ms) of complexes [EuL5], [GdL 1, [EuL6], [GdL6], [EuL12] and [Gde2] 
were recorded by the EPSRC Mass Spectrometry Service at the University of Wales 
at Swansea. 
NMR Spectra were recorded on a Varian Unity 300 spectrometer at 299.91 MHz 
CH), 75.41 MHz (13C) and 188 MHz C9F) or a Varian Mercury 200 spectrometer at 
199.99 MHz CH), 50.29 MHz (13C) and 188.18 MHz C9F) or a Varian Mercury 400 
spectrometer at 399.97 MHz CH), 50.58 MHz (13C) and 376.30 C9F) or a Varian Inova 
500 at 499.87 CH), 125.71 (13C) and 376.35 C9F). Variable-temperature 1H NMR 
studies and two-dimensional spectra were recorded on a Varian Inova 500. 
Chemical shifts are quoted with reference to the residue residual protonated 
solvent and are given in ppm with coupling constants in Hz. 
I.R. spectra were recorded on a Perkin-Elmer FT-IR 1720X spectrometer with 
GRAMS Analyst operating software. Melting points were determined on a 
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Reichert-Kofler block melting point apparatus and are uncorrected. Combustion 
analysis was performed using an Exeter Analytical Inc CE-440 elemental analyser. 
Single crystal X-ray diffraction experiments were carried out using SMART CCD 
area detectors and graphite-monochromated MoKa radiation. The structures were 
solved by direct methods and refined against F2 of all data, using SHELXTL 
programs106 and standard refinement techniques. 
6.2 Photophysical Measurements 
Ultraviolet absorbance spectra were recorded in a Unicam UV2-100 spectrometer 
operating with Unicam Vision software. Samples were contained in quartz 
cuvettes with a path length of 1cm. All spectra were run against a reference of pure 
solvent contained within a matched cell. 
Luminescence spectra were recorded using a Perkin-Elmer LS SOB, operating with 
FL Winlab software, or an Instruments S.A. Fluorolog 3-11, operating with 
DataMax software. Quartz fluorescence cuvettes of path length 1 cm were 
employed. The absorbance of each solution at the excitation wavelength was below 
0.3 to avoid any inner filter effect. Second order diffraction effects were obviated by 
using a cut-off filter to remove the scattered light before it enters the emission 
monochromator. 
Excited state lifetime measurements were generally made on the Perkin-Elmer LS50 
(using Phlemming data acquisition written by Dr A. Beeby, University of Durham), 
by monitoring the integrated intensity of light (at 616 nm for Eu) emitted during a 
fixed gate time, tg, a delay time td, later. At least 20 different delay times were used 
covering two or more lifetimes. The gate time was 0.1 ms, the excitation and 
emission slits were set to 15 and 20 nm respectively. The lifetimes of [EuL9] and 
[Eue~ were measured using a time-resolved fluorescence spectrometer. The 
samples were excited by the fourth harmonic of a Nd : Y AG laser (266 nm, 1 mJ per 
pulse). The luminescence was collected at 90° and the emission wavelength 
selected by a monochromator. The luminescence was recorded using a 
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photomultiplier tube (Hamamatsu R928); averaged and digitised using a digital 
storage oscilloscope (Tektronix TDS 320). 
The pH measurements were made using a Jenway 3320 pH meter (fitted with a 
BDH glass + combination electrode-microsample) calibrated at pH 4, 7 and 10 
buffer solutions. Luminescence pH titrations were carried out in a background of 
constant ionic strength (I= 0.1 M NaCl, 295 K) on solutions of absorbance of< 0.2 at 
wavelengths > A.ex to avoid any errors due to the inner filter effect. 
Cyclic voltammetry of the complexes (0.001 M) was carried out in a background 
electrolyte of tetrabutylammonium perchlorate, TBAP, (0.01 M) in acetonitrile 
controlled with potentiostat EG&G P ARC Model 273. Computer control and data 
storage were achieved using EG&G P ARC Model 270 Research Electrochemistry 
software. The auxiliary electrode was made of platinum foil, (area 1cm2), connected 
to a copper wire mounted in a glass body. The working electrode was made of 
glassy carbon, purchased from BAS. The reference electrode was a non-aqueous 
silver I silver chloride electrode, self-assembly kit, purchased from BAS. The 
electrodes were mounted in a circular Teflon cap and placed in a cylindrical cell 
(diameter 20 mm, length 65 mm), which was filled with 1 ml of the desired solution 
and purged with argon. The cell assembly was placed inside a Faraday cage to 
eliminate strong field interference. 
Potentiometric analyses were carried out using apparatus described 
. 1 153154 . 118119120 . prev1ous y. ' Data were analysed usmg HYPERQUAD ' ' and corrections to 
pKw were applied to allow for solvent contribution.117 All relevant hydrolysis 
constants used, were taken from the IUPAC Stability Constants database Version 
5.12, published by IUPAC and Academic Software, 2000. 
6.3 Relaxivity and 17 0 Measurements 
Longitudinal 1H relaxation times at 60 MHz and 65 MHz were measured using a 
Bruker Minispec mQ 60, operating at 37.0°C and a home-made Varian 65.3 MHz 
instrument, at 22°C, by means of the inversion recovery technique. 
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Variable temperature 170 NMR studies were determined on a Varian !nova 500 
spectrometer at 67.08 MHz. The temperature of the probe head was determined 
using an ethylene glycol standard. 
Variable-temperature proton-solvent longitudinal relaxation times were measured 
in the range 0.01 to 20 MHz in Durham on a Stelar Spinmaster-FFC 2000 Fast Field 
Cycling NMR relaxometer [Stelar, Mede (PV), Italy] by means of the inversion 
recovery technique (32 experiments, four scans). The reproducibility of T1 
measurements was within 1%. The temperature was controlled by a Stelar VTC 90 
airflow heater equipped with a copper constantan thermocouple: the actual 
temperature in the probe head was measured with a Fluke 53 k/j digital 
thermometer with an uncertainty of 0.5 K. 
Protein Titrations: Human Serum Albumin (crystallised and lyophilised) was 
purchased from Sigma (St. Louis, Mo., USA) and was used without any further 
purification. The molecular weight was assumed to be 67 kDa. 
Human Serum was purchased from Sigma (St. Louis, Mo., USA) and was 
rehydrated and used without any further purification. 
6.4 Chapter 2 Experimental 
6.4.1 Ligand Synthesis 
2-(p-Toluenesuifonylaminomethy)pyridine e To a stirred solution of p-toluenesulfonyl 
chloride (3.43 g, 0.018 mmol) in pyridine (10 ml) cooled to -10°C was slowly added 
2-aminomethylpyridine (2.00 g, 0.018 mmol) in pyridine (5 ml). The resulting 
reaction mixture was stirred at -10°C for 3 hours and was held at 5°C overnight. 
The reaction mixture was poured onto crushed ice resulting in the precipitation of a 
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yellow solid, which was removed by filtration and washed with water. The 
precipitate was dissolved in dichloromethane, dried (Na2504) and the solvent 
evaporated yielding pale yellow crystals (2.12 g, 45%). m.p. 76-77°C; 1H NMR 
(200 MHz, CD30D): 6H 2.40 (s, 3H, CH3), 4.15 (s, 2H, CH2), 7.22- 7.45 (4H, m, H3, 
HS, H3', HS'), 7.69 (3H, m, H4, H4', H6'), 8.37 (lH, d, J 4.4, H6); 13C NMR 
(50.29 MHz, CDC13): 6c 21.15 (Me), 47.47 (CH2), 122.00 (C3 or CS), 122.32 (C3 or CS), 
126.75 (C3'+C5'), 129.29 (C2'+C6'), 136.72 (C4), 142.92 (C4'), 148.59 (C2), 155.34 
(Cl'); m/z E5+: 546.7 (100%, 2M+Na), 284.5 (85%, M+Na); umax (KBr)/cm-1 3250 
(vNH), 1599 (v py), 1574 (v py), 1441 (v py), 1385 (6 NH), 1329 (va 502), 1165 (vs 
502), 1111 (6 CH), 1089 (6 CH), 1007, 901 (v N-5), 763 (6 py), 662 (y NH), 543 (6 
502); Found: C, 57.12; H, 5.58; N, 10.25. C13H14N 20 25.0.5H20 requires C, 57.54; H, 
5.57; N, 10.32. Constitution confirmed by x-ray crystallography, C5D Refcode: 
HUGMEB01. 
~~ 
N-S-CF 
H 11 3 
0 
2-(Trifluoromethylsulfonylaminomethyl)pyridine L 2 Under anhydrous conditions in an 
argon atmosphere, a solution of 2-aminomethylpyridine (0.64 g, 5.93 mmol) in 
anhydrous pyridine (5 ml) at -40°C was added dropwise, over 10 minutes, to a 
stirred solution of trifluoromethanesulfonyl chloride (1.0 g, 5.93 mmol) in pyridine 
(10 ml) at -40°C. The resulting bright yellow reaction mixture was stirred at -40°C 
for 2 hours and kept at 5°C overnight. The mixture was poured slowly onto 
crushed ice and stirred. The precipitate that formed was separated by filtration and 
washed with water. This precipitate was dissolved in dichloromethane (50 ml), 
washed with water (2 x 25 ml) and the organic phase was dried (Mg504), filtered 
and evaporated under reduced pressure to give a solid which was recrystallised 
from ethyl acetate and hexane (1 : 1) to yield pale brown crystals (0.36 g, 25% ), m.p. 
82-84°C; 1H NMR (300 MHz, CDC13): 6H 4.49 (2H, s, CH2), 7.24 (2H, m, H3+ HS), 
7.69 (lH, t of d, J 1.8, 7.8, H4), 8.46 (lH, d, J 5.1, H6); 13C NMR (50.3 MHz, CDC13): 
6c 48.05 (CH2), 123.10 (C2), 123.87 (C4), 138.20 (CS), 149.30 (C6), 154.47 (q, CF3); 19F 
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NMR (188 MHz, CD3CN): 6 -79.44 (s, CF3); m/z (E5+): 263 (100%, M+Na+), 241 
(20%, M+H+); umax (KBr)/cm-1 1601 (v py), 1434 (v py), 1379 (6 NH), 1367 (va 502), 
1176 (vs 502), 1143 (6 CH), 1087 (6 CH), 599 (y NH); Found: C, 35.30; H. 3.01; N. 
11.52. C7H 7N20 25F3 requires C. 35.00; H. 2.94; N. 11.66. 
I 
N HO,.. 
6-Methylpyridine-2-aldoxime104' 105 44 Hydroxylamine hydrochloride (1.40 g, 
20.14 mmol) dissolved in water (4 ml), was added to a solution of 6-methyl-2-
pyrdinecarboxaldehyde (1.20 g, 9.90 mmol) in water (2 ml). Potassium carbonate 
(1.60 g, 11.50 mmol) was added and the resulting frothy white reaction mixture was 
heated at 35°C for two hours. The reaction mixture was cooled to room 
temperature, filtered under suction and washed with water to yield a white 
powder. Recrystallisation from ethanol and water yielded a white crystalline solid 
(1.13g, 84%). m.p. 120-122°C, (lit104 170-171°C, lit105 165°C); 1H NMR (300 MHz, 
DM50): 6H 2.54 (3H, s, CH3), 7.29 (1H, d, J 7.5, HS), 7.65 (1H, d, J 7.8, H3), 7.77 
(1H, t, J 7.8, H4), 8.09 (1H, s, HC=C), 11.68 (1H, s, OH); 13C NMR (300 MHz, 
DM50): 6c 24.77 (CH3), 117.78 (C3), 124.12 (CS), 137.91 (C4), 149.95 (q, C6), 152.77 
(q, C2 ), 158.71 (C=N ); (E5+): 158.8 (100%, MNa +). Found: C, 61.75; H, 5.96; N, 
20.71. C7H 8N 20 requires C, 61.75; H, 5.92; N, 20.57. 
2-Aminomethyl-6-methylpyridine 45 10%Pd/C (0.114 g) was added to 
6-methylpyridine-2-aldoxime 44 (1.102g, 8.09 mmol) dissolved in absolute ethanol 
(60 ml). The mixture was hydrogenated in a Parr hydrogenation apparatus at room 
temperature under 40 psi H2 for 41/2 hours. The mixture was filtered through celite, 
which was washed thoroughly with ethanol and dichloromethane, the solvent was 
evaporated under reduced pressure to yield a clear colourless oil (0.915g, 93%); 1H 
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NMR (200 MHz, CDC13): oH 2.47 (3H, s, CH3), 3.87 (2H, s, CH2), 6.93-7.08 (2H, m, 
' 
H3, HS), 7.47 (1H, t, ] 7.6, H4); 13C NMR (200 MHz, CDC13): Oc 24.S6 (CH3), 47.8S 
(CH2), 118.3S (CS), 119.43 (q, C6), 121.61 (C3), 137.09 (C4), 1S8.12 (C2); m/z 
(E5+): 122.9 (100%, MH+): 
0 
11 
N-S-CF 
H 11 3 
0 
2-(Trifluoromethanesulfonylaminomethyl)-6-methylpyridine L3 Under anhydrous 
conditions in an argon atmosphere, a cooled solution of 2-aminomethyl-6-
methylpyridine 45 (0.4Sg, 3.69 mmol) in anhydrous pyridine (2.4 ml) was added 
slowly to a stirred solution of trifluoromethanesulfonyl chloride (0.62g, 3.69 mmol) 
in anhydrous pyridine (6.6 ml), which had been cooled to -40°C. The resulting 
yellow solution was stirred at ~-40°C for two hours then kept at -18°C overnight 
before being added slowly to crushed ice. The ice was stirred and allowed to melt 
resulting in the formation of a green precipitate, which was filtered off under 
suction. This precipitate was dissolved in dichloromethane (10 ml), washed with 
water (2x10 ml), the combined organic phase was dried (Mg504), filtered and the 
solution evaporated under reduced pressure to yield a yellow oil. The aqueous 
phase was extracted with dichloromethane (3xSO ml), the combined organic extracts 
were dried (Mg504), filtered and evaporated under reduced pressure to yield a 
yellow oil which was purified by flash column chromatography (5i02, 1:1 ethyl 
acetate: hexane). Clear crystals formed on the evaporation of the reduced eluting 
solvent. (0.2Sg, 30%). m.p. 73-74°C. 1H NMR (200 MHz, CDC13): oH 2.47 (3H, s, 
CH3), 4.S3 (2H, s, CH~, 7.08 (2H, t, ] 7, H3, HS), 7.61 (1H, t, ] 7.8, H4); 13C NMR 
(S0.3 MHz, CDC13): Oc 12.60 (CH3), 47.80 (CH2), 116.72 (q, C6), 119.49 (CS), 123.17 
(C3), 137.64 (C4), 1S2.77 (C2), 1S8.34 (CF3); 19F NMR (188 MHz, CDC13 ): Op -77.70 
(s, CF3); m/ z (E5+): 2SS (100%, MH\ umax (KBr)/ cm-1 1606 (v py), 1369 (va 502), 
1191 (vs 502), 114S (o CH), 1069 (o CH), 611 (y NH); Found: C, 37.73; H. 3.5S; N. 
10.91. C8H9N 20 25F3 requires C. 37.80; H. 3.S7; N. 11.02. 
1S7 
2-(p-Toluenesulfonylamino)-6-methylpyridine L 4 To a stirred solution of p-toluene-
sulfonyl chloride (192 mg, 1.0 mmol) in pyridine (0.6 ml) cooled to -10°C was 
slowly added a solution of 2-aminomethyl-6-methylpyridine (123 mg, 1.0 mmol) in 
pyridine (1 ml). The resulting yellow reaction mixture was stirred at -10°C for 3 
hours and was held at 5°C overnight. The reaction mixture was poured onto 
crushed ice, which was allowed to melt resulting in the formation of an oil. A 
precipitate formed upon scratching. The solid was removed by filtration, dissolved 
in dichloromethane (5 ml) and washed with water (2 x 5 ml). The organic phase 
was dried (MgS04), filtered and evaporated under reduced pressure to yield a 
yellow oil which was crystallised from ethanol and water (1%) to form a white solid 
(0.53g, 53%); m.p. 83-84°C; 1H NMR (200 MHz, CDC13): 6H 2.38 (3H, s, CH3), 2.46 
(3H, s, CH3), 4.18 (2H, d, J 5.2, CH2), 5.92 (lH, s, NH), 6.97 (2H, t, J 8.4, H3, H5), 7.22 
(2H, d, J 7.8, H3', H5'), 7.47 (lH, t, J 7.8, H4), 7.72 (2H, d, J 6.6, H2', H5'); 13C NMR 
(50.3 MHz, CDC13): Be 21.37 (Me), 24.02 (Me), 47.35 (CH2), 118.74 (C4'), 121.94 (Cl'), 
127.08 (C3'+ C5'), 129.45 (C2'+C6'), 136.63 (q, C6), 136.96 (C2), 143.17 (C3), 154.09 
) 
+ + + (C4, 157.68 (C2); m/z ES : 574.7 (25%, 2M+Na ), 298.7 (100%, M+Na ); Drnax 
(KBr)/ cm-1 1599 (v py), 1458 (v py), 1325 (va 502), 1160 (v5 502), 1090 (6 CH), 816, 
662 (y NH), 551 (6 502). Found: C, 60.57; H, 5.77; N, 10.39. C13H14N20 2S requires 
C, 60.85; H, 5.84; N, 10.14. 
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6.4.2 Complex Synthesis 
Zn(C13H 13N 20 2S)2 [Zn(L1b_] 2-p-Toluenesulfonylaminomethylpyridine e (72 mg, 
0.27 mmol) and zinc acetate (30 mg, 0.14 mmol) were dissolved in methanol (6 ml), 
and the resulting solution was heated under reflux for 6 hours. The solution was 
allowed to cool to room temperature. On standing overnight white crystals 
formed. These were collected by filtration and washed with cold methanol. m.p. 
220°C (dec.); 1H NMR (200 MHz, CD30D): 6H 8.4 (2H, d, J 5, H6), 8.0 (2H, t, J 5, H4), 
7.8 (4H, d, J 8, tos), 7.5 (4H, m, H5,H3), 7.2 (4H, d, J 8, tos), 4.4 (4H, s, CH2), 2.3 (6H, 
s, Me); m/z (FAB): 587 (100%, ZnL2), 431 (39%, ZnL2 - Tos), 325 (22%, ZnL), 263 
(25%, LH); umax (KBr)/ cm-1 1611 (v py), 1568 (v py), 1442 (v py), 1277 (va 502), 1151 
(vs 500, 1104 (6 CH), 1087 (6 CH), 970, 762 (6 py), 670 (y NH), 560 (6 502); Found: 
C, 52.53; H, 4.44; N, 9.40. Zn(C13H13N20 25h .0.5MeOH requires C, 52.69; H, 4.67; N, 
9.27. Constitution confirmed by x-ray crystallography, C5D Refcode: HUSCIH. 
r1 
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Cu(C13H 13N 20 25)2 [Cu(eh] 2-(p-Toluenesulfonylaminomethyl)pyridine e (52 mg, 
0.2 mmol) and copper acetate (40 mg, 0.2 mmol) were dissolved in methanol (10 ml) 
and the solution was heated under reflux for 18 hours. The solution was allowed to 
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cool to room temperature. On standing overnight, blue and brown cubic crystals 
formed. These were collected by filtration and washed with cold methanol. m.p. 
180-182°C; mjz (FAB): 911 (11 %, CuL3), 650 (16%, Cu2L2), 608 (32%, CuL2+Na), 586 
(100%, CuL2) 325 (71 %, CuL), 263 (22%, L+H); Dmax (KBr)/cm-1 1609 (v py), 1570 (v 
py), 1447 (v py), 1276 (va 502), 1139 (vs 502), 1106 (5 CH), 1085 (5 CH), 844, 813, 673 
(y NH), 557 (5 502); A.max(MeCN) 638nm (£ 67dm3mor1cm-1); Found: C, 53.17; H, 
4.46; N, 9.49. Cu(C13H13N20 25h requires C, 53.27; H, 4.47; N, 9.55. Constitution 
confirmed by x-ray crystallography, C5D Refcode: XEZQAU01. 
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Ni(C13H13N20 2S)2 [Ni(L1h] 2-(p-Toluenesulfonylaminomethyl)pyridine L1 (66 mg, 
0.25 mmol) was dissolved in methanol (2.5 ml), and neutralised with 0.1M KOH 
solution (2.5ml, 0.25 mmol), the solvent was evaporated under reduced pressure. 
The resulting brown oil was dissolved in methanol (7 ml) and nickel acetate (31 mg, 
0.12 mmol) was added. The resulting clear green solution was heated under reflux 
with stirring for one hour. The solution was allowed to cool to room temperature. 
An orange precipitate formed overnight, which was collected by filtration and 
washed with cold methanol and water, m.p. 220°C (dec); m/z (FAB): 603 (14%, 
NiL2 + Na), 581 (63%, NiL2), 425 (9%, NiL2 - Tos), 263 (100%, LH); umax (KBr)/cm-1 
1611 (v py), 1478 (v py), 1281 (va 502), 1139 (vs 50z), 1084 (5 CH), 681 (y NH), 557 (5 
502); Found: C, 53.57; H, 4.68; N, 9.58. Ni(C13H 13N20 25h requires C, 53.72; H, 4.51; 
N, 9.64. Constitution confirmed by x-ray crystallography, C5D Refcode: HUSFAC. 
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Co(C13H 13N 20 2S)2 [Co(e)z] 2-(p-Toluenesulfonylaminomethyl)pyridine L1 (131 mg, 
0.5 mmol) was dissolved in methanol (5 ml), and neutralised with 0.1M KOH 
solution (5ml, 0.5 mmol) and the solvent evaporated under reduced pressure. The 
resulting brown oil was dissolved in methanol (10 ml) and cobaltous acetate 
hexahydrate (62 mg, 0.25 mmol) was added. The resulting dark purple solution 
was heated under reflux with stirring for seven hours. The solution was allowed to 
cool to room temperature. On standing, purple crystals formed over a period of 
several days. These were collected by filtration and washed with cold methanol, 
m.p. 240°C (dec.); m/z FAB: 604 (37%, CoL2+Na), 582 (100%, CoL2), 426 (39%, CoL2-
tos), 320 (23%, CoL); Dmax (KBr)/cm-1 1609 (v py), 1439 (v py), 1278 (va 502), 1145 
(vs 502), 1085 (6 CH), 947, 760 (6 py), 669 (y NH), 559 (6 502); Amax(MeCN)/nm 513 
and 579 (e/dm3mol-\m-1 302 and 291); Found: C, 53.20; H, 4.35; N, 9.51. 
Co(C13H13N20 25)z.0.25MeOH requires C, 53.48; H, 4.61; N, 9.50. Constitution 
confirmed by x-ray crystallography, C5D Refcode: HUSFUW. 
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Zn(C7H 6F3N 20 2S)2 [Zn(L 2)z] 2-Trifluoromethanesulfonylaminomethylpyridine L 2 
(75 mg, 0.31 mmol) and zinc acetate (34.2 mg, 0.16 mmol) were dissolved in 
methanol (10 ml) and the solution heated under reflux for 3 hours. The solution 
was allowed to cool to room temperature and left standing to evaporate slowly. On 
standing, white crystals formed which were collected by filtration and washed with 
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cold methanol, m.p. 260°C (dec); 1H NMR (300 MHz, CD3CN): OH 4.78 (2H, s, 
CH2), 7.S4 (1H, t, J 6.6, HS), 7.61 (1H, d, J 7.8, H3), 8.08 (1H, t of d, J 1.8, 8.1, H4), 8.47 
(1H, d, J 5.4, H6); 13C NMR (6S MHz, CD3CN): Oc 49.81 (CH2), 124.16 (C3 or CS), 
124.71 (C3 or CS), 141.S7 (C4), 148.14 (C6), 1S9.00 (q, C2); 19F NMR (188 MHz, 
CD3CN): OF -78.14 (s, CF3); m/z (ES+): S80 (22%, ZnL2K), S64 (100%, ZnL2Na), 262 
(28%, L + Na); Dmax (KBr)/cm-1 1614 (v py), 1447 (v py), 1334 (va 502), 1196 (vs so~, 
1098 (o CH), 962, 603 (y NH); Found: C, 30.87; H. 2.1S; N. 10.08. 
Zn(C7H 6F3N20 2Sh requires C. 30.92; H. 2.22; N. 10.30; Constitution confirmed by 
x-ray crystallography, CSD Refcode: HUSCON. 
Cu(C7H6F3N 20 2S)2 [Cu(L2)z_). The copper (II) complex was prepared as described 
for the zinc analogue to yield blue crystals, m.p. 220-223°C; m/z (ES+): S79 (20%, 
CuL2K), S63 (100%, CuL2Na); Dmax (KBr)/ cm-1 1616 (v py), 1448 (v py), 1364 (0 
NH), 1334 (va 502), 1178 (vs 502), 1092 (o CH), 60S (y NH); Amax(MeCN) 672nm (e 
227dm3mor1cm-1); Found: C, 30.64; H. 2.28; N. 10.27. Cu(C7H 6F3N20 2Sh requires 
C. 31.02; H. 2.23; N. 10.34; Constitution confirmed by x-ray crystallography, CSD 
Refcode: HUSDII. 
Ni(C7H 6F3N 20 2S)2.2Et0H [Ni(L2)z] 2-Trifluoromethanesulfonylaminomethyl-
pyridine L2 (60 mg, 0.2S mmol) and nickel acetate (31 mg, 0.12 mmol) were 
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dissolved in methanol to form a pale green solution which was heated under reflux 
with stirring for four hours. The solution was allowed to cool to room temperature 
and the solvent slowly evaporated yielding a green oil which was dissolved in 
ethanol. Pale blue crystals formed on standing over a period of several days. The 
crystals were collected by filtration and washed with cold methanol. m.p. 120°C 
(dec); m/z (E5+): 558 (100%, NiL2Na); urnax (KBr)/cm-1 1609 (v py), 1444 (v py), 
1305 (va 502), 1182 (vs 502), 1084 (6 CH),, 601 (y NH); Arnax(MeCN)/nm 367 and 
597 (r/ dm3mor1cm-1 52 and 32); Found: C, 34.15; H. 3.82; N. 8.97. 
Ni(C7H 6F3N20 25h2EtOH requires C. 34.36; H. 3.84; N. 8. 90; Constitution 
confirmed by x-ray crystallography, C5D Refcode: HUSFEG. 
Co(C7H 6F3N 20 2S)2 [Co(eh] The cobalt (II) complex was prepared as described for 
the nickel (II) analogue yielding deep pink crystals, m.p. 230°C; m/ z (E5+): 575 
(26%, CoL2K), 564 (100%, CoL2Na); umax (KBr)/ cm-1 1613 (v py), 1446 (v py), 1335 
(va 502), 1186 (vs 502), 1164 (6 CH), 1095 (6 CH), 948, 602 (y NH); Arnax(MeCN) 
SOOnm (r 46drn3mor1cm-1); Found: C, 31.58; H, 2.28; N, 10.44. Co(C7H6F3N20 25h 
requires C. 31.29; H. 2.25; N. 10.43; Constitution confirmed by x-ray 
crystallography, C5D Refcode: HUSGAD. 
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Zn(C8H8N 20 2F35) 2 [Zn(L3)z_J. 2-(Trifluoromethanesulfonylaminomethyl)-6-methyl-
pyridine L3 (2S mg, 0.11 mmol) and zinc acetate (12 mg, O.OS mmol) were dissolved 
in methanol (4 ml). The resulting clear colourless solution was heated under reflux 
with stirring for four hours. After cooling to room temperature, colourless crystals 
formed on standing overnight. The crystals were collected by filtration and washed 
with cold methanol, m.p. 224-226°C; 1H NMR (200 MHz, CD3CN): oH 2.43 (3H, s, 
CH3), 4.77 (2H, s, CH2), 7.44 (2H, t, J 6.8, H3, HS), 8.00 (1H, t, J 7.8, H4); 13C NMR 
(S0.3 MHz, CD3CN): Be 23.87 (CH3), 49.77 (CH2), 121.S8 (C3 or CS), 124.81 (C3 or 
CS), 142.06 (C4), 1S7.73 (q, C2), 1S8.36 (CF3). 19F NMR (188 MHz, CD3CN): oF-
78.11 (s, CF3); m/z (ES+): 608 (12%, ZnL2K\ S92 (100%, ZnL2Na+), 276 (34%, LNa); 
umax (KBr)/cm-1 1611 (v py), 1472 (v py), 133S (va 502), 1194 (vs 502), 1168 (6 CH), 
1092 (6 CH), 604 (y NH); Found: C, 33.48; H. 2.67; N. 9.69. Zn(C8H8N20 2F3S)z 
requires C. 33.61; H. 2.82; N. 9.80. Constitution confirmed by x-ray 
crystallography, CSD Refcode: HUSCUT. 
Cu(C8H8N 20 2F35)2 [Cu(L3)z_J. The copper (II) complex was prepared as described 
for the zinc (II) analogue, yielding lime green crystals, m.p. 180°C (dec); m/z (ES+): 
S92 (24 %, CuL2Na +), 276 (100%, LNa +); umax (KBr)/ cm-1 1611 (v py), 1472 (v py), 
1340 (v py), 1324 (va 502), 1186 (vs 502), 1167 (6 CH), 1088 (6 CH), 601 (y NH); 
Amax(MeCN) 410 and 764nm (r 404 and 74 dm3mor1cm-1); Found: C, 33.S3; H. 2.77; 
N. 9.60. Cu(C8H8N20 2F3S)z requires C. 33.71; H. 2.83; N. 9.83. Constitution 
confirmed by x-ray crystallography, CSD Refcode: HUSDOO. 
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Ni(C8H 8N 20 2F3S)2 [Ni(e)z_], The nickel (II) complex was prepared as above, 
yielding purple crystals, m.p. 235-238°C; m/z (ES+): 604 (18%, NiL2K), 587 (40%, 
NiL2Na), 276 (100%, LNa); Dmax (KBr)/cm-1 1611 (v py), 1474 (v py), 1338 (va 502), 
1190 (vs 502), 1169 (6 CH), 1094 (6 CH), 605 (y NH); A.max(MeCN) 544 and 733 nm 
(e 190 and 51 dm3mol-1cm-1). A satisfactory microanalysis was not obtained for this 
compound; however the proposed constitution is in agreement with 
crystallographic data, CSD Refcode: HUSFIK. 
Co(C8H 8N 20 2F3S)2 [Co(L\] The cobalt complex was prepared as described for the 
zinc (II) analogue, yielding purple crystals, m.p. 200°C (dec); m/z (ES+): 588 (100%, 
CoL2Na\ 276 (41 %, LNa+); Dmax (KBr)/cm-1 1611 (v py), 1473 (v py), 1335 (va SO~, 
1188 (vs 502), 1167 (6 CH), 1090 (6 CH), 605 (y NH); Amax(MeCN) 533 and 564nm 
(e407 and 380 dm3mor1cm-1); Found: C, 33.97; H. 2.84; N. 9.89. Co(C8H8N20 2F3S)z 
requires C. 33.99; H. 2.86; N. 9.91. Constitution confirmed by x-ray 
crystallography, CSD Refcode: HUSGEH. 
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Zn(C14H 15N20 25)2 [Zn(L 4h] 2-(p-Toluenesulfonylaminomethyl)-6-methylpyridine L 4 
(500 mg, 18 mmol) and zinc acetate (190 mg, 9 mmol) were dissolved in methanol 
(35 ml), and the resulting clear solution was heated under reflux for 18 hours. The 
solution was allowed to cool to room temperature. On standing a white oil formed. 
This was crystallised from ethanol. The resulting white crystals were collected by 
filtration and washed with cold methanol. m.p. 220°C (dec); 1H NMR (200 MHz, 
CD30D): oH 2.36 (6H, s, 2CH3), 2.41 (6H, s, 2CH3), 4.47 (4H, s, broad, 2CH2), 7.32 
(4H, d, I 8, 2H3', 2H5'), 7.35 (4H, d, I 7.6, 2H2', 2H5'); 7.81 (4H, d, I 8.2, 2H3, 2H5), 
7.88 (2H, t, I 7.8, 2H4); 13C NMR (50.3 MHz, CD30D): Be 21.37 (Me), 23.79 (Me), 
121.94 (C4'), 124.91 (Cl'), 128.29 (C3'+ CS'), 130.39 (C2'+C6'), 140.40 (q, C6), 141.92 
(C2), 143.24 (C3), 158.37 (C4), 159.86 (C2); mjz (ESMS): 615 (20%, ZnL2), 637 (100%, 
ZnL2Na); umax (KBr)/ cm-1 1607 (v py), 1577 (v py), 1448 (v py), 1266(va 502), 1149 
(vs SO~, 1095 (6 CH), 1085 (6 CH), 974, 788 (6 py), 669 (y NH), 557 (6 S02); Found: 
C, 54.49; H, 4.86; N, 9.07. Zn(C14H15N20 2Sh requires C, 54.59; H, 4.91; N, 9.09. 
Constitution confirmed by x-ray crystallography, CSD Refcode: HUSDAA. 
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Cu(C14H 15N20 25)2 [Cu(L 4h] 2-(p-Toluenesulfonylaminomethyl)-6-methylpyridine 
L 4 (50 mg, 0.18 mmol) and copper acetate (18 mg, 0.09 mmol) were dissolved in 
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methanol (10 ml) and the solution was heated under reflux for 15 hours. The 
resulting brown solution was allowed to cool to room temperature. On standing a 
brown oil formed, this was recrystallised from methanol to yield brown crystals 
which were collected by filtration and washed with cold methanol. m.p. 
220°C(dec); mjz (FAB): 614 (46%, CuL~,; umax (KBr)/cm-1 1607 (v py), 1576 (v py), 
1441 (v py), 1274 (va 502), 1142 (vs 502), 1084 (6 CH), 958, 927 (6 py), 669 (y NH), 
555 (6 502); Amax(MeCN) 448, 784nm (£ 2017, 215 dm3mor1cm-1); Found: C, 54.79; 
H, 5.13; N, 8.84. Cu(C13H13N20 2S)z requires C, 54.75; H, 4.92; N, 9.12. Constitution 
confirmed by x-ray crystallography, CSD Refcode: HUSDUU. 
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Ni(C14H 15N20 25)2 [Ni(L 4};] 2-p-Toluenesulfonylaminomethyl-6-methylpyridine L 4 
(50 mg, 0.18 mmol) and nickel acetate (22 mg, 0.09 mmol) were dissolved in 
methanol (10 ml). The resulting clear pink solution was heated under reflux with 
stirring for eight hours. The solution was allowed to cool to room temperature and 
left standing, a purple-brown oil formed. This was crystallised from ethanol to 
form purple crystals which were collected by filtration and washed with cold 
methanol and water, m.p. 220°C (dec); umax (KBr)/cm-1 1599 (v py), 1458 (v py), 
1324 (va 502), 1160 (vs 502), 1091 (6 CH), 662 (y NH), 551 (6 502); "-max(MeCN) 544, 
760nm (£ 71, 30 dm3mor1cm-1); Found: C, 55.01; H, 4.77; N, 8.79. Ni(C13H13N20 2S)z 
requires C, 55.19; H, 4.96; N, 9.19. Constitution confirmed by x-ray crystallography, 
CSD Refcode: HUSFOQ. 
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Co(C14H 15N 20 25)2 [Co(L 4h] 2-(p-Toluenesulfonylaminomethyl)-6-methylpyridine L 4 
(50 mg, 0.18 mmol) and cobaltous acetate hexahydrate (22 mg, 0.09 mmol) were 
dissolved in methanol (10 ml). The resulting purple solution was heated under 
reflux with stirring for eight hours. The solution was allowed to cool to room 
temperature. On standing a pink oil formed. This was recrystallised from ethanol 
to yield purple crystals. These were collected by filtration and washed with cold 
methanol, m.p. 240°C (dec); umax (KBr)/cm-1 1610 (v py), 1444 (v py), 1335 (va 502), 
1166 (vs 502), 1090 (5 CH), 958, 789 (5 py), 643 (y NH), 573 (5 502); 
Amax(MeCN)/nm 532 and 564 (£/ dm3mor1cm-1 576 and 536); Found: C, 55.33; H, 
5.12; N, 8.90. Co(C13H13N20 25h requires C, 55.17; H, 4.96; N, 9.19. Constitution 
confirmed by x-ray crystallography, C5D Refcode: HUSGIL. 
Hg(C13H 13N 20 2S)2 [Hg(L1)~. A clear colourless solution of mercury acetate (41 mg, 
0.09 mmol) and 2-p-Toluenesulfonylaminomethylpyridine L1 (66 mg, 0.19 mmol) in 
methanol (7 ml) was heated under reflux for 18 hours. It was then allowed to cool 
to room temperature. On standing clear colourless crystals formed. These were 
collected by filtration and washed with cold methanol. m.p. 220°C (dec.); 1H NMR 
(200 MHz, CD30D): 5H 8.1 (2H, d, J 5, H6), 7.8 (4H, d, J 8, tos), 7.7 (2H, t, J 6, H4), 7.3 
- 7.2 (8H, m, tos, H3, H5), 4.5 (4H, s, CH2), 2.3 (6H, s, Me); Dmax (KBr)/cm-1 1598 (v 
py), 1436 (v py), 1282 (va 502), 1144 (vs 502), 1102 (5 CH); A satisfactory 
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microanalysis was not obtained for this compound, however the proposed 
constitution is in agreement with crystallographic data. 
Hg(C7H 6F3N 20 2S)2 [Hg(L2h,] A clear colourless solution of mercury acetate (33 mg, 
0.10 mmol) and e (50 mg, 0.208 mmol) in methanol (7 rnl) was heated under reflux 
for 18 hours. It was then allowed to cool to room temperature. On standing clear 
colourless crystals formed. 1H NMR (200 MHz, CD3CN): 5H 4.85 (2H, s, CH:0, 7.48 
(4H, m, H3 + H5), 7.95 (2H, t, J 7.8, H4), 8.41 (2H, d, J 5, H6); 13C NMR (65 MHz, 
CD3CN): Be 49.39 (CH2), 124.68 (C3 or CS), 124.91 (C3 or CS), 140.40 (C4), 148.92 
(C6); 19F NMR (188 MHz, CD3CN): 5F -77.43 (s, CF3); mjz (FAB): 703 (55%, ZnL2Na), 
681 {100%, ZnL2H); umax {KBr)/ cm-1 1603 (v py), 1441 (v py), 1331 (va 50:0, 1176 (v5 
502), 1098 (5 CH); Found: C, 24.71; H, 1.73; N, 8.24. Hg(C7H 6F3N20 25h requires 
C, 24.76; H, 1.78; N, 8.25. Constitution confirmed by x-ray crystallography 
6.5 Chapter 3 Experimental 
6.5.1 ligand synthesis 
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Pyridine-2-carboxylic acid (2-hydroxyethyl)-amide 46 1-(3-Dimethylaminopropyl)-3-
ethylcarbodiimide (5.00 g, 26.1 mmol), ethanolamine (1.45 g, 23.7 mmol) and HOBt 
(3 mg, catalytic) were added to a pale yellow solution of picolinic acid (2.92 g, 
23.7 mmol) in water (25 rnl). The resulting red solution was stirred at room 
temperature for 48 hours. The solvent was then removed under reduced pressure 
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to give an orange-brown oil. Flash column chromatography (Si02, 10% MeOH in 
EtOAc) isolated the desired product as a clear oil (0.462 g, 11.7% ). Rf = 0.46 (Si02, 
10% MeOH in EtOAc); 1H NMR (200 MHz, CDC13): 3.66 (2H, quart, J 5.6, CH2NH), 
3.85 (2H, t, J 4.6, CH20H), 7.43 (1H, t, J 6.1, HS), 7.85 (1H, t, J 7.6, H4), 8.16 (1H, d, J 
7.8, H3), 8.19 (1H, br s, NH), 8.55 (1H, d, J 4.6, H6); 13C NMR (CDC13, 50 MHz) 6c: 
42.44 (CH2), 62.06 (CH20H), 122.31 (C3), 126.31 (CS), 137.44 (C4), 148.17 (C6), 149.72 
(q, C2), 165.37 (C=O); m/z (ES) 189 (100%, MH\ 355 (100%, 2MNa\ IR (thin 
film): 1671 (C=O), 1524 (NH). 
0 
H 
N~Br 
Pyridine-2-carboxylic acid (2-bromoethyl)-amide 47 Triphenyl phosphine (351 mg, 
1.34 mmol) was added portionwise to a stirred, pale yellow solution of 46 (148 mg, 
0.89 mmol) and carbon tetrabromide (370 mg, 1.11 mmol) which had been cooled 
with an ice bath. The resulting bright yellow solution was allowed to warm 
gradually to room temperature and stirred for 18 hours. The solvent was removed 
under reduced pressure. Flash column chromatography (Si02, 5% MeOH in 
EtOAc) gave the desired product as a clear oil (99 mg, 48%). Rf = 0.64 (10% Si02, 
MeOH in EtOAc); 1H NMR (200 MHz, CDC13): 3.46 (2H, t, J 5.4, CH2Br), 3.61 (2H, 
quart, J 6.6, CH2NH), 7.41 (1H, t, J 6.1, HS), 7.82(1H, t, J 7.6, H4), 8.14 (1H, d, J 7.8, 
H3), 8.18 (1H, br s, NH), 8.52 (1H, d, J 3.9, H6); 13C NMR (CDC13, 60 MHz) 6c: 
31.97 (CH2), 41.27 (CH2), 122.41 (C3), 126.52 (CS), 137.51 (C4), 148.35 (C6), 149.57 (q, 
I + 79 + )/ 81 +) C2), 164.60 (C=O); m z (ES ): 251 (100%, Br MNa ), 253 (lOO~o, Br MNa ; IR 
(thin film): 1671 (C=O), 1524 (NH). 
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1,4,7-Tris(tert-butoxycarboxymethyl)-1,4,7,10-tetraazacyclododecane155 48 Tert-butyl 
bromoacetate (1.88 g, 9.6 mmol) was added to a solution of cyclen (0.55 g, 
3.2 mmol), and sodium hydrogen carbonate (0.81 g, 9.6 mmol) in dry acetonitrile 
(15 ml). The suspension was stirred under argon for 18 hours. The solvent was 
then removed under reduced pressure and the resulting solid was dissolved in 
dichloromethane and filtered to remove the inorganic solids. The solvent was then 
evaporated under reduced pressure and the pale oil obtained was recrystallised 
from toluene to give needle shaped crystals (0.77 g, 47%). 1H NMR (200 MHz, 
CDC13): 1.42 (27H, s, 1Bu), 2.95 (16H, br m, ring CH2), 3.26 (2H, s, acetate CH2), 3.34 
(4H, s, 2 acetate CH2); 13C NMR (CDC13, 60 MHz) Be: 30.2 (C(~H3h), 49.5 (CH2), 
50.4 (CH2), 51.2 (CH0, 53.1 (CH2), 53.6 (CH2), 60.4 (CH2), 83.6 (C(CH3h), 171.4 
(C=O), 172.2 (C=O); m/ z (ES+): 515 (100%, M+). 
0 0~t~uo~ 
7 IN N 
tBuO [ J 0 
N N~~ u N "-' ~OtBu H I h 
0 
1,4, 7-Tris-tert-butoxycarbonylmethyl-10-[2-(pyridine-2-carbamoylethyl) ]-1,4, 7,1 Otetraaza-
cyclododecane 49 Under an argon atmosphere, a stirred suspension of 47 (99 mg, 
0.43 mmol), 48 (222 mg, 0.43 mmol) and potassium carbonate (299 mg, 2.16 mmol) 
in acetonitrile (4 ml) was heated under reflux for 18hours. It was then cooled to 
room temperature and filtered; the filtercake was washed thoroughly with 
dichloromethane. The solvent was then evaporated under reduced pressure and 
the resulting brown oil was purified by flash column chromatography (Si02, 
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gradient elution 2% MeOH in OCM ~ S% MeOH in OCM), a clear colourless oil 
(98 mg, 29%) was obtained. Rf = 0.6S (Si02, 10% MeOH in OCM). 1H NMR 
(300 MHz, COC13): 1.27 (18H, s, 2 tBu), 1.3S (9H, s, tBu), 2.27- 3.54 (26H, br m, 13 
CH2), 7.36 (1H, t, J 4.8, H5), 7.69 (1H, t, J 7.6, H4), 8.02 (1H, d, J 7.8, H3), 8.23 (1H, 
br t, NH), 8.4S (1H, d, J 5. 7, H6); 13C NMR (7S MHz, COC13) Be: 27.80 (C(CH1h), 
36.SS, (CH2), S0.37 (CH2), SS.34 (br CH2), SS.70 (CH2), 56.54 (CH2), 82.2S (C(CH3h), 
122.17 (C3), 126.33 (CS), 137.17 (C4), 148.09 (C6), 149.60 (q, C2), 16S.68 (C=O), 172.72 
(C=O), 172.8S (C=O); m/ z (ES\ 68S.5 (100%, MNa +), 663.6 (90%, MH\ Acc.MS 
(ES+): Found 663.4497, C34H59N60 7 requires 663.444S. 
H0-.~,0 
o~l\) 
I '[N NJ OH O s:-~N~~~ 
0 
1,4, 7-Tris-carboxymethyl-1 0-[3-(pyridine-2-carbamoylethyl) ]-1,4,7,1 Otetraaza-
cyclododecane L5 Under an argon atmosphere, a solution of 49 (99 mg, 0.145 mmol) 
trifluoroacetic acid (2 ml) was left standing for 48 hours. The solvent was then 
removed under reduced pressure. The resulting solid was washed with dichloro-
methane (3 x 2 ml) and the solvent removed under reduced pressure to give a pale 
yellow oil. 1H NMR (300 MHz, 0 20): 3.10- 3.99 (26H, br m, 13CH2), 8.1S (1H, t, J 
6.6, HS), 8.34 (1H, t,] 7.8, H4), 8.62 (1H, d, J 7.8, H3), 8.77 (1H, d, J 5.7, H6); 13C 
NMR (75 MHz, 0 20) Be: 48.96- S4.42 (br m, CH0, 12S.23 (C3), 129.93 (CS), 141.86 
(C4), 143.16 (q, C2), 147.67 (C6), 161.0S (C=ONH), 162.S5 (C=ONH), 163.03 (C=O). 
0 
H 
N~OH 
Pyridine-2-carboxylic acid (3-hydroxy-propyl)-amide 50 3-Aminopropan-1-ol (1.78 g, 
23.7 mmol) and a catalytic amount of HOBt (3 mg) were added to a stirred dark red 
172 
solution of picolinic acid (2.92 g, 23.7 mmol) and EDC (S.OO g, 26.0 mmol) in 
dichoromethane (2S ml). The reaction mixture was stirred at room temperature for 
48 hours. Silica (~S g) was then added to the black solution and the solvent 
evaporated under reduced pressure. Flash column chromatography (Si02, 10% 
methanol in ethyl acetate) was used to purify the product, which was obtained as a 
yellow oil (1.19 g, 28%). Rf = 0.29 (10% MeOH in EtOAc, SiO~; 1H NMR 
(300 MHz, CDC13): 1.80 (2H, quintet, I 5.4, CH2CH2CH2), 3.6S (4H, m, 
CH2CH2CH2), 7.43 (1H, t, I 7.6, HS), 7.8S (1H, t, I 7.6, H4), 8.19 (1H, d, I 7.8, H3), 
8.24 (1H, br s, NH), 8.S3 (1H, d, I 4.2, H6); 13C NMR (CDC13, 60 MHz) 6c: 32.67 
(CH2 CH2 CH2), 3S.90 (CH2NH), S9.07 (CH20H), 122.4S (C3), 126.4S (CS), 137.S7 
(C4), 148.2S (C6), 149.SS (q, C2), 16S.68 (C=O); m/ z (ES+): 383 (90%, 2MNa \ 203 
(100%, MNa\ 181 (41 %, MH\ Acc.MS (El\ Found 180.0894, C9H12N20 2 requires 
180.0898; IR (thin film) 3373 (OH), 1660 (C=O), 1S34 (NH), 1434 (v py). 
Oy~~Br 
0 
Pyridine-2-carboxylic acid (3-bromopropyl)-amide 51 Triphenylphosphine (72S mg, 
2.77 mmol) was added portionwise to a stirred yellow solution of 50 (332 mg, 
1.84 mmol) and carbon tetrabromide (76S mg, 2.31 mmol) in dichloromethane 
(10 ml) which had been cooled in an ice bath. The ice bath was then allowed to 
melt gradually and the resulting pale yellow solution was stirred for 18 hours at 
room temperature before the solvent was removed under reduced pressure 
yielding a pale brown oil. Flash column chromatography (Si02, S% methanol in 
ethyl acetate) yielded the desired product as a clear colourless oil (119 mg, 27%). Rf 
= 0.48 (10% MeOH in EtOAc, SiO~; 1H NMR (300 MHz, CDC13): 2.18 (2H, quintet, 
I 6.6, CH2CH2CH2), 3.46 (2H, t, J 5.4, CH2Br), 3.61 (2H, quart, J 6.6, CH2NH), 7.41 
(1H, t, J 6.1, HS), 7.82(1H, t, I 7.6, H4), 8.14 (1H, d, I 7.8, H3), 8.18 (1H, br s, NH), 
8.S2 (1H, d, I 3.9, H6); 13C NMR (CDC13, 60 MHz) 6c: 30.87 (CH2), 32.48 (CH~, 
37.96 (CH~, 122.27 (C3), 126.33 (CS), 137.S2 (C4), 148.08 (C6), 149.6S (q, C2), 164.62 
(C=O); m/ z (ES+): 242 (100%, M\ IR (thin film): 1667 (C=O), 1S29 (NH). 
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1,4, 7-Tris-tert-butoxycarbonylmethyl-1 0-[3-(pyridine-2-carbamoylpropyl) ]-1,4, 7,10-
tetraaza-cyclododecane 52 Under an argon atmosphere a suspension of 51 (119 mg, 
0.49 mmol), 48 (252 mg, 0.49 mmol) and potassium carbonate (338 mg, 2.45 mmol) 
in acetonitrile (3 ml) was heated under reflux for 48 hours. It was then allowed to 
cool to room temperature before removing the inorganic salts by filtration and 
washing them thoroughly with dichloromethane. The solvent was then removed 
under reduced pressure to give a yellow oil (330 mg). Flash column 
chromatography (Si02, gradient elution DCM ~ 5% MeOH in DCM) yielded the 
desired product as a clear colourless oil (100 mg, 30%). Rf = 0.11 (Si02, 10% MeOH 
in EtOAc); 1H NMR (300 MHz, CDC13): 1.36 (27H, s, 3tBu), 1.73 (2H, quintet, J 6.9, 
CH2CH2CH2), 2.25 - 3.04 (20H, br m, ring CH2 + CH2CH2CH2), 3.14 (2H, s, 
CH2CO), 3.39 (4H, s, 2CH2CO), 7.40 (1H, t, J 6.1, HS), 7.80 (1H, t, J 7.6, H4), 8.10 (1H, 
d, J 7.8, H3), 8.94 (1H, d, J 3.9, H6); 13C NMR (CDC13, 75 MHz) 6c: 26.64 
(CH2CH2CH2), 27.82 (tBu), 27.95 (tBu), 37.74 (NHCH2CH2), 50.29, 50.46, 51.95 (br, 
ring CH2s) , 55.76 (NCH2CO), 56.55 (NCH2CO), 82.45 (C(CH3h), 82.77 (QCH3h), 
122.06 (C3), 126.37 (CS), 137.44 (C4), 148.12 (C6), 149.59 (q, C2), 164.41 (C=ONH), 
172.64 (C=O), 173.57 (C=O); mjz (ES) 699.5 (100%, MNa\ 677.6 (25%, MH+). 
1,4, 7-Bis-carboxymethyl-1 0-[3-(pyridine-2-carbamoylpropyl) ]-1,4, 7,1 Otetraaza-
cyclododecane L6 Under an argon atmosphere, a solution of 52 (100 mg, 0.148 mmol) 
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in dichloromethane (1 ml) and trifluoroacetic acid (1 ml) was left standing for 18 
hours. The solvent was then removed under reduced pressure. The resulting solid 
was washed with dichloromethane (3 x 2 ml) and the solvent removed under 
reduced pressure to give the trifluoroacetate salt as a pale yellow oil. 1H NMR 
(300 MHz, 0 20): 2.03 (2H, br t, CH2CH6CH2), 2.90- 3.46 (26H, br m, ring CH2 + 
CH6CH2CH6 + 3CH2CO), 8.12 (1H, t,] 6.9, H5), 8.34 (1H, t,] 7.8, H4), 8.62 (1H, d,] 
8.1, H3), 8.77 (1H, d, J 5.1, H6); 13C NMR (75 MHz, 0 20) 6c: 23.14 (CH2CH6CH2), 
37.74 (NHCH6CH2), 48.13 (CH2), 48.52 (CH2), 50.10 (CH2), 51.95 (CH2), 52.20 (CH2) I 
52.94 (CH~, 53.97 (CH2), 54.51 (CH2), 125.01 (C3), 129.83 (CS), 142.15 (C4), 147.94 
(C6), 160.18 (C=ONH), 162.33 (C=ONH), 162.81 (C=ONH), 174.32 (C=O); m/ z 
(ES+): 509.5 (100%, MH\ 
6.5.2 Complex synthesis 
Eu(C22H31N 60 7) [EuL 1 Europium acetate (12 mg, 0.032 mmol) was added to a 
solution of L6 (pH 5.4, 16 mg, 0.032 mmol) in water (2 ml) and methanol (2 drops). 
The resulting pale yellow solution was heated under reflux for 48 hours before 
being cooled to room temperature. The pH was then increased to 10 using sodium 
hydroxide (1M solution) and the solution allowed to stand for 50 minutes. The 
europium hydroxide which formed was removed by filtration. The pH was 
adjusted back to pH 5.5 and the water removed by lyophilisation to yield a white 
solid. 1H NMR (500 MHz, 0 20): the spectrum obtained was very complex; three 
major species were present, which were exchange broadened at 4°C; mjz (ES-): 
642.8 (100%, M-H); Acc.MS (ES-): Found 643.1393, C22H 31N60 7Eu requires 
643.1394; IR (KBr, cm-1): 1699 (C=O), 1684 (C=O), 1560 (NH), 1407, 1206, 1131; 
kH:zO: 1.65 ms-\ k020: 0.53 ms-
1
; qEu = 1.1. 
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Gd(C22H31N 60 7) [GdL5] Gadolinium acetate (12 mg, 0.032 mmol) was added to a 
solution of L5 (pH 5.5, 16 mg, 0.032 mmol) in water (2 ml) and methanol (2 drops). 
The resulting pale yellow solution was heated under reflux for 48 hours before 
being cooled to room temperature. The pH was then increased to 10 using sodium 
hydroxide (1M solution) and the solution allowed to stand for 50 minutes. The 
gadolinium hydroxide which formed was removed by filtration. The pH was 
adjusted back to pH 5.5 and the water removed by lyophilisation to yield the 
desired complex as a white solid. m/ z (ES-): 647.5 (85%, M-H-); Acc.MS (ES-): 
Found 648.1426, C22H 31N60 7Gd requires 648.1422; IR (KBr, cm-1): 1699 (C=O), 1684 
(C=O), 1560 (NH), 1407, 1206, 1131; r1r (60 MHz, 37°C): 2.89 mM-1s-\ r1r (65 MHz, 
22oC): 3.50 mM-1s-1. 
Eu(C23H33N 60 7) [EuL6] The pH of a solution of L6 (0.073 mmol) in water (1.5 ml) 
and methanol (0.5 ml) was increased to pH 5.5 using KOH solution. Europium 
acetate (23 mg, 0.07 mmol) was added and the resulting solution was heated under 
reflux for 18 hours. After the solution was cooled, the pH was raised to 10 and the 
resulting suspension was filtered through a syringe filter to remove the excess 
europium as Eu(OHh The pH was then lowered to 5.5 and the solution 
lyophilised to give the complex as a white powder. 1H NMR (500 MHz, COSY, 
0 20) was characteristic of a square antiprism constitution, one major and one 
minor isomer were present in ratio of 1 : 4. Partial assignment: 35.7 (0.2H, s, Hax' 
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minor isomer), 34.1 (0.2H, s, Haxt minor isomer), 32.2 (1H, s, Hax(1)), 29.3 (1H, s, H6), 
27.5 (1H, s, Hax(2)), 25.8 (1H, s, Hax(3)), 23.41 (1H, s, Hax(4)), 13.8 (1H, s), 11.3 (1H, s), 
8.9-0 (br m), 4.6 (Heq(1)), 1.8 (H'ax(1)), -1.6 (H'eq(1)), -3.6 (Heq(4)), -3.9 (Heq(2)), -4.6 
(H' eq(2)), -5.1 (H' ax(4)), -7.4 (H' ax(2)), -7.8 (Heq(3)), -11.3 (H' eq(4)), -11.5 (H' eq(3), -13.9 
(H'ax(3)), -14.9 (CH2C02), 16.7 (CH2CO:J, -18.0 (CH2CO:J, -20.0 (CH2C02), -20.2 
(CH2C02); m/z (ES+): 1351.2 (40%, [KM2 - H;n, 1312.9 (40%, [M2 - H;n, 656.8 
(60%, M-H-); Acc.MS (ES+): Found 659.1696, C23H34N60 7Eu requires 659.1696; IR 
(KBr, cm-1): 1699 (C=O), 1684 (C=O), 1560 (NH), 1407, 1206, 1131; k1-120: 0.87ms-1; 
k020: 0.58ms-
1
; qEu = 0. 
Gd(C23H33N 60 7) [GdL 1 Gadolinium acetate (26 mg, 0.07 mmol) was added to a 
solution of L5 (0.07 mmol) in water (1.5 ml, pH 5.5) and methanol (0.5 ml). The 
resulting pale yellow solution was heated under reflux for 48 hours before being 
cooled to room temperature. The pH was then increased to 10 with sodium 
hydroxide (1M solution) for 50 minutes. The gadolinium hydroxide precipitate 
which formed was removed by filtration. The pH was then adjusted back to pH 5.5 
and the water was removed by lyophilisation to yield the complex as a white solid. 
mjz (ES-): 1323.7 (60%, [M2- H 2n, 1361.7 (60%, [KM2 - H2n, 661.6 (40%, M-H-); 
Acc.MS (ES+): Found 702.1291, C23H33N60 7GdK requires 702.1283; IR (KBr, cm-1): 
1699 (C=O), 1684 (C=O), 1560 (NH), 1407, 1206, 1131; r1P (60 MHz, 37°C): 
2.18 mM-1s-\ r1P (65 MHz, 22°C): 2.45 mM-1s-1. 
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6. 6 Chapter 4 Experimental 
6.6.1 Ligand Synthesis 
~0 0'--../ 
0 0 
Pyridine-2,6-dicarboxylic acid diethyl ester136 55 Concentrated sulphuric acid (0.6 ml) 
was added to a suspension of 2,6-pyridinedicarboxylic acid (10.00 g, 59.8 mmol) in 
dry ethanol (100 ml) heating under argon at reflux. The reaction mixture, which 
gradually became clear and colourless, was boiled for 18 hours before being 
allowed to cool to room temperature and quenched with excess sodium hydrogen 
carbonate. The solvent was then evaporated under reduced pressure and the 
resulting residue was dissolved in dichloromethane (50 ml) and washed 
successively with water (50 ml) and aqueous sodium hydrogen carbonate solution 
(3 x 50 ml). The organic phase was then dried (MgS04), filtered, and concentrated 
under reduced pressure to yield a white crystalline solid (9.01 g, 67%). m.p. 38-
39°C (no melting point given in literature136); 1H NMR (200 MHz, CDC13): 6H 1.46 
(6H, t, I 7, 2Me), 4.47 (4H, quartet, I 7.2, 2CH2), 7.98 (1H, t, I 7.2, H4), 8.21 (2H, d, I 
7.2, H3 + HS); 13C NMR (50.3 MHz, CDC13): Be 14.24 (2Me), 62.33 (2CH2), 127.87 
(C4), 138.28 (C3 + CS), 148.67 (q, C2 + C6), 164.65 (C=O); m/ z (ES\ 469 (100%, 
2M+Na+), 246 (42%, M+Na\ 224 (17%, M+H+). 
~0 OH 
0 
6-Hydroxymethyl-pyridine-2-carboxylic acid ethyl ester136 56 Sodium borohydride 
(0.91 g, 24.2 mmol) was added to a solution of 55 (9.01 g, 40.4 mmol) in dry ethanol 
(80 ml). The resulting suspension was heated under reflux for three hours before 
being allowed to cool to room temperature and quenched with water (60 ml). It 
was then concentrated under reduced pressure to -70 ml and extracted with 
chloroform (3 x 80 ml). The combined organic phase was dried (MgS04), filtered 
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and concentrated under reduced pressure to yield a white solid (3.3 g), which was 
recrystallised from ethanol to give the desired product (3.22 g, 44%). m.p 91-92°C 
(no melting point given in literature136); 1H NMR (200 MHz, CDC13): OH 1.42 (3H, t, 
J 7.2, Me), 3.76 (1H, br s, OH) 4.47 (2H, quartet, J 7.2, CH2CH3), 4.85 (2H, s, 
CH20H), 7.48 (1H, d, J 7.2, H5), 7.83 (1H, t, J 7.2, H4), 8.00 (1H, d, J 7.2, H3); 13C 
NMR (50.3 MHz, CDC13): Oc 14.45 (Me), 62.08 (CH2CH3), 62.59 (CH20H), 123.91 
(C3), 123.98 (CS), 137.75 (C4), 160.04 (C=O); m/z (ES+): 204.0 (100%, MNa\ 
~0 
0 
6-Azomethyl-ptjridine-2-carboxylic acid ethyl ester136 57 Methanesulfonyl chloride 
(2.01 ml, 17.1 mmol) was added to a stirred suspension of 56 (3.10 g, 17.1 mmol) 
and triethylamine (2.38 ml, 17.1 mmol) in toluene (40 ml) which had been cooled in 
an ice bath. The reaction mixture was allowed to warm gradually to room 
temperature and stirred for 3 hours. Tetrabutylammonium bromide (0.606 g, 
1.88 mmol), sodium azide (8.90 g, 136.86 mmol) and water (32 ml) were added and 
the resulting orange reaction mixture was heated at 90°C for 18 hours. The mixture 
was cooled to room temperature and the organic phase was separated. The 
aqueous phase was extracted with toluene ( 4 x 100 ml), and the combined organic 
extracts were dried (NaS04), filtered and concentrated under reduced pressure to 
yield a brown oil (4.01 g). Flash column chromatography (Si02, EtOAc) yielded the 
desired product as a pale yellow oil (2.21 g, 63%); Rf = 0.62 (Si02, EtOAc); 1H NMR 
(200 MHz, CDC13): oH 1.42 (3H, t, J 7, Me), 4.48 (2H, J 7, CH2CH3) 4.62 (2H, s, 
CH2N3), 7.58 (1H, d, J 7.6, H3), 7.87 (1H, t, J 7.6, H4), 8.07 (1H, d, J 7.6, H5); 13C 
NMR (50.3 MHz, CDC13): Oc 14.39 (Me), 55.59 (CH2N3), 62.17 (CH7CH3), 124.32 
(C3), 125.00 (CS), 138.13 (C4), 148.31 (q, C6) 156.58 (q, C2), 165.00 (C=O); m/z (ES\ 
435 (100%, 2M+Na +), 229 (56%, MNa \ 207 (69%, MH) 
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6-Aminomethyl-pyridine-2-carboxylic acid ethyl ester136 58 10% Palladium on carbon 
(0.33 g) was added to a pale yellow solution of 57 (2.22 g, 10.8 mmol) in ethanol 
(50 ml). The resulting black suspension was hydrogenated on a Parr hydrogenator 
(30 psi) for 24 hours at room temperature. It was then filtered through celite and 
the filtercake washed with lots of ethanol. The filtrate was acidified with trifluoro-
acetic acid (0.82 ml, 10.8 mmol) then the solvent was evaporated under reduced 
pressure to yield the trifluoroacetate salt as a yellow oil (3.43 g) which crystallised 
on standing. 1H NMR (200 MHz, CDC13): oH 1.38 (3H, t, J 7.2, Me), 4.38 (2H, J 7.2, 
CH2CH3) 4.44 (2H, s, CH2NH2), 7.58 (1H, d,] 7.6, H3), 7.85 (1H, t, I 7.6, H4), 7.99 
(1H, d, I 7.6, HS), 8.78 (2H, br s, NH~; 13C NMR (50.3 MHz, CDC13): Oc 14.14 (Me), 
43.61 (CH2NH~, 62.38 (CH2CH3), 124.91 (C3), 126.34 (CS), 138.64 (C4), 147.43 (q, 
C2) 153.15 (q, C6), 164.97 (C=O); mfz (ES+): 167.1 (100%, MH+-CH2), 180.1 (56%, 
MH+). 
OA: ~ N 0 
11 
0 N-S-CF 
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6-(Methanesulfonylamino-methyl)-pyridine-2-carboxylic acid ethyl ester 59 Under 
anhydrous conditions in an argon atmosphere, trifluoromethanesulfonyl chloride 
(1.65 ml, 10.87 mmol) was added to a solution of 58.TFA (3.20 g, 10.87 mmol) in 
anhydrous pyridine (30 ml) which had been cooled to -40°C. The solution was 
stirred at -40°C for two hours before being allowed to warm gradually to room 
temperature. It was stirred at room temperature for 18 hours then poured onto ice 
(200 ml), which was allowed to melt. The resulting gloopy brown solution was 
extracted with diethyl ether (4 x 75 ml). The combined organic phase was then 
dried (Na2S04), filtered and evaporated under reduced pressure. The resulting 
solid was then dissolved in dichoromethane and dried thoroughly under reduced 
pressure to remove all the residual pyridine. A pale brown solid was obtained 
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(2.3S g, 69% ). m.p. 70- 72°C; 1H NMR (200 MHz, CDC13): 8H 1.44 (3H, t, CH3), 3.49 
(1H, s, NH), 4.4S (2H, q, CH2CH3), 4.70 (2H, d, J 6.4, CH2NH), 7.50 (1H, d, J 7.6, H3), 
7.87 (1H, t, J 7.8, H4), 8.06 (1H, d, J 7.8, HS); After a D20 shake, the NH peak 
disappeared and the CH2NH peak became a singlet. 
13C NMR (S0.3 MHz, CDC13): 
6c 14.29 (CH3), 44.24 (CH2), 62.1S (CH2), 124.41 (C3), 12S.S3 (CS), 138.34 (C4), 147.89 
(q, C2), 1S4.59 (q, C6), 164.78 (q, C=O); 19F NMR (188 MHz, CD3CN): 6 -76.2S (s, 
CF3); m/ z (ES) 299 (100%, M- CH/), 28S (80%, M- C2H4 \ transesterification 
occurs in methanol carrier solvent; umax (KBr)/cm-1 3393 (NH), 1719 (C=O), 1S90 
(v py), 1421 (v py), 1372 (va SO~, 1298, 1178 (v5 502). 
~0 
6-tert-Butoxycarbonylamino-methyl-pyridine-2-carboxylic acid ethyl ester 62 Following 
the method of Saito et al.,137 BOC anhydride (3.89g, 17.88 mmol) and 10% palladium 
on carbon (0.307 g) was added to a clear solution of 100 (3.07 g)14.90 mmol) in ethyl 
acetate. The resulting black suspension was shaken under hydrogen (40psi) on a 
Parr hydrogentor for 18 hours at room temperature. The reaction mixture was then 
filtered through a pad of Celite which was then washed thoroughly with ethyl 
acetate. The resulting solution was concentrated under reduced pressure and then 
purified by flash column chromatography (Si02, EtOAc) to give the desired 
product as a clear oil (3.80 g, 91 %). Rf = O.S2 (Si02, EtOAc); 1H NMR (300 MHz, 
CD3Cl): 6H 1.48 (9H, s, t-Bu), 4.46 (2H, quintet, J 6.9, CH2CH3), 4.S1 (2H, d, J 5.7, 
CH2NH), 7.48 (1H, d, J 7.8, HS), 7.80 (1H, t, J 7.5, H4), 7.99 (1H, d, J 7.2, H3); 13C 
NMR (S0.8 MHz, CDC13): 6c 28.38 (C(CH2h), 4S.93 (CH2), S0.42 (CH2), S2.88 (CH~, 
79.72 (C(CH3h), 123.76 (C4), 12S.37 (CS), 137.79 (C3), 147.33 (C6), 1S6.1S (C2), 
1S8.87 (C=O) 16S.68 (C=O); m/z (ES\ 303.2 (100%, MNa\ 289.2 (70%, MNa+-
CH2 (tranesterification)); IR (thin film): 3373 (NH), 1693 (C=O), 1172; Acc.MS (ES+): 
Found 303.1300, C14H 20N20 4Na requires 303.1321. 
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[6-(3-Hydroxy-ethylcarbamoyl)-pyridine.:.2-ylmethyl]-carbamic tert-butyl ester 63 A pale 
yellow solution of 62 (298 mg, 1.06 mmol) in ethanolamine (5 ml) and methanol 
(3 ml) was stirred at room temperature for 48 hours. The solvent was then removed 
using a Kiigelrohr apparatus, purification of the resulting yellow oil by flash 
column chromatography (Si02, EtOAc) yielded the desired- product as a clear 
colourless oil (68 mg, 22%). Rf = 0.66 (Si02, 10%MeOH in EtOAc); 1H NMR 
(200 MHz, CD3Cl): BH 1.46 (9H, s, t-Bu), 3.66 (2H, quartet, I 5.2, NHCH2CH0, 3.84 
(2H, t, I 5, HOCH2CH2), 4.46 (2H, d, I 6.2, ArCH2NH), 5.28 (1H, br s, NH), 7.40 (1H, 
d, J 7.6, H3), 7.82 (1H, t, J 7.8, H4), 8.05 (1H, d, I 7.6, H5), 8.38 (1H, br s, NH); 13C 
NMR (75.4 MHz, CDCI3): Be 28.52 (C(CH1h), 42.67 (CH2), 45.87 (CH2), 62.53 (CH0, 
62.53 (CH2), 120.99 (C4), 124.32 (q, C2), 138.26 (C3), 149.13 (CS), 156.17 (q, C6), 
+ +) + 157.17 (C=O), 165.41 (C=O); m/z (ES ): 318 (100%, MNa ; Acc.MS (ES ): Found 
318.1414, C14H 21N30 4Na requires 318.1430; IR (thin film): 3200 (br OH), 1655 
(C=O), 1526 (NH). 
H 
HO~N 
[6-(3-Hydroxy-propylcarbamoyl)-pyridine-2-ylmethyl]-carbamic tert-butyl ester 64 A 
solution of 62 (400 mg, 1.43 mmol) in 3-aminopropan-1-ol (4 ml) and methanol 
(2 ml) was stirred at room temperature for 48 hours. The solvent was then removed 
using a Kiigelrohr apparatus, purification of the resulting yellow oil by flash 
column chromatography (Si02, EtOAc) yielded the desired product as a clear oil 
(262 mg, 59%). Rf = 0.67 (Si02, 10% MeOH in EtOAc), 1H NMR (300 MHz, CD3Cl): 
BH 1.48 (9H, s, t-Bu), 1.83 (2H, quintet, J 6, CH2CH2CH2), 3.62 - 3.73 (4H, m, 
CH2CH2CH2), 4.46 (2H, d, J 5.1, CH2NH), 5.44 (1H, br s, NH), 7.40 (1H, d, I 7.5, H3), 
7.83 (1H, t, J 7.8, H4), 8.06 (1H, d, J 7.8, H5), 8.49 (1H, br s, NH); 13C NMR 
(75.4 MHz, CDCI3): Be 28.64 (C(CH3h), 32.31 (CH0, 32.48 (CH0, 36.68 (CH2), 45.75 
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(CH2), 121.07 (C4), 124.3S (C2), 138.4S (C3), 149.11 (CS), 1S7.0S (C6), 177.17 (C=O), 
182.97 (C=O); m/z (ES) 332 (100%, MNa+); Acc.MS (ES+): Found 332.1S70, 
H 
Br~N 
[6-(2-Bromo-ethylcarbamoyl)-pyridin-2-ylmethyl]-carbamic acid tert-butyl ester 68 Under 
an argon atmosphere, triphenylphosphine (1.107 g, 4.22 mmol) was added to a 
stirred clear solution of 63 (0.830 g, 2.81 mmol) and carbon tetrabromide (1.166 g, 
3.S2 mmol) in dichloromethane (3S ml) which had been cooled on an ice-bath. The 
resulting pale yellow solution was allowed to warm gradually to room temperature 
and stirred for 18 hours. The resulting red solution was concentrated under 
reduced pressure and purified by flash column chromatography (Si02, EtOAc) to 
give a clear colourless oil (0.833 g, 82%). 1H NMR (300 MHz, CD3Cl): 6H 1.47(9H, s, 
t-Bu), 3.S9 (2H, t, J 6, HOCH2CH2), 3.88 (2H, quartet, J 6, NHCH2CH2), 4.48 (2H, d, 
J 5.4, ArCH2NH), S.28 (1H, br s, NH), 7.43 (1H, d, J 7.5, H3), 7.84 (1H, t, J 7.8, H4), 
8.07 (1H, d, J 7.6, HS), 8.39 (1H, br s, NH); 13C NMR (7S.4 MHz, CDC13): Be 28.SO 
(C(CH24), 32.07 (CH2), 41.17 (CH2), 4S.74 (CH2), 120.97 (C4), 124.38 (q, C2), 138.2S 
(C3), 148.92 (CS), 1S6.12 (q, C6), 1S7.16 (C=O), 164.3S (C=O); m/z (ES+): 382.0 
(8S%, MNa \ 380.0 (100%, MNa \ 
H 
Br~N 
Acc.MS (ES+): Found 380.0569, 
[6-(3-Bromo-propylcarbamoyl)-pyridine-2-ylmethyl]-carbamic tert-butyl ester 69 
Triphenylphosphine (184 mg, 0.704 mmol) was added to a solution of 64 (14S mg, 
0.469 mmol) and carbon tetrabromide (195 mg, O.S86 mmol) in dichloromethane 
(5 ml) which had been cooled in an ice bath. The resulting yellow solution was 
allowed to warm gradually to room temperature and then stirred at room 
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temperature for 18 hours. The solvent was then removed under reduced pressure 
and the resulting pink oil was purified by flash column chromatography (Si02, 
EtOAc) to yield a clear colourless oil (132 mg, 78%). Rf = 0.55 (Si02, EtOAc); 1H 
NMR (200 MHz, CDC13): oH 1.45 (9H, s, t-Bu), 2.20 (2H, quintet, J 6.6, CH2CH2CH2), 
3.48 (2H, q, ] 6.6, CH2CH2NH), 3.60 (2H, q, ] 6.6, BrCH2CH2), 4.46 (2H, d, ] 2, 
CH2NH), 5.36 (1H, br s, NH), 7.38 (1H, d, J 6.6, H3), 7.80 (1H, t,] 6.6, H4), 8.03 (lH, 
d, J 6.6, H5), 8.84 (1H, br s, NH); 13C NMR (75.4 MHz, CDC13): Oc 28.50 (C(CH1lJ), 
31.00 (CH2), 32.48 (CH2), 38.12 (CH2), 45.79 (CH~, 79.96 (C(CH3)J), 120.90 (C4), 
124.19 (C3), 138.24 (C5), 149.19 (C6), 156.06 (q, C2), 157.05 (C=O), 164.52 (C=O); 
m/z (ES+): 394 (100%, 79BrMNa+), 396 (94%, 81BrMNa+); Acc.MS (ES+): Found 
394.0740, C15H22N30 3NaBr requires 394.0742. 
{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-ethylcarbomoyl]-pyridin-2-ylmethyl}-carbamic acid 
tert-butyl ester 77 Under an argon atmosphere, a solution of 68 (291 mg, 
0.815 mmol) in dry chloroform (50 ml) was added to a solution of cyclen (421 mg, 
2.44 mmol) in dry chloroform (25 ml). The resulting clear colourless solution was 
stirred at room temperature for four days. The chloroform was then removed 
under reduced pressure and the resulting yellow oil was dissolved in 
dichloromethane (25 ml) and washed with water (2 x 10 ml). The organic phase 
was then evaporated under reduced pressure yielding a clear oil (347 mg, 94% ). 1H 
NMR (300 MHz, CD3Cl): oH 1.40 (9H, s, t-Bu), 2.50 - 2.65 (18H, m, 8 ring CH2, 
NCH2CH2), 3.52 (2H, quartet, J 5.1, NHCH2CH2), 4.32 (2H, d,] 5.7, ArCH2NH), 7.33 
(1H, d, J 7.5, H3), 7.74 (1H, t, J 7.5, H4), 8.03 (1H, d, J 7.5, H5); 13C NMR (75.4 MHz, 
CDC13): Oc 28.64 (C(CH1h), 37.88 (CH2), 44.70 (CH2), 45.77 (CH2), 46.50 (CH2), 
51.92 (CH2), 54.55 (CH2), 78.92 (~(CH3h), 120.51 (C4), 124.56 (q, C2), 137.96 (C3), 
149.72 (C5), 156.76 (q, C6), 157.12 (C=O), 164.21 (C=O); m/z (ES+): 512.3 (15%, 
MCu+), 450.3 (100%, MH\ Acc.MS (ES+): Found 450.3175, C22H40N70 3 requires 
450.3193. 
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{ 6-[2 -(1,4, 7, 10-Te traaza-cyclododec-yl)-propylcarbomoyl ]-pyridin-2 -ylmethyl }-carbamic 
acid tert-butyl ester 78 Cyclen (323 mg, 1.871 mmol) was added in portions to a 
solution of 69 (232 mg, 0.623 mmol) in dry chloroform (75 ml) which was stirred 
under argon at room temperature. The resulting clear solution was stirred at room 
temperature under argon for 6 days until TLC (10% MeOH in DCM) showed no 
starting material to remain. The solvent was then evaporated under reduced 
pressure and the resulting clear oil was dissolved in dichloromethane (25 ml) and 
washed with water (20 ml). The organic phase was separated and evaporated 
under reduced pressure to give a clear oil (285 mg, 98% yield). 1H NMR (300 MHz, 
CD3Cl): 6H 1.42 (9H, s, t-Bu), 1.85 (2H, t, J 6.3, CH2CH2CH~, 2.48- 2.79 (18H, m, 8 
ring CH2, NCH2CH2), 3.58 (2H, quartet, J 6.3, NHCH2CH2), 4.35 (2H, br s, 
ArCH2NH), 7.38 (1H, d, J 7.8, H3), 7.43 (1H, br s, NH), 7.78 (1H, t, J 7.7, H4), 8.03 
(1H, d, J 7.8, HS), 8.31 (1H, br s, NH); 13C NMR (75.4 MHz, CDC13): 6c 26.53 (CH2), 
28.76 (C(CH2h), 36.67 (CH2), 44.97 (CH2), 46.17 (CH2), 46.37 (CH2), 46.91 (CH2), 
50.67 (CH2), 51.37 (CH2), 54.55 (CH2), 74.96 (C(CH3h), 120.65 (C4), 124.79 (q, C2), 
138.26 (C3), 149.86 (CS), 157.34 (C=O), 164.45 (C=O); m/z (ES+): 464.3 (100%, 
MH+), 526.3 (12%, MCu); Acc.MS (ES+): Found 464.3334, C23H 42N70 3Na requires 
464.3349. 
{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-ethylcarbomoyl]-pyridin-2-ylmethyl }-carbamic acid 
tert-butyl ester - N,N',N",N"'-1,4,7,10-tert-butyl acetate 79 A suspension of 77 
(401 mg, 0.89 rnmol), t-butyl bromoacetate (573 mg, 2.94 rnmol) and sodium 
carbonate {312 mg, 2.94 mmol) in dry acetonitrile (15 ml) were heated at 60°C for 18 
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hours under an argon atmosphere. TI1e reaction mixture was then allowed to cool 
to room temperature and the solvent was evaporated under reduced pressure. The 
resulting oil was dissolved in dichloromethane (20 ml) and washed with water (3 x 
10 ml). The organic phase was then dried (K2C03) filtered and evaporated under 
reduced pressure to give the desired product as a pale brown oil (688 mg, 97%). 1H 
NMR (300 MHz, CD3Cl): 51-I 1.49 (36H, s, 4 x t-Bu), 1.92- 3.37 (26H, m, 13 CH2s), 
4.20 (2H, d, J 7.8, ArCH2NH), 5.77 (1H, br s, NH), 7.40 (1H, d, J 7.8, H3), 7.72 (1H, t, J 
7.8, H4), 7.89 (1H, d, J 7.8, HS), 8.36 (1H, br s, NH); 13C NMR (75.4 MHz, CDC13): Be 
27.8 (C(CH1h), 37.7 (CH2), 45.8 (CH2), 50.2 (CH2), 51.9 (CH~, 55.6 (CH~, 56.5 
(CH2), 82.4 (s;;;:(CH3h), 120.4 (C4), 124.0 (C2), 138.0 (C3), 149.0 (CS), 157.7 (q, C6), 
I + + 164.4 (C=O), 172.5 (C=O), 173.6 (C=O); m z (ES ): 814.9 (100%, MNa ), 792.5 (48%, 
MH+). 
{ 6-[2 -(1,4, 7,10-Tetraaza-cyclododec-yl)-propylcarbomoyl] -pyridin-2 -ylme thyl }-carbamic 
acid tert-buh;l ester- N,N',N"-1,4,7,-tert-butyl acetate 80 A suspension of 78 (207 mg, 
0.45 mmol), t-butyl bromoacetate (287 mg, 1.47 mmol) and sodium carbonate 
(156 mg, 1.47 mmol) were heated at 60°C for 18 hours under an argon atmosphere. 
The reaction mixture was then allowed to cool to room temperature and the solvent 
was evaporated under reduced pressure. The resulting oil was dissolved in 
dichloromethane (20 ml) and washed with water (3 x 10 ml). The organic phase 
was then dried (K2C03) filtered and evaporated under reduced pressure to give the 
desired product as a yellow oil. 1H NMR (300 MHz, CD3Cl): 6H 1.39 (36H, s, 4 x t-
Bu), 1.89 (2H, br t, CH2CH2CH2), 2.25 - 3.38 (26H, m, 13 CH2s), 4.40 (2H, br s, 
ArCH2NH), 5.78 (1H, br s, NH), 7.39 (1H, d, J 7.2, H3), 7.73 (1H, t, J 7.8, H4), 7.92 
(1H, d, J 7.2, HS), 8.22 (1H, br s, NH); m/ z (ES+): 806.6 (100%, MH\ 828.4 (30%, 
MNa\ 
186 
As the synthetic pathway is analogous for the C2 and C3 appended D03A ligand 
systems ll7 and L8; the synthetic details will only be described for the C3 variant. 
1,4, 7-Tris( carboxymethyl)-{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-propylcarbomoyl]-
pyridin-2-ylmethyl}-carbamic acid tert-butyl ester L11 A solution of 80 (397 mg, 
0.92 mmol) in TFA (4 ml) was left standing under an argon atmosphere for 18 
hours. The solvent was then removed under reduced pressure. The resulting pale 
brown oil was resuspended in dichloromethane (3 x 4 ml) which was then 
evaporated in order to remove all residual TFA. 1H NMR (300 MHz, D20): 6H 2.07 
(2H, br quintet, CH2CH2CH2), 2.92 - 3.51 (26H, m, 13 CH2s), 4.36 (2H, s, 
ArCH2NH), 7.56 (1H, t, J 7.2, H4), 7.80 (2H, m, H3 + H5); m/ z (ES+): 566.4 (100%, 
MH\ 
1,4,7-Tris(methoxycarboxymethyl)-{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-
propylcarbomoyl]-pyridin-2-ylmethyl}-amine 83 The TFA salt of L11 (0.92 mmol) was 
dissolved in dry methanol (3 x 5 ml) which was then evaporated under high 
vacuum. The resulting oil was then redissolved in dry methanol (10 ml) and acetyl 
chloride (0.5 ml) was added to generate dry HCl in situ. The resulting solution was 
heated under reflux for 48 hours. It was then allowed to cool to room temperature 
and the solvent was evaporated to yield the desired product. 1H NMR (300 MHz, 
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CD3Cl): OH 2.02 (2H, br s, CH2CH2CH2), 2.79- 4.36 (28H, m, 13 x CH2), 3.47 (9H, s, 3 
OCH1), 7.33 (1H, d, J 7.5, H5), 7.72 (1H, t, J 7.5, H4), 7.83 (1H, d, J7.8, H3); m/ z 
(ES+): 290.9 (100%, MH2+), 314.7 (52%, MNa2+), 580.4 (90%, MH+); Acc.MS (ES+): 
0
yoMe 
~1\~0 
N N:._ \ [ J OMe MeO N N H ~LJ~N 
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1,4, 7-Tris(methoxycarboxymethyl)-{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-
propylcarbomoyl]-pyridin-2-ylmethyl}-trifluoromethanesulfonamide 85 Under an argon 
atmosphere trifluoromethane sulfonyl chloride (225 mg, 1.34 mmol) was added to a 
solution of 83 (258 mg, 0.446 mmol) and Htinig's base (172 mg, 1.34 mmol) in 
dichloromethane (5 ml) which had been cooled to -40°C. The solution was held at-
40°C for one hour, then allowed to warm to -20°C and kept at this temperature for 
18 hours. The solvent was then removed under reduced pressure and the resulting 
brown oil was purified by flash column chromatography (Si02, 5% MeOH in DCM) 
to give the desired product contaminated with Htinig's base as a pale yellow oil. Rf 
= 0.61 (Si02, 10% MeOH in DCM); 1H NMR (300 MHz, CD3Cl): OH 2.75- 3.64 (26H, 
m, 13 x CH2), 3.88 (9H, s, 3 OCH1), 4.13 (2H, s, CH2NH2), 7.76 (1H, d, J 7.2, H5), 8.00 
{1H, d, J 6.9, H5), 8.12 (1H, t, J 8.1, H4); 19F NMR (282 MHz, CDC13): Op -78.8 (s, 
CF3); m/z (ES+): 712.4 (65%, MH+). 
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1,4, 7-Tris( carboxymethyl)-{6-[2-(1,4, 7,10-Tetraaza-cyclododec-yl)-propylcarbomoyl]-
pyridin-2-ylmethyl}-trifluoromethanesulfonamide L8 A suspension of 85 (23 mg, 
0.033 mmol) and lithium hydroxide (15 mg) in deuterium oxide (0.7 ml) was left 
standing at room temperature for 24 hours. The hydrolysis of the methyl esters 
was monitored by 1H NMR. The ligand was complexed in situ. oH 2.75- 3.64 (26H, 
m, 14 CH2s), 7.76 (1H, d, J 7.2, H5), 8.00 (1H, d, J 6.9, H5), 8.12 (1H, t, J 8.1, H4); 19F 
NMR (282 MHz, 0 20): oF -78.8 (s, CF3). 
As the synthetic pathway is analogous for the C2 and C3 appended aD03A ligand 
system e and L 10; the synthetic details will only be described for the C2 variant. 
0 
M eo 
OMe 
0 Br 
Dimethyl a-bromo adipate142 76 A solution of monomethyladipic acid (21g, 131 mmol) 
in thionyl chloride (38 ml) and carbon tetrachloride (60 ml) were heated to 65°C for 
40 minutes. N-bromosuccinimide (27.8g, 157 mmol), carbon tetrachloride (50 ml) 
and hydrogen bromide (5 drops) were then added and the resulting orange 
solution was heated at 85°C for 2 hours. The resulting brown solution was then 
cooled with an ice bath and quenched with methanol (80 ml), the suspension which 
formed was stirred overnight. The succinimide precipitate was removed by 
filtration and washed with methanol. The methanol was then removed under 
reduced pressure; the resulting brown oil was dissolved in dichloromethane 
(150 ml) and washed with water (100 ml), then saturated sodium hydrogen 
carbonate (100 ml), then more water (100 ml). The organic phase was then dried 
(Na2S04), filtered and concentrated under reduced pressure to yield a purpley oil 
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(42.3 g). Fractional distillation (125-126°C, 0.1 mm Hg) yielded the desired product 
in 71% yield. 1H NMR (250 MHz, CDC13) CH: 1.64 (2H, m, CHCH2CHBr), 2.05 (2H, 
m, C!:bCHBr), 2.34 (2H, bt, J 7.2, C!:bC02CH3), 3.66 (3H, s, CHBrC02CH2), 3.77 (3H, 
s, CH2C02C!::b), 4.22 (1H, dd J 6.6, 7.9, CHBr); 13C NMR (62.9 MHz, CDC13) Cc: 
22.41 (CH2CH2CHBr), 32.79 (£H2C02CH3), 33.88 (CH2CHBr), 44.91 (CHBr), 51.42 
(CH2COCH3), 52.76 (CHBrCO£H3), 169.79 (CH£02CH3), 172.99 (CHBrC02CH3); 
mjz (ES+): 528.7 (64%, 2MNa\ 276.8 (100%, MNa) 
~~~~ H NI(O~ 
eN ~ 0 0 
R \_j 0 
M eO 
R= OMe 
0 R 
1,4, 7-Tris-[(4'-methoxycarbonyl)-1 'methoxycarbonylbutyl]-{6-[2-(1,4, 7,10-Tetraaza-
cyclododec-yl)-ethylcarbomoyl]-pyridin-2-ylmethyl}-carbamic acid tert-butyl ester 86 
Under anhydrous conditions and an argon atmosphere, a stirred suspension of 77 
(68 mg, 0.151 mmol), a-bromoadipate 76 (170 mg, 0.499 mmol) and sodium 
carbonate (53 mg, 0.499 mmol) in dry acetonitrile (3 ml) was heated at reflux for 10 
days. The reaction mixture was then allowed to cool to room temperature and 
filtered to remove the inorganic solids, evaporation of the solvent yielded a yellow 
oil which was purified by gradient elution column chromatography (Si02, 
1% MeOH in DCM 7 5% MeOH in DCM). The desired product was obtained as a 
yellow oil (67 mg, 46% yield). Rf = 0.22 (Si02, 10% MeOH in DCM). 1H NMR 
(300 MHz, CD3Cl): CH 1.42 (9H, s, t-Bu), 1.59 -3.55 (41H, br m, CH2s), 3.60 (18H, s, 6 
CH3), 4.42 (2H, s, ArCH2NH), 7.40 (1H, d, J 6.6, H3), 7.76 (1H, t, J 7.5, H4), 7.98 (1H, 
d, J 7.2, H5); 13C NMR (75.4 MHz, CDC13): Cc 22.18 (CH3), 28.51 (C(CH2h), 33.63, 
39.99, 45.73, 50.49, 51.63, 74.81 (C(CH3h), 120.68 (C4), 137.94 (C3), 149.72 (CS), 
156.29 (q, C6), 157.67 (C=O), 173.61 (C=O); m/z (ES+): 966.4 (100%, MH\ 
Acc.MS (ES+): Found 966.5485, C46H 76N70 15 requires 966.5399. 
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1,4,7-Tris-[(4'-methoxycarbonyl)-l'methoxycarbonylbutyl]-{6-[2-(1,4,7) 0-Tetraaza-
cyclododec-yl)-ethylcarbomoyl]-pyridin-2-ylmethyl}-amine 88 Under an argon 
abnosphere, a solution of 86 (55 mg, 0.067 mmol) in trifluoroacetic acid (1.5 ml) was 
left standing for 18 hours. The solvent was then removed under reduced pressure 
and the resulting brown oil was redissolved in dichloromethane (1 ml) and the 
solvent evaporated under reduced pressure. This was repeated three times to 
remove the residual TFA. 1H NMR (300 MHz, CD3Cl): 6H 1.59 -3.55 (41H, br m, 
CH2s), 3.60 (18H, s, 6 CH3), 4.42 (2H, s, ArCH2NH), 7.40 (1H, d, J 6.6, H3), 7.76 (1H, 
t, J 7.5, H4), 7.98 (1H, d, J 7.2, H5); m/z (ES+): 434.1 (100%, MH2\ 866.3 (12%, 
MH+). Acc.MS (ES\ Found 866.4825, C41H68N70 13 requires 866.4875. 
0 
M eo 
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OMe 
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N-S-CF 
11 
3 
0 
1A,7-Tris-[ ( 4'-methoxycarbonyl)-l'methoxycarbonylbutyl]-{6-[2-(1A,7,1 0-Tetraaza-
cyclododec-yl)-ethylcarbomoyl]-pyridin-2-ylmethyl}-trifluoromethanesulfoanmide 90 
Under anhydrous conditions and an argon abnosphere, trifluoromethanesulfonyl 
chloride (0.0072ml, 0.067 mmol) was added to a stirred solution of 88 (0.0673 mmol) 
in dichloromethane (0.5 ml) and Hunig's base (0.012ml, 0.0673 mmol) which had 
been cooled to -40°C. The reaction mixture was stirred at -40°C for two hours, then 
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held at -18°C for 18 hours. The solvent was removed under reduced pressure and 
the resulting brown oil was purified by flash column chromatography (Si02, 2% 
MeOH in DCM). The desired product was obtained as a clear oil (15 mg, 22% 
yield). 1H NMR (300 MHz, CD3Cl): 6H 1.63 -3.46 (44H, br m, CH2s), 3.66 (18H, m, 6 
CH3), 3.96 (2H, s, ArCH~NH), 7.36 (1H, d, J 7.8, H3), 7.83 (1H, t, J 7.8, H4), 8.01 (1H, 
d, J 8.1, H5); 19F NMR (282 MHz, CD3Cl): 6F -79.10 (s, CF3); m/z (ES+): 998.6 (100%, 
MH\ Acc.MS (ES\ Found 998.4404, C44H67N70 15F3S requires 998.4368. 
0 
uo 
R= 
0 R 
0 
11 
N-S-CF 
11 3 
0 
Oli 
1,4,7-Tris-[(4'-carbonxy)-1' carbonylbutyl]-{6-[2-(1,4,7,10-Tetraaza-cyclododec-yl)-
ethylcarbomoyl]-pyridin-2-ylmethyl}-trifluoromethanesulfoanmide L9 A suspension of 90 
(15 mg, 1.5}lmol) and lithium hydroxide (29 mg, 0.69 mmol) in D20 (0.7 ml) and 
dMeOH (0.4 ml) was agitated at room temperature for 24 hours. The reaction was 
monitored by lH NMR. The hydrolysed product was complexed without further 
purification. 1H NMR (300 MHz, CD3Cl): 6H 1.30 -3.52 (44H, br m), 7.44 (1H, d, J 
7.8, H3), 7.70 (2H, m, H4, H5); 19F NMR (282 MHz, D20): 6F -78.79 (s, CF3). 
6.6.2 Complex Synthesis 
The lanthanide complexes were all formed in a similar fashion: an aqueous 
solution containing the ligand and the lanthanide chloride hexahydrate in a 1 : 1 
ratio, was adjusted to pH 5.5 using 1M NaOH solution and heated at 90°C for 18 
hours. The solution was then cooled, the pH was raised to 10 and the solution was 
filtered to remove excess lanthanide as insoluble Ln(OHh The pH was then 
lowered to 5.5 and the solution lyophilised to give the desired complex as a white 
powder. H+ loaded Amberlite IRC-50 weakly acidic cation exchange resin was 
used to remove the salt from the complexes. 
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0 
Eu(C24H 33N 70 9SF:J [Eue] 1H NMR (500 MHz, D20): The spectrum was exchange 
broadened. 19F NMR (500 MHz, D20): 79.35; kH2o 1.57 ms-1; k020 0.50 ms-1; q = 
0.98; "-max(H20) 271 nm (e 4693 dm3mor1cm-1). 
0 
11 
N-S-CF H 11 3 
0 
Gd(C24H 33N 70 9SF:J [Gde] r1P: 6.74 mM-1s-1 (65 MHz, 22°C); 4.34 mM-1s-1 
(60 MHz, 37°C). 
0 
11 
N-S-CF 
H 11 3 
0 
Eu(C25H 35N 70 9SF:J [EuL8] 1H NMR (500 MHz, D20): The spectrum was exchange 
broadened. 19F NMR (500 MHz, D20): 79.20; kH2o 1.69 ms-1; k020 0.49 ms-1; q = 
1.14; "-max(H20) 271 nm (e 4693 dm3mor1cm-1). 
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Gd(C25H 35N 70 9SF:J [GdL8] r1P: 6.56 mM-1s-1 (65 MHz, 22oC); 4.34 mM-1s-1 
(60 MHz, 37°C). 
0 
0 
o (OH2)2HA 
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Eu(C42H 54N 70 21SF:J [EuL9] 1H NMR (500 MHz, D20): The spectrum was exchange 
broadened. 19F NMR (500 MHz, D20): 79.20; kH2o 2.05 ms-1; k020 0.26 ms-1; q = 
1.85; A.max(H20) 271 nm (E 4693 dm3mol-1cm-1). 
0 
o o (OHz)zHA 
-:+! /V N ,__ I -6~~~~~] N 0 0 Gd 11 { I '~ 0 N-S-CF N\..f-JN H 11 3 OJ~ 0 0 ~0 r 
0 
0 
0 
0 
Gd(C42H 54N 70 21 SF:J [GdL9] r1r: 13.40 mM-1s-1 (65 MHz, 22°C); 8.70 mM-1s-1 
(60 MHz, 37°C). 
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Eu(C43H 56N 70 21 SF.J [EuL10] 1H NMR (500 MHz, 0 20): The spectrum was exchange 
broadened; 19F NMR (500 MHz, 0 20): 77.35; kHzO 1.84 ms-1; k 0 :P 0.22 ms-1; q = 
1.65; Amax(H20) 271 nm (r 4693 dm3mor1cm-1). 
0 
0 
0 
0 
Gd(C43H 56N 70 21 SF.J [Gde] r1P: 19.9 mM-1s-1 (65 MHz, 22°C); 13.63 mM-1s-1 
(60 MHz, 37°C). 
6. 7 Chapter 5 Experimental 
0~ 
NOH 
Ethyl 2-Hydroxyimino-2-(pyridyl-2')acetate 97147'148 A solution of sodium nitrite 
(0.96 g, 13.9 mmol) in water (2.42 ml) was added in portions over 30 minutes to a 
stirred solution of ethyl (2-pyridyl) acetate (2.00 g, 12.1 mmol) in glacial acetic acid 
(3 ml), cooled in an ice-bath. The reaction mixture was allowed to warm to room 
temperature and stirred for 40 minutes before water (7 ml) was added. The 
resulting two phase system was stirred at room temperature for two hours. The 
195 
organic and aqueous phases were separated, the organic phase was washed with 
water (20 ml) and the aqueous phase was washed with dichloromethane (20 ml). 
The combined organic phases were dried (MgS04), filtered and evaporated under 
reduced pressure to yield a yellow oil which crystallised on standing. The solid 
was recrystallised from methanol to yield a white crystalline solid (2.00 g, 8S%), 
m.p. 130-132 oc (lie47 m.p. 149-1S0°C); 1H NMR (300 MHz, CDC13): cSH 1.38 (3H, 2t, 
CH3), 4.4S (2H, 2d, CH2), 7.30 (m, Ar), 7.48 (t, Ar), 7.72 (m, Ar), 7.94 (td, Ar), 8.04 
(d,] 7.2, Ar), 8.S6 (d,] 5.1, Ar), 8.60 (d,] 4.8, Ar), 8.88 (broads, OH); the compound 
appears to exist in two forms (E and Z isomers); 13C NMR (6S MHz, CDC13): cSc 
14.10 (CH3), 62.03 (CH2), 123.79 (CS), 12S.4S (C3), 138.46 (C4), 143.01 (q, C2), 
14S.23 (C6), 149.61 (C=N ), 163.6S (C=O); (ES\ 411 (48%, 2M+Na\ 216 (100%, 
MNa+). 
0~ 
NH 
0~ 
Ethyl N-acetyl-2-(pyridyl-2')glycinate 98 Following the method of Kolar et al.156'157 for 
a related quinoline compound, zinc dust (1.472 g, 6S.39 mmol) was added portion-
wise to a clear colourless solution of 97 (96S mg, 192.89 mmol) in glacial acetic acid 
(1S ml) and acetic anhydride (S ml). The resulting suspension was stirred at room 
temperature for two hours, diluted with ice-water (100 ml) and stirred for a further 
40 minutes before being extracted with chloroform (3 x 100 ml). The combined 
organic extracts were washed with S% aqueous sodium hydrogen carbonate 
solution (100 ml) and water (100 ml), dried (MgS04), filtered and solvent removed 
under reduced pressure to yield a yellow oil which was purified by column 
chromatography (Si02, EtOAc, Rf = 0.26), to yield a clear oil (0.441 g, 40%); 
1H NMR (200 MHz, CDC13): cSH 1.20 (3H, t, MeCH2), 2.09 (3H, s, MeC=O), 4.17 (2H, 
m, CH2), S.63 (1H, d,] 7.2, CH), 7.28 (2H, m, HS + NH), 7.SO (1H, d,] 7.8, H3), 7.70 
(1H, td,] 7.6, 1.6, H4), 8.S3 (1H, d,] 4.8, H6); 13C NMR (S0.3 MHz, CDC13): cSc 13.92 
(Me CH2), 22.86 (MeC=O), S7.36 (CH2), 61.77 (CH), 123.26 (CS), 123.29 (C3), 
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137.07(C4), 149.10 (C6), 154.15 (q, C2), 169.71 (C=O), 169.88 (C=O); m/ z (ES+): 467 
(100%, M2Na+), 245 (62%, MNa+); C11H14N20 3.115H20 requires C: 58.50%, H: 6.43%, 
N: 12.24%, found C: 58.42%, H 6.22%, N: 12.24%. Constitution confirmed by x-ray 
crystallography (03srv088): CnH14 N2 03; formula weight 222.24 (gM-1); T = 120(2) 
K; A 0.71073 A (Mo Ka); cystal system orthorhombic; space group Fdd2; Unit cell 
dimensions: a= 38.06(3) A, a= 90°, b = 8.236(6) A, p = 90°, c = 14.590(11) A, y = 90°; 
Volume= 4573(6) A3; Z = 16; density (calculated) 1.291 Mgjm3; crystal size 0.20 x 
0.18 x 0.10 mm3; theta range for data collection 2.14 to 23.29°; total number of 
reflections collected = 4772; independent reflections = 1472; [R(int) = 0.0878]; 
completeness to theta = 23.29°; 99.7 %; refinement method: full-matrix least-squares 
on P; data/ restraints/ parameters: 1472 / 1 / 145; final R indices [1>2sigma(I)]: R1 
= 0.0460, wR2 = 0.0909; R indices (all data): R1 = 0.0728, wR2 = 0.0989. 
OH 
NH 
0~ 
N-Acetyl-2-pyridylglycine 96 Sodium hydroxide solution (0.02M, 30 ml) was added 
to ethyl N-acetyl-2-(2' -pyridyl)glycinate 98 (100 mg, 0.45 mmol), the resulting 
solution was stirred at room temperature for 18 hours. The reaction mixture was 
neutralised to pH 7 using 0.1M HCl(aq). The water was removed by lyophilisation 
to yield as white solid. 1H NMR (200 MHz, D20): 6H 2.07 (3H, s, Me), 5.31 (1H, s, 
CH), 7.36 (1H, t, J 5.6, HS), 7.46 (1H, d, J 7.8, H3), 7.84 (1H, t, J 7.6, H4), 8.44 (1H, d, J 
4.8, H6); 13C NMR (50.3 MHz, CDC13): 6c 22.86 (Me), 61.03 (CH), 123.28 (CS), 123.66 
(C3), 138.57 (C4), 148.90 (C6), 156.98 (q, C2), 173.49 (C=O), 175.17 (C=O). 
NH o=< 
CH3 
OH 
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N-(2-Hydroxy-1-pyridin-2-yl-ethyl)-acetamide 99 following the proceedure of 
Gilbertson and Chang/58 lithium borohydride (0.19 g, 18.0 mmol) was added in 
portions to a stirred solution of 98 (2.0 g, 9.0 mmol) in dry THF (80 ml) which was 
cooled in an ice bath. The resulting pink reaction mixture was allowed to warm 
gradually to room temperature; stirring was continued for a further 18 hours. The 
reaction was then quenched with 1M HCl (10 ml), neutralised with aqueous 
sodium hydrogen carbonate, and extracted with dichloromethane (3 x 70 ml). Then 
combined organic extracts were dried (MgS04) and concentrated under reduced 
pressure to give a white solid which was recrystallised from ethanol to give the 
desired product as a white crystalline solid (0.66 g, 41 %). m.p. 112-ll4°C; Rf = 0.39 
(Si02, 10% MeOH in DCM); 1H NMR (200 MHz, CDC13): 61-1 2.06 (2H, s, CH3), 3.91 
(1H, dd, l8 A 4.5, J8 x 11.3, CHAH120H), 3.9S (1H, dd, lAB 4.5, lAx 11.5, C~H80H), 
4.91 (1H, m, CHCH2), 7.16 (1H, br s, NH), 7.2S (1H, t, l 6.6, HS), 7.37 (1H, d, l 7.8, 
H3), 7.71 (1H, t, l 7.8, H4), 8.S1 (1H, d, l 4.8, H6); 13C NMR (S0.3 MHz, CDC13): 6c 
23.47 (CH3), S4.76 (CH2), 66.69 (CH), 123.12 (C3 or CS), 123.37 (C3 or CS), 137.42 
(C4), 148.80 (C6), 1S8.57 (q, C2); m/z ES+: 181.0 (100%, MH\ C9H12N20 2 requires 
C: S9.99%, H: 6.71 %, N: 1S.33%, found C: S9.69%, H: 6.70%, N: 1S.S4%. 
OH 
2-Amino-1-pyridin-2-yl-ethanol 100 A solution of 99 (0.300 g, 1.66 mmol) in 6M 
hydrochloric acid (15 ml) and heated under reflux for four hours. The solution was 
then allowed to cool to room temperature and the solvent was evaporated to yield 
the salt of the desired product as a yellow oil. 1H NMR (300 MHz, D20): 61-1 3.98 
(1H, dd, l 8 A 4.8, l 8 x 12.4, CHAH120H), 4.10 (1H, dd, lAB 4.8, lAx 12.5, CH&H8 0H), 
4.91 (2H, t, l 4.8, CHCH2), 8.04 (1H, t, l 6.6, HS), 8.12 (1H, d, J 8.1, H3), 8.61 (1H, t, l 
8.1, H4), 8.79 (1H, d, l 6.3, H6); 13C NMR (7S.4 MHz, D20): 6c 52.9S (CH2), 60.SS 
(CH), 126.00 (C3 or CS), 127.81 (C3 or CS), 142.60 (C4), 147.15 (q, C2), 148.10 (C6); 
m/z ES+: 139.2 (100%, MH+). 
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(±)-N-(2-Hydroxy-1-pyrindin-2-yl-ethyl)-trifluromethanesulfonamide 101 An aqueous 
solution of 100 (0.536 g, 3.88 mmol), was eluted through an OH" loaded Amberlite 
anion exchange column, the solvent was then removed under reduced pressure. 
Under an atmosphere of argon, the resulting solid was dissolved in dry 
dichloromethane (9 ml) and Hiinig's base (0.67 ml, 3.9 mmol) and the solution 
cooled to -40°C. Trifluoromethanesulfonyl chloride (0.41 ml, 3.9 mmol) was added 
and the reaction mixture was stirred at -40°C for one hour then warmed gradually 
to -20°C and held at this temperature for 18 hours, before being allowed to warm to 
room temperature. The solvent was removed under reduced pressure and the 
resulting oil was purified by flash column chromatography (Si02, EtOAc). The 
product was obtained as a pale yellow solid (0.826 g, 79%). Rf = 0.42 (Si02, EtOAc), 
m.p. 86 - 87°C; 1H NMR (200 MHz, CDC13): OH 3.86 (1H, dd, lAB 4.1, lAx 11.6, 
CHAHBOH), 3.91 (1H, dd, laA 4.2, lax 11.7, CHAH.!!OH), 4.68 (2H, t, l 4.0, CHCH2), 
7.S4 (1H, t, l 6.6, HS), 7.61 (1H, d, l 7.8, H3), 8.08 (1H, t, l 8.1, H4), 8.47 (1H, d, l 5.4, 
H6); 13C NMR (S0.29 MHz, CDC13): oc S9.20 (CH2), 6S.71 (CH), 122.99 (C3 or CS), 
123.88 (C3 or CS), 137.9S (C4), 149.12 (C6), 1S6.81 (q, C2); 19F NMR (188 MHz, 
CDC13): oF -77.94 (s, CF3); mjz ES+: 624.6 (100%, (M-H)zCu\ 292.9 (20%, MNa\ 
270.9 (5%, MH\ (KBr)/cm-1 328S (v OH), 1S97 (v py), 137S (6 NH), 1229 (va SOz), 
1192 (vs 502), 1147 (o CH), 1074 (o CH), 604 (y NH); Found: C, 3S.81; H, 3.40; N, 
10.22. C8H9N20 3F3S requires C, 3S.56; H, 3.3S; N, 10.36. 
(±)-N-(2-Methanesulfoxy-1-pyrindin-2-yl-ethyl)-trifluromethanesulfonamide 104 
Methanesulfonyl chloride (21 mg, 0.18 mmol) was added to a solution of 101 
(50 mg, 0.18 mmol) and triethylamine (0.026ml, 0.18 mmol) in dichloromethane 
(2 ml) which had been cooled with an ice bath. The reaclion mixture was then 
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allowed to warm gradually to room temperature and was stirred for 4 hours. The 
formation of the mesylate was monitored by TLC; Rf = 0.57 (Si02, 10% MeOH in 
DCM). The product was not isolated but reacted on in situ. 
0 tot~u 
N N B!SN ) 
0 \_j 7 
tBuO~ 
0 
---N 
0 
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-s H // -cF3 
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1,4, 7-Tris-tert-butoxycarbonylmethyl-10-[ (±)-N-(2-Hydroxy-1-pyrindin-2-yl-ethyl)-
trifluromethanesulfonamide ]-1,4, 7,1 Otetraaza-et;clododecane 105 Under an argon 
atmosphere, a yellow solution of 104 in dichloromethane (2 ml) was added to a 
suspension of 48 (95 mg, 0.18 mmol) and caesium carbonate (301 mg, 0.92 mmol) in 
dry acetonitrile (3 ml). The resulting suspension was heated under reflux for 18 
hours before being allowed to cool to room temperature. The reaction mixture was 
filtered to remove inorganic solids and washed thoroughly with dichloromethane. 
Flash column chromatography (Si02, gradient elution 2% MeOH in DCM ~ 15% 
MeOH in DCM) isolated the desired product as a pale brown oil (31 mg, 22% ). Rf = 
0.43 (Si02, 10% MeOH in DCM). 1H NMR (300 MHz, CDC13): The aromatic region 
of the 1H NMR suggests that this molecule exists in two different conformations in 
chloroform solution. 1.37 (18H, s, 2 tBu), 1.44 (9H, s, tBu), 1.98- 3.61 (22H, br m, 11 
CH2), 6.99 (O.SH, d, J 7.5, H3), 7.07 (0.5H, t, J 6.0, HS), 7.18 (O.SH, t, J 6.0, HS), 7.35 
(O.SH, d, J 7.8, H3), 7.60 (1H, m, H4), 8.40 (0.5H, d, J 3.6, H6), 8.45 (0.5H, d, J 3.6, 
H6); 13C NMR (125 MHz, CDC13) 6c: 27.71 (C(~), 29.61, (CH2), 39.02 (CH2), 
43.33 (CH2), 44.87 (CH2), 45.35 (CH2), 52.62 (CH2), 53.22 (CH0, 53.43 (CH2), 56.71 
(CH2), 57.34 (CH2), 57.79 (CH2), 64.69 (CH), 86.69 (C(CH3h), 123.44 (C3), 124.48 
(CS), 136.61 (C4), 149.33 (C6), 154.49 (q, C2), 175.54 (C=O), 176.25 (C=O), 176.66 
(C=O); 19F NMR (188 MHz, CDC13): 6F -77.70 (s, CF3); m/ z (ES+): 805.3 (100%, 
MCa +); Ace. MS (ES\ Found 805.3524, C34H56N60 8SF3Ca requires 805.3458. 
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1,4,7-Tris-carboxymethyl-10-[ (±)-N-(2-Hydroxy-1-pyrindin-2-yl-ethyl) trijluromethane 
sulfonamide ]-1,4,7,10tetraaza-cyclododecane L 12 Under an argon abnosphere, a 
solution of 105 (31 mg, 0.04 mmol) in trifluoroacetic acid (1 ml) was left standing for 
48 hours. The solvent was then removed under reduced pressure. The resulting 
solid was washed with dichloromethane (3 x 2 ml) and the solvent removed under 
reduced pressure to give a pale yellow oil. 1H NMR (300 MHz, 0 20): 1.98- 3.61 
(22H, br m, 11 CH2), 7.65 (0.5H, br, H3), 7.95 (0.5H, m, H5), 8.06 (0.5H, m, H5), 8.26 
(0.5H, d, J 7.8, H3), 8.59 (1H, m, H4), 8.74 (0.5H, d, J 6.0, H6), 8.83 (0.5H, d, J 5.1, 
H6); 19F NMR (282 MHz, 0 20): 6F -76.10 (s, CF3); m/z (ES) 657.1 (36%, MNaCa\ 
317.3 (100%, MCa2+). 
Gd(C22H3aN60 8SF} [GdL12] An aqueous solution (2 ml) containing L11 (26 }lffiOl) 
and gadolinium chloride hexahydrate (10 mg, 26 }lffiOl) was adjusted to pH 5.5 
using 1M NaOH solution and heated at 90°C for 18 hours. After the solution was 
cooled, the pH was raised to 10 and the solution was filtered to remove excess 
gadolinium as Gd(OHh- The pH was then lowered to 5.5 and the solution 
lyophilised to give the complex as a white powder. m/z (ES-): 751.5 (100%, 
[M-HD; Acc.MS (ES-): Found 752.0969, C22H 29N60 8 SF3Gd requires 752.0966; r1P 
(60 MHz, 37°C): 2.67 mM-\-1; r1P (65 MIIz, 22°C): 3.73 mM-1s-1. 
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Eu(C22H3aN60 8SF:J [EuL12] An aqueous solution (2 ml) containing L11 (13 proal) 
and europium chloride hexahydrate (5 mg, 13 11mol) was adjusted to pH 5.5 using 
1M NaOH solution and heated at 90°C for 18 hours. After the solution was cooled, 
the pH was raised to 10 and the solution was filtered to remove excess europium as 
Eu(OHh- The pH was then lowered to 5.5 and the solution lyophilised to give the 
desired complex as a white powder. 1H NMR (200 MHz, D20): shows that at least 
three isomers were present; the peaks were characteristic of a major (A) and a 
minor (B) square antiprism (SAP) conformation and a minor (C) twisted square 
antiprism (TSAP) in a ratio of 21 : 4: 9. Partial assignment 35.1 (1H, s, Hax' B), 34.2 
(1H, s, Hax' B), 32.9 (1H, s, Hax' A), 30.8 (1H, s, Hax' A), 29.5 (1H, s, Hax' B), 27.1 (1H, 
s, Hw B), 26.4 (1H, s, Hax' A), 23.2 (1H, s, Hax' C), 22.6 (1H, s, Hax' C), 22.3 (1H, s, 
Hax' C), 19.8 (1H, s, Hax' C), 14.0 (1H, s, Hav A), 12.9 (1H, s, Hav B), the remaining 
resonances span 11.8 to - 20.2ppm; 19F NMR (188 MHz, D20): 5F -76.03 (s, CF3); 
m/z (ES-): 746.6 (48%, [M-Hn; Acc.MS (ES-): Found 747.0942, C22H29N60 8 SF3Eu 
requires 747.0937; kH2o (A.ex 262 nm, A.em 616 nm): 1.35 ms-
1
; k020: 0.53 ms-\ qEu = 
0.7. 
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February 26 Dr Mike Griffin, Forensic Science Service, Metropolitan Police 
Smack, Crack, Speed and Weed: A forensic chemist's tale 
March 12 Professor David Williams, Cardiff 
Beer and Health: 7000 years of history 
March 15 
October 2 
October 15 
October 16 
October 23 
October 30 
Dr Graham Saunders, Queens University, Belfast 
Dehydrofluorinative Carbon-Carbon Coupling as a Route to 
Complexes of Hybrid Cyclopentadienide- and Arene-Phosphine 
Ligands 
Professor Gideon Davies, Department of Chemistry, University of 
York 
Structural Enzymology of Glycosyl Transfer: How Enzymes Make 
and Degrade Polysaccharides 
Professor Mike Zaworotko from the University of South Florida 
Suparamolecular Synthesis of Functional Molecules & Materials 
Dr. Hubert LeBozec, Universite de Rennes 1, France 
Design of Molecular and Supramolecular Metal Polypyridine 
Complexes for Nonlinear Optics 
Professor Marcetta Darensbourg, Department of Chemistry, Texas 
A&M University 
Functioning Catalysts Inspired by Active Sites in Bio-Organometallic 
Chemistry: The Hydrogenases 
Professor Tim Bugg, Department of Chemistry, Warwick University 
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Enzymes in Aromatic Degradation 
November 5 Dr Cliff Ludman, University of Durham 
Explosions: a demonstration lecture 
November 6 Professor Steve Perkins, Department of Biochemistry and Molecular 
Biology, UCL 
Modelling large uncrystallisable protein structures using X-ray and 
neutron scattering 
November 12 Dr Dave Alker, Pfizer 
The Discovery of a New Medicine 
November 13 Professor Geoffrey Lawrance, Newcastle University, Australia 
Designer Ligands: Macrocyclic and alicyclic molecules for metal 
complexation and biocatalysis 
November 27 Professor Marc Lemaire, University Claude Bernard, Lyon 
Organic Synthesis and Heterogenous Asymmetric Catalysis 
2003 
January 15 
January 22 
Professor Pat Bailey, Department of Chemistry, UMIST 
Planned and unplanned routes to bio-active target molecules 
Dr David Procter, Department of Chemistry, University of Glasgow 
New Strategies and Methods for Organic Synthesis 
February 11 Dr Jolm Emsley, University of Cambridge 
False Alarms: Chemistry & the Media 
February 19 Professor Tony Ryan, Department of Chemistry, University. of 
Sheffield 
March4 
March 12 
Introducing Soft Nanotechnology 
Professor Richard Taylor, University of York 
Adventures in Natural Product Synthesis 
Professor David Lilley, School of Life Sciences, University of Dundee 
Structure, folding and catalytic activity in RNA molecules 
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Publications 
Examination of cobalt, nickel, copper and zinc (11) complex geometry and binding 
affinity in aqueous media using simple pyridylsulfonamide ligands. 
A. Congreve, R. Kataky, M.Knell, D. Parker, H. Puschmann, K. Senanayake, 
L. Wylie, New J. Chem., 27 (1): 98-106 2003. 
Steric control of lanthanide hydration state: fast water exchange at gadolinium in a 
mono-amide 'DOT A' complex. 
A. Congreve, D. Parker, E. Gianolio, M. Botta, Dalton Trans., in press. 
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